1.1 	A bill for an act
1.2 	relating to cannabis; modifying cannabis business, hemp business, and cannabis 
1.3 	event organizer license and endorsement provisions; establishing a cannabis 
1.4 	macrobusiness license; modifying labeling requirements for cannabinoid products 
1.5 	and lower-potency hemp edibles; modifying studies and an annual market analysis 
1.6 	conducted by the Office of Cannabis Management; providing that data reported 
1.7 	to the Office of Cannabis Management through the statewide monitoring system 
1.8 	is not public data; modifying provisions related to public data on cannabis business 
1.9 	license applicants and license holders; modifying provisions relating to a local 
1.10 	unit of government's regulation of cannabis businesses; requiring reports;amending 
1.11 	Minnesota Statutes 2024, sections 342.01, subdivisions 14, 20, 52, 54, by adding 
1.12 	a subdivision; 342.02, subdivision 2; 342.07, subdivision 3; 342.09, subdivision 
1.13 	3; 342.14, subdivisions 1b, 10; 342.15, subdivisions 2, 5; 342.175; 342.185, 
1.14 	subdivisions 1, 2, 3; 342.19, subdivision 6; 342.20, subdivisions 1, 2, 3, by adding 
1.15 	a subdivision; 342.22, subdivisions 1, 4, 5; 342.23, subdivision 5, by adding a 
1.16 	subdivision; 342.25, subdivisions 1, 2, 3, 4, 5, 6, 7; 342.26, subdivisions 1, 2, 3, 
1.17 	4, 5; 342.27, subdivisions 1, 2, 12, by adding a subdivision; 342.28, subdivisions 
1.18 	6, 7, 9, 11, by adding subdivisions; 342.29, subdivisions 5, 6, 8, 8a, 10, by adding 
1.19 	subdivisions; 342.30, subdivision 3, by adding a subdivision; 342.31, subdivisions 
1.20 	3, 5; 342.32, subdivision 3, by adding a subdivision; 342.35, subdivision 1; 342.37, 
1.21 	subdivision 1; 342.39, as amended; 342.40, subdivision 1; 342.41, subdivision 1; 
1.22 	342.44, subdivision 2; 342.45, subdivision 3; 342.51, subdivision 3, by adding 
1.23 	subdivisions; 342.515, as amended; 342.61, subdivision 5, by adding a subdivision; 
1.24 	342.63, subdivision 4, by adding a subdivision; 342.66, subdivision 3; 342.80; 
1.25 	Minnesota Statutes 2025 Supplement, sections 342.01, subdivisions 48, 50; 342.04; 
1.26 	342.10; 342.11; 342.12; 342.13; 342.14, subdivisions 3, 6; 342.16; 342.18, 
1.27 	subdivision 2; 342.22, subdivision 3; 342.28, subdivisions 1, 8; 342.29, subdivisions 
1.28 	1, 7; 342.30, subdivision 1; 342.32, subdivision 1; 342.40, subdivision 7; 342.43, 
1.29 	subdivision 2; 342.44, subdivision 1; 342.46, subdivision 8; 342.51, subdivision 
1.30 	2; 342.61, subdivision 4; 342.62, subdivision 2; 342.63, subdivisions 2, 3, 5, 6; 
1.31 	proposing coding for new law in Minnesota Statutes, chapter 342; repealing 
1.32 	Minnesota Statutes 2024, sections 151.72, subdivisions 1, 2, 4, 5, 5b, 5c, 6, 7; 
1.33 	342.51, subdivision 1; Minnesota Statutes 2025 Supplement, section 151.72, 
1.34 	subdivisions 3, 5a.
2.1 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

2.2 	Section 1. Minnesota Statutes 2024, section 342.01, subdivision 14, is amended to read:
2.3 		Subd. 14.Cannabis business. "Cannabis business" means any of the following licensed 
2.4 	under this chapter:
2.5 	(1) cannabis microbusiness;
2.6 	(2) cannabis mezzobusiness;
2.7 	(3) cannabis cultivator;
2.8 	(4) cannabis manufacturer;
2.9 	(5) cannabis retailer;
2.10 	(6) cannabis wholesaler;
2.11 	(7) cannabis transporter;
2.12 	(8) cannabis testing facility;
2.13 	(9) cannabis event organizer;
2.14 	(10) cannabis delivery service; and
2.15 	(11) medical cannabis combination business macrobusiness.

2.16 	EFFECTIVE DATE. This section is effective January 1, 2027.

2.17 	Sec. 2. Minnesota Statutes 2024, section 342.01, subdivision 20, is amended to read:
2.18 		Subd. 20.Cannabis product. (a) "Cannabis product" means any of the following:
2.19 	(1) cannabis concentrate;
2.20 	(2) a product infused with cannabinoids, including but not limited to tetrahydrocannabinol, 
2.21 	extracted or derived from cannabis plants or cannabis flower;
2.22 	(3) a ratio hemp-infused cannabis product; or
2.23 	(3) (4) any other product that contains cannabis concentrate.
2.24 	(b) Cannabis product includes adult-use cannabis products, including but not limited to 
2.25 	edible cannabis products and medical cannabinoid products. Cannabis product does not 
2.26 	include cannabis flower, artificially derived cannabinoid, lower-potency hemp edibles, 
2.27 	hemp-derived consumer products, or hemp-derived topical products.

2.28 	EFFECTIVE DATE. This section is effective January 1, 2027.

3.1 	Sec. 3. Minnesota Statutes 2025 Supplement, section 342.01, subdivision 48, is amended 
3.2 	to read:
3.3 		Subd. 48.License holder. "License holder" means a person, cooperative, or business 
3.4 	that holds any of the following licenses:
3.5 	(1) cannabis microbusiness;
3.6 	(2) cannabis mezzobusiness;
3.7 	(3) cannabis cultivator;
3.8 	(4) cannabis manufacturer;
3.9 	(5) cannabis retailer;
3.10 	(6) cannabis wholesaler;
3.11 	(7) cannabis transporter;
3.12 	(8) cannabis testing facility;
3.13 	(9) cannabis event organizer;
3.14 	(10) cannabis delivery service;
3.15 	(11) lower-potency hemp edible manufacturer;
3.16 	(12) lower-potency hemp edible wholesaler;
3.17 	(13) lower-potency hemp edible retailer; or
3.18 	(14) medical cannabis combination business macrobusiness.

3.19 	EFFECTIVE DATE. This section is effective January 1, 2027.

3.20 	Sec. 4. Minnesota Statutes 2025 Supplement, section 342.01, subdivision 50, is amended 
3.21 	to read:
3.22 		Subd. 50.Lower-potency hemp edible. (a) "Lower-potency hemp edible" means any 
3.23 	product that:
3.24 	(1) is intended to be eaten or consumed as a beverage by humans;
3.25 	(2) contains hemp concentrate or an artificially derived cannabinoid, in combination 
3.26 	with food ingredients;
3.27 	(3) is not a drug;
3.28 	(4) does not contain a cannabinoid derived from cannabis plants or cannabis flower;
4.1 	(5) is a type of product approved for sale by the office or is substantially similar to a 
4.2 	product approved by the office, including but not limited to products that resemble 
4.3 	nonalcoholic beverages, candy, and baked goods; and
4.4 	(6) meets either of the requirements in paragraph (b).
4.5 	(b) A lower-potency hemp edible includes:
4.6 	(1) a product that:
4.7 	(i) is not intended to be consumed as a beverage and consists of servings that contain 
4.8 	no more than five milligrams of delta-9 tetrahydrocannabinol; is intended to be consumed 
4.9 	as a beverage and contains no more than ten milligrams of delta-9 tetrahydrocannabinol in 
4.10 	a single container; is intended to be consumed in any approved manner and consists of 
4.11 	servings or a container that contain no more than up to 100 milligrams of cannabidiol, up 
4.12 	to 100 milligrams of cannabigerol, up to 100 milligrams of cannabinol, or up to 100 
4.13 	milligrams of cannabichromene, or any combination of cannabidiol, cannabigerol, cannabinol, 
4.14 	and cannabichromene as long as the combination or the individual amounts of each 
4.15 	cannabinoid does not exceed 400 milligrams; is intended to be consumed in any approved 
4.16 	manner and contains no more than the established limit of any other cannabinoid authorized 
4.17 	by the office; or is intended to be consumed in any approved manner and contains any 
4.18 	combination of those cannabinoids that does not exceed the identified amounts for the 
4.19 	applicable product category;
4.20 	(ii) does not contain more than a combined total of 0.5 milligrams of all other 
4.21 	cannabinoids per serving; and
4.22 	(iii) does not contain an artificially derived cannabinoid other than delta-9 
4.23 	tetrahydrocannabinol, except that a product may include artificially derived cannabinoids 
4.24 	created during the process of creating the delta-9 tetrahydrocannabinol that is added to the 
4.25 	product, if no artificially derived cannabinoid is added to the ingredient containing delta-9 
4.26 	tetrahydrocannabinol and the ratio of delta-9 tetrahydrocannabinol to all other artificially 
4.27 	derived cannabinoids is no less than 20 to one; or
4.28 	(2) a product that:
4.29 	(i) contains hemp concentrate processed or refined without increasing the percentage of 
4.30 	targeted cannabinoids or altering the ratio of cannabinoids in the extracts or resins of a hemp 
4.31 	plant or hemp plant parts beyond the variability generally recognized for the method used 
4.32 	for processing or refining or by an amount needed to reduce the total THC in the hemp 
4.33 	concentrate; and
5.1 	(ii) consists of servings that contain no more than five milligrams of total THC.

5.2 	Sec. 5. Minnesota Statutes 2024, section 342.01, subdivision 52, is amended to read:
5.3 		Subd. 52.Medical cannabinoid product. (a) "Medical cannabinoid product" means a 
5.4 	cannabis product that:
5.5 	(1) consists of or contains cannabis concentrate or hemp concentrate or is infused with 
5.6 	cannabinoids, including but not limited to artificially derived cannabinoids; and
5.7 	(2) is provided to a patient enrolled in the registry program; a visiting patient; a registered 
5.8 	designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a 
5.9 	registered designated caregiver, cannabis retailer, or cannabis business with a medical 
5.10 	cannabis retail endorsement to treat or alleviate the symptoms of a qualifying medical 
5.11 	condition.
5.12 	(b) A medical cannabinoid product must be in the form of:
5.13 	(1) liquid, including but not limited to oil;
5.14 	(2) pill;
5.15 	(3) liquid or oil for use with a vaporized delivery method;
5.16 	(4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;
5.17 	(5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and 
5.18 	sublingual tablets;
5.19 	(6) edible products in the form of gummies and chews;
5.20 	(7) topical formulation; or
5.21 	(8) any allowable form or delivery method approved by the office.
5.22 	(c) Medical cannabinoid product does not include adult-use cannabis products or 
5.23 	hemp-derived consumer products.

5.24 	EFFECTIVE DATE. This section is effective January 1, 2027.

5.25 	Sec. 6. Minnesota Statutes 2024, section 342.01, subdivision 54, is amended to read:
5.26 		Subd. 54.Medical cannabis flower. "Medical cannabis flower" means cannabis flower 
5.27 	provided to a patient enrolled in the registry program or a visiting patient; a registered 
5.28 	designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a 
5.29 	registered designated caregiver, cannabis retailer, or cannabis business with a medical 
6.1 	cannabis retail endorsement to treat or alleviate the symptoms of a qualifying medical 
6.2 	condition. Medical cannabis flower does not include adult-use cannabis flower.

6.3 	EFFECTIVE DATE. This section is effective January 1, 2027.

6.4 	Sec. 7. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to 
6.5 	read:
6.6 		Subd. 63a.Ratio hemp-infused cannabis product. (a) "Ratio hemp-infused cannabis 
6.7 	product" means a product that:
6.8 	(1) contains cannabis extracts in combination with cannabinoids derived from hemp as 
6.9 	defined by United States Code, title 7, section 1639o(1), that are not artificially derived 
6.10 	cannabinoids and have been approved by the office as nonintoxicating, in the same or 
6.11 	different concentrations than naturally occur in the plant; and
6.12 	(2) is a product category approved by the office.
6.13 	(b) Ratio hemp-infused cannabis products must not include more than 100 milligrams 
6.14 	of cannabidiol, cannabigerol, cannabinol, or cannabichromene per serving.
6.15 	(c) If a ratio hemp-infused cannabis product is meant to be eaten, the product must not 
6.16 	include more than ten milligrams of THC per serving and 200 milligrams of THC per 
6.17 	package.
6.18 	(d) If a ratio hemp-infused cannabis product is meant to be consumed as a beverage, the 
6.19 	product must not include more than ten milligrams of THC per serving, and a single beverage 
6.20 	container may not contain more than two servings.
6.21 	(e) If a ratio hemp-infused cannabis product is meant to be used as a transdermal or 
6.22 	topical product, the product must not include more than the limit approved by the office in 
6.23 	rule.
6.24 	(f) If a ratio hemp-infused cannabis product is designed for a vaporized delivery method, 
6.25 	the product must not exceed the limit approved by the office in rule.

6.26 	EFFECTIVE DATE. This section is effective January 1, 2027.

6.27 	Sec. 8. Minnesota Statutes 2024, section 342.02, subdivision 2, is amended to read:
6.28 		Subd. 2.Powers and duties. (a) The office has the following powers and duties:
6.29 	(1) to develop, maintain, and enforce an organized system of regulation for the cannabis 
6.30 	industry and hemp consumer industry;
7.1 	(2) to establish programming, services, and notification to protect, maintain, and improve 
7.2 	the health of citizens;
7.3 	(3) to prevent unauthorized access to cannabis flower, cannabis products, lower-potency 
7.4 	hemp edibles, and hemp-derived consumer products by individuals under 21 years of age;
7.5 	(4) to establish and regularly update standards for product manufacturing, testing, 
7.6 	packaging, and labeling, including requirements for an expiration, sell-by, or best-used-by 
7.7 	date;
7.8 	(5) to promote economic growth with an emphasis on growth in areas that experienced 
7.9 	a disproportionate, negative impact from cannabis prohibition;
7.10 	(6) to issue and renew licenses;
7.11 	(7) to require fingerprints from individuals determined to be subject to fingerprinting, 
7.12 	including the submission of fingerprints to the Federal Bureau of Investigation where 
7.13 	required by law and to obtain criminal conviction data for individuals seeking a license 
7.14 	from the office on the individual's behalf or as a cooperative member or director, manager, 
7.15 	or general partner of a business entity;
7.16 	(8) to receive reports required by this chapter and inspect the premises, records, books, 
7.17 	and other documents of license holders to ensure compliance with all applicable laws and 
7.18 	rules;
7.19 	(9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations 
7.20 	pursuant to the office's authority;
7.21 	(10) to impose and collect civil and administrative penalties as provided in this chapter;
7.22 	(11) to publish such information as may be deemed necessary for the welfare of cannabis 
7.23 	businesses, cannabis workers, hemp businesses, and hemp workers and the health and safety 
7.24 	of citizens;
7.25 	(12) to make loans and grants in aid to the extent that appropriations are made available 
7.26 	for that purpose;
7.27 	(13) to authorize research and studies on cannabis flower, cannabis products, artificially 
7.28 	derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the 
7.29 	cannabis industry, and the hemp consumer industry;
7.30 	(14) to provide reports as required by law;
7.31 	(15) to develop a warning label regarding the effects of the use of cannabis flower and 
7.32 	cannabis products by persons 25 years of age or younger;
8.1 	(16) to determine, based on a review of medical and scientific literature, whether it is 
8.2 	appropriate to require additional health and safety warnings containing information that is 
8.3 	both supported by credible science and helpful to consumers in considering potential health 
8.4 	risks from the use of cannabis flower, cannabis products, lower-potency hemp edibles, and 
8.5 	hemp-derived consumer products, including but not limited to warnings regarding any risks 
8.6 	associated with use by pregnant or breastfeeding individuals, or by individuals planning to 
8.7 	become pregnant, and the effects that use has on brain development for individuals under 
8.8 	the age of 25;
8.9 	(17) to establish limits on the potency of cannabis flower and cannabis products that can 
8.10 	be sold to customers by licensed cannabis retailers, licensed cannabis microbusinesses, and 
8.11 	licensed cannabis mezzobusinesses with an endorsement to sell cannabis flower and cannabis 
8.12 	products to customers;
8.13 	(18) to establish rules authorizing an increase in plant canopy limits and outdoor 
8.14 	cultivation limits to meet market demand and limiting cannabis manufacturing consistent 
8.15 	with the goals identified in subdivision 1;
8.16 	(19) to order a person or business that cultivates cannabis flower or manufactures or 
8.17 	produces cannabis products, medical cannabinoid products, artificially derived cannabinoids, 
8.18 	lower-potency hemp edibles, hemp-derived consumer products, or hemp-derived topical 
8.19 	products to recall any cannabis flower, product, or ingredient containing cannabinoids that 
8.20 	is used in a product if the office determines that the flower, product, or ingredient represents 
8.21 	a risk of causing a serious adverse incident; and
8.22 	(20) to exercise other powers and authority and perform other duties required by law.
8.23 	(b) In addition to the powers and duties in paragraph (a), the office has the following 
8.24 	powers and duties until January 1, 2027:
8.25 	(1) to establish limits on the potency of adult-use cannabis flower and adult-use cannabis 
8.26 	products that can be sold to customers by licensed cannabis retailers, licensed cannabis 
8.27 	microbusinesses, and licensed cannabis mezzobusinesses with an endorsement to sell 
8.28 	adult-use cannabis flower and adult-use cannabis products to customers; and
8.29 	(2) to permit, upon application to the office in the form prescribed by the director of the 
8.30 	office, a licensee license holder under this chapter to perform any activity if such permission 
8.31 	is substantially necessary for the licensee license holder to perform any other activity 
8.32 	permitted by the applicant's license and is not otherwise prohibited by law.

8.33 	EFFECTIVE DATE. This section is effective the day following final enactment.

9.1 	Sec. 9. Minnesota Statutes 2025 Supplement, section 342.04, is amended to read:
9.2 	342.04 STUDIES; REPORTS.
9.3 		Subdivision 1.Studies required. (a) The office shall conduct a study to determine the 
9.4 	expected size and growth of the regulated cannabis industry and hemp consumer industry, 
9.5 	including an estimate of the demand for cannabis flower and cannabis products, the number 
9.6 	and geographic distribution of cannabis businesses needed to meet that demand, and the 
9.7 	anticipated business from residents of other states.
9.8 	(b) The office shall conduct a study to determine the size of the illicit cannabis market, 
9.9 	the sources of illicit cannabis flower and illicit cannabis products in the state, the locations 
9.10 	of citations issued and arrests made for cannabis offenses, and the subareas, such as census 
9.11 	tracts or neighborhoods, that experience a disproportionately large amount of cannabis 
9.12 	enforcement.
9.13 	(c) The office shall conduct a study on impaired driving to determine:
9.14 	(1) the number of accidents involving one or more drivers who admitted to using cannabis 
9.15 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products, 
9.16 	or who tested positive for cannabis or tetrahydrocannabinol;
9.17 	(2) the number of arrests of individuals for impaired driving in which the individual 
9.18 	tested positive for cannabis or tetrahydrocannabinol; and
9.19 	(3) the number of convictions for driving under the influence of cannabis flower, cannabis 
9.20 	products, lower-potency hemp edibles, hemp-derived consumer products, or 
9.21 	tetrahydrocannabinol.
9.22 	(d) The office shall provide preliminary reports on the studies conducted pursuant to 
9.23 	paragraphs (a) to (c) to the legislature by January 15, 2024, and shall provide final reports 
9.24 	to the legislature by January 15, 2025. The reports may be consolidated into a single report 
9.25 	by the office.
9.26 	(e) The office shall collect existing data from the Department of Human Services, 
9.27 	Department of Health, Direct Care and Treatment, Minnesota state courts, and hospitals 
9.28 	licensed under chapter 144 on the utilization of mental health and substance use disorder 
9.29 	services, emergency room visits, and commitments to identify any increase in the services 
9.30 	provided or any increase in the number of visits or commitments. The office shall also obtain 
9.31 	summary data from existing first episode psychosis programs on the number of persons 
9.32 	served by the programs and number of persons on the waiting list. All information collected 
10.1 	by the office under this paragraph shall be included in the report required under paragraph 
10.2 	(f).
10.3 		Subd. 2.Annual market analysis. (f) (a) The office shall conduct an annual market 
10.4 	analysis on the status of the regulated cannabis industry and submit a report of the findings. 
10.5 	An annual market analysis under this subdivision must include:
10.6 	(1) the number of licenses issued by the office;
10.7 	(2) recommendations on the number of licenses that the office should make available;
10.8 	(3) information about the stability of the regulated market, including an assessment of 
10.9 	the available supply and whether the supply is sufficient for consumer demand in the state;
10.10 	(4) the impact of unregulated sales of cannabis flower and cannabis products on the 
10.11 	regulated market; and
10.12 	(5) the status of the medical cannabis patient registry program.
10.13 	(b) The office may solicit the input of consumers, market stakeholders, and potential 
10.14 	new applicants for the annual market analysis under paragraph (a). The office shall submit 
10.15 	the report by January 15, 2025, and each January 15 thereafter and the report may be 
10.16 	combined with the annual report submitted by the office. The process of completing the 
10.17 	market analysis must include holding public meetings to solicit the input of consumers, 
10.18 	market stakeholders, and potential new applicants and must include an assessment as to 
10.19 	whether the office has issued the necessary number of licenses in order to: annual market 
10.20 	analysis under paragraph (a) as part of the annual report required in subdivision 3.
10.21 	(1) ensure the sufficient supply of cannabis flower and cannabis products to meet demand;
10.22 	(2) provide market stability;
10.23 	(3) ensure a competitive market; and
10.24 	(4) limit the sale of unregulated cannabis flower and cannabis products.
10.25 		Subd. 3.Annual report required. (g) (a) The office shall submit an annual report to 
10.26 	the legislature by January 15, 2024, and each January 15 thereafter year. The annual report 
10.27 	shall must include but not be limited to the following:
10.28 	(1) the status of the regulated cannabis industry;
10.29 	(2) the status of the illicit cannabis market and;
10.30 	(3) the status of the hemp consumer industry commercial and consumer industries;
11.1 	(3) the number of accidents, arrests, and convictions involving drivers who admitted to 
11.2 	using cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
11.3 	consumer products or who tested positive for cannabis or tetrahydrocannabinol;
11.4 	(4) the change in potency, if any, of cannabis flower and cannabis products available 
11.5 	through the regulated market;
11.6 	(5) progress on providing opportunities to individuals and communities that experienced 
11.7 	a disproportionate, negative impact from cannabis prohibition, including but not limited to 
11.8 	providing relief from criminal convictions and increasing economic opportunities;
11.9 	(6) the status of racial and geographic diversity in the cannabis industry;
11.10 	(7) proposed legislative changes, including but not limited to recommendations to 
11.11 	streamline licensing systems and related administrative processes; and
11.12 	(8) information on the adverse effects of second-hand smoke from any cannabis flower, 
11.13 	cannabis products, and hemp-derived consumer products that are consumed by the 
11.14 	combustion or vaporization of the product and the inhalation of smoke, aerosol, or vapor 
11.15 	from the product; and
11.16 	(9) (8) recommendations for the levels of funding for:
11.17 	(i) a coordinated education program to address and raise public awareness about the top 
11.18 	three adverse health effects, as determined by the commissioner of health, associated with 
11.19 	the use of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
11.20 	consumer products by individuals under 21 years of age;
11.21 	(ii) a coordinated education program to educate pregnant individuals, breastfeeding 
11.22 	individuals, and individuals who may become pregnant on the adverse health effects of 
11.23 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
11.24 	products;
11.25 	(iii) training, technical assistance, and educational materials for home visiting programs, 
11.26 	Tribal home visiting programs, and child welfare workers regarding safe and unsafe use of 
11.27 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
11.28 	products in homes with infants and young children;
11.29 	(iv) model programs to educate middle school and high school students on the health 
11.30 	effects on children and adolescents of the use of cannabis flower, cannabis products, 
11.31 	lower-potency hemp edibles, hemp-derived consumer products, and other intoxicating or 
11.32 	controlled substances;
12.1 	(v) (i) grants issued through the CanTrain, CanNavigate, CanStartup, and CanGrow 
12.2 	programs; and
12.3 	(vi) (ii) grants to organizations for community development in social equity communities 
12.4 	through the CanRenew program;.
12.5 	(vii) training of peace officers and law enforcement agencies on changes to laws involving 
12.6 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
12.7 	products and the law's impact on searches and seizures;
12.8 	(viii) training of peace officers to increase the number of drug recognition experts;
12.9 	(ix) training of peace officers on the cultural uses of sage and distinguishing use of sage 
12.10 	from the use of cannabis flower, including whether the Board of Peace Officer Standards 
12.11 	and Training should approve or develop training materials;
12.12 	(x) the retirement and replacement of drug detection canines; and
12.13 	(xi) the Department of Human Services and county social service agencies to address 
12.14 	any increase in demand for services.
12.15 	(g) In developing the recommended funding levels under paragraph (f), clause (9), items 
12.16 	(vii) to (xi), the office shall consult with local law enforcement agencies, the Minnesota 
12.17 	Chiefs of Police Association, the Minnesota Sheriff's Association, the League of Minnesota 
12.18 	Cities, the Association of Minnesota Counties, and county social services agencies.
12.19 	(b) The annual report under this subdivision must include:
12.20 	(1) an assessment of available data and updated information regarding the impact of 
12.21 	cannabis use on impaired driving;
12.22 	(2) an assessment of available data and updated information regarding the impact of the 
12.23 	adverse effects of secondhand smoke from cannabis flower and cannabis products;
12.24 	(3) updated information from the Department of Human Services, Department of Health, 
12.25 	Direct Care and Treatment, Minnesota state courts, and hospitals licensed under chapter 
12.26 	144 regarding the utilization of mental health and substance use disorder services, emergency 
12.27 	room visits, and civil commitments; and
12.28 	(4) updated information about existing summary data on first episode psychosis programs.
12.29 		Subd. 4.Collaboration with other agencies and organizations. The office must 
12.30 	collaborate with state agencies and leading organizations with expertise on cannabis-related 
12.31 	programs to support education, prevention, public safety initiatives, and industry and market 
12.32 	evaluations, including:
13.1 	(1) the Department of Employment and Economic Development;
13.2 	(2) the Department of Health;
13.3 	(3) the Department of Public Safety;
13.4 	(4) the Department of Education;
13.5 	(5) the Department of Human Services;
13.6 	(6) the Department of Children, Youth, and Families;
13.7 	(7) Direct Care and Treatment;
13.8 	(8) the Department of Agriculture;
13.9 	(9) local government organizations;
13.10 	(10) law enforcement agencies; and
13.11 	(11) county social service agencies.

13.12 	Sec. 10. Minnesota Statutes 2024, section 342.07, subdivision 3, is amended to read:
13.13 		Subd. 3.Edible cannabinoid product handler endorsement. (a) Any person A license 
13.14 	holder seeking to manufacture, process, sell, handle, or store an edible cannabis product or 
13.15 	lower-potency hemp edible, other than an edible cannabis product or lower-potency hemp 
13.16 	edible that has been placed in its final packaging, must first apply for and obtain an edible 
13.17 	cannabinoid product handler endorsement.
13.18 	(b) In consultation with the commissioner of agriculture, the office shall establish an 
13.19 	edible cannabinoid product handler endorsement.
13.20 	(c) The office must regulate edible cannabinoid product handlers in a manner consistent 
13.21 	with Department of Agriculture regulation of food handlers under chapters 28A, 31, and 
13.22 	34A and associated rules, with the following exceptions:
13.23 	(1) the office must issue an edible cannabinoid product handler endorsement, rather than 
13.24 	a license;
13.25 	(2) eligibility for an edible cannabinoid product handler endorsement is limited to persons 
13.26 	who possess a valid license issued by the office;
13.27 	(3) the office may not charge a fee for issuing or renewing the endorsement;
13.28 	(4) the office must align the term and renewal period for edible cannabinoid product 
13.29 	handler endorsements with the term and renewal period of the license issued by the office; 
13.30 	and
14.1 	(5) an edible cannabis product or a lower-potency hemp edible must not be considered 
14.2 	adulterated solely because the product or edible contains tetrahydrocannabinol, cannabis 
14.3 	concentrate, hemp concentrate, artificially derived cannabinoids, or any other material 
14.4 	extracted or derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant 
14.5 	parts.
14.6 	(d) The An edible cannabinoid product handler endorsement must prohibit prohibits the 
14.7 	manufacture of edible cannabis products at the same premises where food is manufactured, 
14.8 	except for the limited production of edible products produced solely for product development, 
14.9 	sampling, or testing. This The limitation in this paragraph does not apply to the manufacture 
14.10 	of lower-potency hemp edibles.
14.11 	(e) An edible cannabinoid product handler endorsement is available to the following 
14.12 	license holders:
14.13 	(1) cannabis microbusinesses;
14.14 	(2) cannabis mezzobusinesses;
14.15 	(3) cannabis manufacturers;
14.16 	(4) cannabis macrobusinesses; and
14.17 	(5) lower-potency hemp edible manufacturers.
14.18 	(f) A lower-potency hemp edible manufacturer with an edible cannabinoid product 
14.19 	handler endorsement may only manufacture lower-potency hemp edibles and must not add 
14.20 	any cannabis flower, cannabis concentrate, or cannabinoid derived from cannabis flower 
14.21 	or cannabis concentrate to a product consistent with the requirements in section 342.45.

14.22 	Sec. 11. Minnesota Statutes 2024, section 342.09, subdivision 3, is amended to read:
14.23 		Subd. 3.Home extraction of cannabis concentrate by use of volatile solvent 
14.24 	prohibited. No person may use a volatile solvent to separate or extract cannabis concentrate 
14.25 	or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis 
14.26 	macrobusiness, cannabis manufacturer, medical cannabis combination business, or 
14.27 	lower-potency hemp edible manufacturer license issued under this chapter.

14.28 	EFFECTIVE DATE. This section is effective January 1, 2027.

15.1 	Sec. 12. Minnesota Statutes 2025 Supplement, section 342.10, is amended to read:
15.2 	342.10 LICENSES; TYPES.
15.3 	The office shall issue the following types of license:
15.4 	(1) cannabis microbusiness;
15.5 	(2) cannabis mezzobusiness;
15.6 	(3) cannabis cultivator;
15.7 	(4) cannabis manufacturer;
15.8 	(5) cannabis retailer;
15.9 	(6) cannabis wholesaler;
15.10 	(7) cannabis transporter;
15.11 	(8) cannabis testing facility;
15.12 	(9) cannabis event organizer;
15.13 	(10) cannabis delivery service;
15.14 	(11) lower-potency hemp edible manufacturer;
15.15 	(12) lower-potency hemp edible wholesaler;
15.16 	(13) lower-potency hemp edible retailer; and
15.17 	(14) medical cannabis combination business macrobusiness.

15.18 	EFFECTIVE DATE. This section is effective January 1, 2027.

15.19 	Sec. 13. Minnesota Statutes 2025 Supplement, section 342.11, is amended to read:
15.20 	342.11 LICENSES; FEES.
15.21 	(a) The office shall require the payment of application fees, initial licensing fees, and 
15.22 	renewal licensing fees as provided in this section. The initial license fee shall include the 
15.23 	fee for initial issuance of the license and the first annual renewal. The renewal fee shall be 
15.24 	charged at the time of the second renewal and each subsequent annual renewal thereafter. 
15.25 	Nothing in this section prohibits a local unit of government from charging the retailer 
15.26 	registration fee established in section 342.22. Application fees, initial licensing fees, and 
15.27 	renewal licensing fees are nonrefundable.
15.28 	(b) Application and licensing fees shall be as follows:
16.1 	(1) for a cannabis microbusiness:
16.2 	(i) an application fee of $500;
16.3 	(ii) an initial license fee of $0; and
16.4 	(iii) a renewal license fee of $2,000;
16.5 	(2) for a cannabis mezzobusiness:
16.6 	(i) an application fee of $5,000;
16.7 	(ii) an initial license fee of $5,000; and
16.8 	(iii) a renewal license fee of $10,000;
16.9 	(3) for a cannabis cultivator:
16.10 	(i) an application fee of $10,000;
16.11 	(ii) an initial license fee of $20,000; and
16.12 	(iii) a renewal license fee of $30,000;
16.13 	(4) for a cannabis manufacturer:
16.14 	(i) an application fee of $10,000;
16.15 	(ii) an initial license fee of $10,000; and
16.16 	(iii) a renewal license fee of $20,000;
16.17 	(5) for a cannabis retailer:
16.18 	(i) an application fee of $2,500;
16.19 	(ii) an initial license fee of $2,500; and
16.20 	(iii) a renewal license fee of $5,000;
16.21 	(6) for a cannabis wholesaler:
16.22 	(i) an application fee of $5,000;
16.23 	(ii) an initial license fee of $5,000; and
16.24 	(iii) a renewal license fee of $10,000;
16.25 	(7) for a cannabis transporter:
16.26 	(i) an application fee of $250;
16.27 	(ii) an initial license fee of $500; and
17.1 	(iii) a renewal license fee of $1,000;
17.2 	(8) for a cannabis testing facility:
17.3 	(i) an application fee of $5,000;
17.4 	(ii) an initial license fee of $5,000; and
17.5 	(iii) a renewal license fee of $10,000;
17.6 	(9) for a cannabis delivery service:
17.7 	(i) an application fee of $250;
17.8 	(ii) an initial license fee of $500; and
17.9 	(iii) a renewal license fee of $1,000;
17.10 	(10) for a cannabis event organizer:
17.11 	(i) an application fee of $750; and
17.12 	(ii) an initial license fee of $750 $0;
17.13 	(iii) a renewal license fee of $750; and
17.14 	(iv) a temporary cannabis event application fee of $750;
17.15 	(11) for a lower-potency hemp edible manufacturer:
17.16 	(i) an application fee of $250;
17.17 	(ii) an initial license fee of $1,000; and
17.18 	(iii) a renewal license fee of $1,000;
17.19 	(12) for a lower-potency hemp edible wholesaler:
17.20 	(i) an application fee of $250;
17.21 	(ii) an initial license fee of $10,000; and
17.22 	(iii) a renewal license fee of $10,000;
17.23 	(13) for a lower-potency hemp edible retailer:
17.24 	(i) an application fee of $250 or, if the lower-potency hemp retailer operates more than 
17.25 	one retail location, $250 per retail location;
17.26 	(ii) an initial license fee of $250 or, if the lower-potency hemp retailer operates more 
17.27 	than one retail location, $250 per retail location; and
18.1 	(iii) a renewal license fee of $250 or, if the lower-potency hemp retailer operates more 
18.2 	than one retail location, $250 per retail location; and
18.3 	(14) for a medical cannabis combination business macrobusiness:
18.4 	(i) an application fee of $10,000;
18.5 	(ii) an initial license fee of $20,000; and
18.6 	(iii) a renewal license fee of $70,000.

18.7 	EFFECTIVE DATE. This section is effective January 1, 2027.

18.8 	Sec. 14. Minnesota Statutes 2025 Supplement, section 342.12, is amended to read:
18.9 	342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
18.10 		Subdivision 1.Transfer of licenses. (a) Licenses issued under this chapter that are 
18.11 	available to all applicants pursuant to section 342.14, subdivision 1b, paragraph (c), may 
18.12 	be freely transferred subject to the prior written approval of the office unless the license 
18.13 	holder has not received a final site inspection or the license holder is a social equity applicant.
18.14 	(b) Licenses issued as social equity licenses pursuant to either section 342.14, subdivision 
18.15 	1b, paragraph (b), or section 342.175, paragraph (b), may only be transferred to another 
18.16 	social equity applicant for three years after the date on which the office issues the license. 
18.17 	Three years after the date of issuance, a license holder may transfer a license to any entity. 
18.18 	Transfer of a license that was issued as a social equity license must be reviewed by the 
18.19 	Division of Social Equity and is subject to the prior written approval of the office.
18.20 	(c) Preliminary license approval issued pursuant to section 342.14, subdivision 5, may 
18.21 	not be transferred.
18.22 	(d) A new license must be obtained when:
18.23 	(1) the form of the licensee's legal business structure converts or changes to a different 
18.24 	type of legal business structure; or
18.25 	(2) the licenseelicense holder dissolves; consolidates; reorganizes; undergoes bankruptcy, 
18.26 	insolvency, or receivership proceedings; merges with another legal organization; or assigns 
18.27 	all or substantially all of its assets for the benefit of creditors.
18.28 	(e) Licenses must be renewed annually.
18.29 	(f) License holders may petition the office to adjust the tier of a license issued within a 
18.30 	license category if the license holder meets all applicable requirements.
19.1 	(g) (f) The office by rule may permit the relocation of a licensed cannabis business; 
19.2 	permit the relocation of an approved operational location, including a cultivation, 
19.3 	manufacturing, processing, or retail location; adopt requirements for the submission of a 
19.4 	license relocation application; establish standards for the approval of a relocation application; 
19.5 	and charge a fee not to exceed $250 for reviewing and processing applications. Relocation 
19.6 	of a licensed premises pursuant to this paragraph does not extend or otherwise modify the 
19.7 	license term of the license subject to relocation.
19.8 		Subd. 2.License reclassification availability. (a) Subject to section 342.14, subdivision 
19.9 	1a, the office may determine whether licenses are available for a license holder that is a 
19.10 	cannabis microbusiness to petition to reclassify the license holder as a cannabis 
19.11 	mezzobusiness. The number of reclassified licenses approved for social equity qualified 
19.12 	petitioners must be equal to or greater than the number of reclassified licenses approved for 
19.13 	all applicants.
19.14 	(b) Subject to section 342.14, subdivision 1a, and limitations in section 342.515, 
19.15 	subdivision 9, paragraph (b), the office may determine whether licenses are available for a 
19.16 	license holder that is a cannabis mezzobusiness to petition to reclassify the license holder 
19.17 	as a cannabis macrobusiness. The number of reclassified licenses approved for social equity 
19.18 	qualified petitioners must be equal to or greater than the number of reclassified licenses 
19.19 	approved for all applicants.
19.20 	(c) If the office determines that licenses are available pursuant to paragraph (a) or (b), 
19.21 	the office must announce the date when the office will begin accepting petitions from 
19.22 	applicants seeking reclassification.
19.23 		Subd. 3.Reclassification eligibility. (a) A cannabis microbusiness license holder is 
19.24 	eligible to petition to reclassify the license holder as a cannabis mezzobusiness if:
19.25 	(1) the cannabis microbusiness has held and operated a medical cannabis cultivation 
19.26 	endorsement for a minimum of two years; and
19.27 	(2) the cannabis microbusiness is in good standing with the office.
19.28 	(b) A cannabis mezzobusiness is eligible to petition to reclassify the license holder as a 
19.29 	cannabis macrobusiness if:
19.30 	(1) the cannabis mezzobusiness has held and operated a medical cannabis cultivation 
19.31 	endorsement for a minimum of two years;
19.32 	(2) the cannabis mezzobusiness has held and operated either a medical cannabis 
19.33 	manufacturing endorsement or a medical cannabis retail endorsement;
20.1 	(3) the cannabis mezzobusiness is in good standing with the office; and
20.2 	(4) the cannabis mezzobusiness has not reclassified its license in the previous 12 months 
20.3 	before the petition.
20.4 		Subd. 4.Reclassification petition process. (a) The office must establish procedures for 
20.5 	the processing of petitions to reclassify under this subdivision. A license holder that seeks 
20.6 	to reclassify its license as a cannabis mezzobusiness or cannabis macrobusiness must include 
20.7 	in its petition the following information, if applicable:
20.8 	(1) its status as a social equity license holder;
20.9 	(2) the number of medical endorsements held and a description of the manner in which 
20.10 	medical patients are provided services;
20.11 	(3) financial statements exhibiting the ability to operate a larger license;
20.12 	(4) a transition plan that describes how the license holder will comply with all statutes 
20.13 	and rules applicable to the reclassified license; and
20.14 	(5) a description of the planned growth of the license holder up to the limits of the new 
20.15 	license type.
20.16 	(b) After a license holder submits a petition to reclassify that contains all required 
20.17 	information, the office must review the petition. The office may deny a petition if:
20.18 	(1) the petition is incomplete;
20.19 	(2) the license holder does not meet the qualifications under this section;
20.20 	(3) the petition contains a materially false statement about the applicant;
20.21 	(4) the license holder does not meet the qualifications under section 342.16;
20.22 	(5) the license holder is prohibited from holding a license under section 342.18, 
20.23 	subdivision 2;
20.24 	(6) the license holder does not meet the minimum requirements under section 342.18, 
20.25 	subdivision 3;
20.26 	(7) the petition was not submitted by the petition deadline;
20.27 	(8) the license holder has unpaid fines or fees or has engaged in substantial noncompliance 
20.28 	with this chapter; or
20.29 	(9) the office determines that the license holder would be prohibited from holding a 
20.30 	license for any other reason.
21.1 	(c) The office may request additional information from any license holder if the office 
21.2 	determines that the information is necessary to review or process the petition. If the license 
21.3 	holder does not provide the additional requested information within 14 calendar days of the 
21.4 	office's request for information, the office may deny the petition.
21.5 	(d) If the office denies a petition, the office must notify the license holder of the denial 
21.6 	and the basis for the denial.
21.7 	(e) A license holder whose petition is not denied under this subdivision is a qualified 
21.8 	petitioner.
21.9 		Subd. 5.Reclassification approval process for petitioners to a cannabis 
21.10 	mezzobusiness license. (a) The office shall reclassify the license of all qualified petitioners 
21.11 	holding a social equity cannabis microbusiness license to a cannabis mezzobusiness license.
21.12 	(b) In the event the number of qualified petitioners not classified as social equity cannabis 
21.13 	microbusiness license holders for a reclassification to a cannabis mezzobusiness license 
21.14 	exceeds the number of qualified petitioners classified as social equity license holders, the 
21.15 	office shall select qualified petitioners using the methods in section 342.14, subdivision 4.
21.16 	(c) Reclassification according to this subdivision must not remove the social equity 
21.17 	license status from a social equity license.
21.18 	(d) A license holder that submits a petition to reclassify its license may continue 
21.19 	operations pending office determination on the petition. A license holder that submits a 
21.20 	petition to reclassify its license that is denied retains its existing license.
21.21 		Subd. 6.Reclassification approval process for petitioners to a cannabis 
21.22 	macrobusiness license. (a) In the event the number of qualified petitioners for a 
21.23 	reclassification to a cannabis macrobusiness license exceeds the number of available licenses 
21.24 	for a cannabis macrobusiness determined by the office pursuant to subdivision 2, the office 
21.25 	shall select qualified petitioners using the methods in section 342.14, subdivision 4.
21.26 	(b) Reclassification according to this subdivision must not remove the social equity 
21.27 	license status from a social equity license.
21.28 	(c) A license holder that submits a petition to reclassify its license may continue 
21.29 	operations pending office determination on the petition. A license holder that submits a 
21.30 	petition to reclassify its license that is denied retains its existing license.

21.31 	EFFECTIVE DATE. Subdivision 1 is effective August 1, 2026. Subdivisions 2 to 6 
21.32 	are effective January 1, 2027.

22.1 	Sec. 15. Minnesota Statutes 2025 Supplement, section 342.13, is amended to read:
22.2 	342.13 LOCAL CONTROL.
22.3 	(a) A local unit of government may not prohibit the possession, transportation, or use 
22.4 	of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
22.5 	consumer products authorized under this chapter.
22.6 	(b) Except as provided in section 342.22, a local unit of government may not prohibit 
22.7 	the establishment or operation of a cannabis business or hemp business licensed under this 
22.8 	chapter.
22.9 	(c) By ordinance, a local unit of government may adopt reasonable restrictions on the 
22.10 	time, place, and manner of the operation of a cannabis business provided that such restrictions 
22.11 	do not prohibit the establishment or operation of cannabis businesses. A local unit of 
22.12 	government may prohibit the operation of a cannabis business within 1,000 feet of a school, 
22.13 	or 500 feet of a day care, residential treatment facility, or an attraction within a public park 
22.14 	that is regularly used by minors, including a playground or athletic field.
22.15 	(d) The office shall work with local units of government to:
22.16 	(1) develop model ordinances for reasonable restrictions on the time, place, and manner 
22.17 	of the operation of a cannabis business;
22.18 	(2) develop standardized forms and procedures for the issuance of a retail registration 
22.19 	pursuant to section 342.22; and
22.20 	(3) develop model policies and procedures for the performance of compliance checks 
22.21 	required under section 342.22.
22.22 	(e) If a local unit of government is conducting studies or has authorized a study to be 
22.23 	conducted or has held or has scheduled a hearing for the purpose of considering adoption 
22.24 	or amendment of reasonable restrictions on the time, place, and manner of the operation of 
22.25 	a cannabis business, the governing body of the local unit of government may adopt an 
22.26 	interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting 
22.27 	the planning process and the health, safety, and welfare of its citizens. Before adopting the 
22.28 	interim ordinance, the governing body must hold a public hearing. The interim ordinance 
22.29 	may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction 
22.30 	or a portion thereof until January 1, 2025.
22.31 	(f) (e) Within 30 days of receiving a copy of an application from the office, a local unit 
22.32 	of government shall certify on a form provided by the office whether a proposed cannabis 
22.33 	business complies with local zoning ordinances and, if applicable, whether the proposed 
23.1 	business complies with the State Fire Code and the State Building Code. The office may
23.2 	must not issue a license to an applicant if the local unit of government informs the office 
23.3 	that the proposed cannabis business does not meet comply with local zoning and ordinances,
23.4 	land use laws, the State Fire Code, or the State Building Code and submits evidence of the 
23.5 	proposed cannabis business's lack of compliance. If the local unit of government does not 
23.6 	provide the certification under this paragraph to the office within 30 days of receiving a 
23.7 	copy of an application from the office, the office may waive the requirement for local 
23.8 	government certification and may issue a license to the applicant. Regardless of whether 
23.9 	the office has waived local government certification, the proposed cannabis business's 
23.10 	location must meet the requirements of this chapter.
23.11 	(g) (f) The office by rule shall establish an expedited complaint process to receive, 
23.12 	review, and respond to complaints made by a local unit of government about a cannabis 
23.13 	business. At a minimum, the expedited complaint process shall require the office to provide 
23.14 	an initial response to the complaint within seven days and perform any necessary inspections 
23.15 	within 30 days. Nothing in this paragraph prohibits a local unit of government from enforcing 
23.16 	a local ordinance. If a local unit of government notifies the office that a cannabis business 
23.17 	other than a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness, cannabis 
23.18 	macrobusiness, or lower-potency hemp edible retailer with a retail operations endorsement, 
23.19 	or medical cannabis combination business operating a retail location poses an immediate 
23.20 	threat to the health or safety of the public, the office must respond within one business day 
23.21 	and may take any action described in section 342.19 or 342.21.
23.22 	(h) (g) A local government unit that issues a cannabis retailer registration under section 
23.23 	342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis 
23.24 	macrobusinesses with a retail operations endorsement, cannabis mezzobusinesses with a 
23.25 	retail operations endorsement, and cannabis microbusinesses with a retail operations 
23.26 	endorsement to no fewer than one registration for every 12,500 residents. After each 
23.27 	increment of 12,500 residents, the number of required registrations must be rounded up to 
23.28 	the next whole number of registrations.
23.29 	(i) If a county has one active registration for every 12,500 residents, a city or town within 
23.30 	the county is not obligated to register a cannabis business.
23.31 	(h) A county that has consent from a city or town to issue retail registrations for the 
23.32 	jurisdiction according to section 342.22, subdivision 1, may develop a process, in consultation 
23.33 	with the consenting city or town, for issuing retail registrations throughout the county that 
23.34 	meets the required minimum in paragraph (g) and limits the number of registrations allowed 
23.35 	in each city or town that has delegated authority to the county.
24.1 	(j) (i) Nothing in this section shall prohibit a local government unit from allowing licensed 
24.2 	cannabis retailers in excess of the minimums set in paragraph (h) (g).
24.3 	(k) (j) Notwithstanding the foregoing provisions, the state shall not issue a license to 
24.4 	any cannabis business to operate in Indian country, as defined in United States Code, title 
24.5 	18, section 1151, of a Minnesota Tribal government without the consent of the Tribal 
24.6 	government.

24.7 	Sec. 16. Minnesota Statutes 2024, section 342.14, subdivision 1b, is amended to read:
24.8 		Subd. 1b.Maximum number of licenses. (a) Before July 1, 2026 2027, the office may 
24.9 	issue up to the maximum total number of licenses in each license category listed in paragraphs 
24.10 	(b) and (c).
24.11 	(b) For licenses that are available to social equity applicants, the maximum number of 
24.12 	licenses that the office may issue are:
24.13 	(1) cannabis cultivator licenses, 25;
24.14 	(2) cannabis manufacturer licenses, 12;
24.15 	(3) cannabis retailer licenses, 75; and
24.16 	(4) cannabis mezzobusiness licenses, 50.
24.17 	(c) For licenses that are available to all applicants, the maximum number of licenses 
24.18 	that the office may issue are:
24.19 	(1) cannabis cultivator licenses, 25;
24.20 	(2) cannabis manufacturer licenses, 12;
24.21 	(3) cannabis retailer licenses, 75; and
24.22 	(4) cannabis mezzobusiness licenses, 50.
24.23 	(d) Beginning July 1, 2026 2027, the office must determine the number of cannabis 
24.24 	cultivator licenses, cannabis manufacturer licenses, cannabis retailer licenses, and cannabis 
24.25 	mezzobusiness licenses that the office will issue consistent with the goals identified in 
24.26 	subdivision 1a. If the office makes any of those types of licenses available, the number of 
24.27 	licenses available to social equity applicants must be equal to or greater than the number 
24.28 	of licenses available to all applicants.
24.29 	(e) The office may issue as many licenses as the office deems necessary of a license 
24.30 	type that is not listed in this subdivision. If the office limits the number of license types not 
24.31 	listed in this subdivision available in any licensing period, the office must identify the 
25.1 	number of licenses available to social equity applicants and the number of licenses available 
25.2 	to all applicants. The number of licenses available to social equity applicants must be equal 
25.3 	to or greater than the number of licenses available to all applicants. The office is not required 
25.4 	to issue a license for a license type that is not listed in this subdivision.
25.5 	(f) The office is not required to issue licenses to meet the maximum number of licenses 
25.6 	that may be issued under paragraphs (b) and (c).

25.7 	Sec. 17. Minnesota Statutes 2025 Supplement, section 342.14, subdivision 3, is amended 
25.8 	to read:
25.9 		Subd. 3.Review. (a) After an applicant submits an application that contains all required 
25.10 	information and pays the applicable application fee, the office must review the application.
25.11 	(b) The office may deny an application if:
25.12 	(1) the application is incomplete;
25.13 	(2) the application contains a materially false statement about the applicant or omits 
25.14 	information required under subdivision 1;
25.15 	(3) the applicant does not meet the qualifications under section 342.16;
25.16 	(4) the applicant is prohibited from holding the license under section 342.18, subdivision 
25.17 	2;
25.18 	(5) the application does not meet the minimum requirements under section 342.18, 
25.19 	subdivision 3;
25.20 	(6) the applicant fails to pay the applicable application fee;
25.21 	(7) the application was not submitted by the application deadline;
25.22 	(8) the applicant submitted more than one application for a license type; or
25.23 	(9) the office determines that the applicant would be prohibited from holding a license 
25.24 	for any other reason.
25.25 	(c) If the office denies an application, the office must notify the applicant of the denial 
25.26 	and the basis for the denial.
25.27 	(d) The office may request additional information from any applicant if the office 
25.28 	determines that the information is necessary to review or process the application. If the 
25.29 	applicant does not provide the additional requested information within 14 calendar days of 
25.30 	the office's request for information, the office may deny the application.
26.1 	(e) An applicant whose application is not denied under this subdivision is a qualified 
26.2 	applicant.
26.3 	(f) An applicant's status as a qualified applicant under this section expires after six 
26.4 	months. For an applicant who achieved qualified applicant status before June 1, 2026, 
26.5 	qualified applicant status expires on January 1, 2027. The office must deny an application 
26.6 	submitted by an applicant whose qualified applicant status has expired. An applicant whose 
26.7 	qualified applicant status expired may apply anew according to this section.
26.8 	(g) If the office determines that an applicant is not eligible for a license under this section, 
26.9 	the office may revoke the applicant's qualified applicant status.

26.10 	EFFECTIVE DATE. This section is effective the day following final enactment.

26.11 	Sec. 18. Minnesota Statutes 2025 Supplement, section 342.14, subdivision 6, is amended 
26.12 	to read:
26.13 		Subd. 6.Completed application; final authorization; issuance of license. (a) Within 
26.14 	18 months of receiving notice of preliminary license approval, an applicant must provide:
26.15 	(1) the address and legal property description of the location where the business will 
26.16 	operate;
26.17 	(2) the name of the local unit of government where the business will be located; and
26.18 	(3) if applicable, an updated description of the location where the business will operate, 
26.19 	an updated security plan, and any other additional information required by the office.
26.20 	(b) Upon receipt of the information required under paragraph (a) from an applicant that 
26.21 	has received preliminary license approval, the office must:
26.22 	(1) forward a copy of the application to the local unit of government in which the business 
26.23 	operates or intends to operate with a form for certification as to whether a proposed cannabis 
26.24 	business complies with local zoning ordinances and, if applicable, whether the proposed 
26.25 	business complies with the state fire code and building code;
26.26 	(2) schedule a site inspection; and
26.27 	(3) require the applicant to pay the applicable license fee.
26.28 	(c) The office may deny final authorization if:
26.29 	(1) an applicant fails to submit any required information;
26.30 	(2) the applicant submits a materially false statement about the applicant or fails to 
26.31 	provide any required information;
27.1 	(3) the office confirms that the cannabis business for which the office granted a 
27.2 	preliminary license approval does not meet local zoning and land use laws;
27.3 	(4) the applicant fails to pay the applicable license fee; or
27.4 	(5) the office determines that the applicant is disqualified from holding the license or 
27.5 	would operate in violation of the provisions of this chapter.; or
27.6 	(6) the applicant fails to demonstrate that the proposed cannabis business's location 
27.7 	complies with local zoning ordinances, the State Fire Code, or the State Building Code.
27.8 	(d) Within 90 days of receiving the information required under paragraph (a) and the 
27.9 	results of any required background check, the office shall grant final authorization and issue 
27.10 	the appropriate license or send the applicant a notice of rejection setting forth specific 
27.11 	reasons that the office did not approve the application.

27.12 	Sec. 19. Minnesota Statutes 2024, section 342.14, subdivision 10, is amended to read:
27.13 		Subd. 10.Revocation or expiration of preliminary approval. (a) A preliminary license 
27.14 	approval expires after 18 months unless the office revokes the preliminary license approval 
27.15 	or grants an extension. The office may must grant a onetime an initial extension of up to 
27.16 	six months upon request by the applicant. The office may grant an additional extension of 
27.17 	up to six months if an applicant has made good faith efforts to convert a preliminary license 
27.18 	approval into a license. The office must not issue a license to an applicant whose preliminary 
27.19 	license approval has expired.
27.20 	(b) If the office determines that an applicant is not eligible for a license, the office may 
27.21 	revoke a preliminary license approval.
27.22 	(c) The office must notify an applicant if the office revokes the applicant's preliminary 
27.23 	license approval or if the applicant's preliminary license approval expires.

27.24 	Sec. 20. Minnesota Statutes 2024, section 342.15, subdivision 2, is amended to read:
27.25 		Subd. 2.Criminal offenses; disqualifications. (a) The office may by rule determine 
27.26 	whether any felony convictions, including but not limited to convictions for noncannabis 
27.27 	controlled substance crimes in the first or second degree, human trafficking, labor trafficking, 
27.28 	fraud, or financial crimes, disqualify an individual from holding or receiving a cannabis 
27.29 	business license issued under this chapter or working for a cannabis business, and the length 
27.30 	of any such disqualification. In adopting rules pursuant to this subdivision, the office shall 
27.31 	not disqualify an individual for a violation of section 152.025.
28.1 	(b) The office must not issue a cannabis business license to any person or business who 
28.2 	was convicted of illegally selling cannabis after August 1, 2023, unless five years have 
28.3 	passed since the date of conviction.
28.4 	(c) The office must not issue a cannabis business license to any person or business who 
28.5 	violated this chapter after August 1, 2023, unless five years have passed since the date of 
28.6 	violation. The office may set aside the violation if the office finds that the violation occurred 
28.7 	as a result of a mistake made in good faith and the violation did not involve gross negligence, 
28.8 	an illegal sale of cannabis, or cause harm to the public. The office must not issue a license 
28.9 	to any person or business who the office has assessed a fine to under section 342.09, 
28.10 	subdivision 6.

28.11 	Sec. 21. Minnesota Statutes 2024, section 342.15, subdivision 5, is amended to read:
28.12 		Subd. 5.Civil and regulatory offenses; disqualifications. (a) The office may determine 
28.13 	whether any civil or regulatory violations, as determined by another state agency, local unit 
28.14 	of government, or any other jurisdiction, disqualify an individual from holding or receiving 
28.15 	a cannabis business license issued under this chapter or disqualify an individual from working 
28.16 	for a cannabis business, and the length of the disqualification. Upon the office's request, a 
28.17 	state agency, as defined in section 13.02, subdivision 17, except for the Department of 
28.18 	Revenue, may release civil investigative data, including data classified as protected nonpublic 
28.19 	or confidential under section 13.39, subdivision 2, if the request is related to a specific 
28.20 	applicant and the data is necessary to make a determination under this section.
28.21 	(b) The office must not issue a cannabis business license to any person or business who 
28.22 	violated this chapter after August 1, 2023, unless five years have passed since the date of 
28.23 	the violation. The office must set aside the violation if the office finds that the violation:
28.24 	(1) occurred as a result of a mistake made in good faith;
28.25 	(2) did not involve gross negligence;
28.26 	(3) did not involve an illegal sale of cannabis; and
28.27 	(4) did not cause harm to the public.
28.28 	(c) The office must not issue a cannabis business license to any person or business who 
28.29 	was assessed a fine by the office under section 342.09, subdivision 6.

29.1 	Sec. 22. Minnesota Statutes 2025 Supplement, section 342.16, is amended to read:
29.2 	342.16 CANNABIS BUSINESSES; GENERAL OWNERSHIP 
29.3 	DISQUALIFICATIONS AND REQUIREMENTS.
29.4 	(a) A license holder or an applicant must meet each of the following requirements, if 
29.5 	applicable, to hold or receive a cannabis license issued under this chapter:
29.6 	(1) be at least 21 years of age;
29.7 	(2) have completed an application for licensure or application for renewal;
29.8 	(3) have paid the applicable application fee and license fee;
29.9 	(4) if the applicant or license holder is a business entity, be incorporated in the state or 
29.10 	otherwise formed or organized under the laws of the state;
29.11 	(5) not be employed by the office or any state agency with regulatory authority under 
29.12 	this chapter or the rules adopted pursuant to this chapter;
29.13 	(6) not be a licensed peace officer, as defined in section 626.84, subdivision 1, paragraph 
29.14 	(c);
29.15 	(7) never have had a license previously issued under this chapter revoked, and never 
29.16 	have had a cannabis license, a registration, an agreement, or another authorization to operate 
29.17 	a cannabis business issued under the laws of another state revoked;
29.18 	(8) have filed any previously required tax returns for a cannabis business;
29.19 	(9) have paid and remitted any business taxes, gross receipts taxes, interest, or penalties 
29.20 	due relating to the operation of a cannabis business;
29.21 	(10) have fully and truthfully complied with all information requests of the office relating 
29.22 	to license application and renewal;
29.23 	(11) not be disqualified under section 342.15;
29.24 	(12) not employ an individual who is disqualified from working for a cannabis business 
29.25 	under this chapter;
29.26 	(13) meet the ownership and operational requirements for the type of license and, if 
29.27 	applicable, endorsement sought or held; and
29.28 	(14) not have had any confirmed willful labor violation with the Minnesota Department 
29.29 	of Labor, National Labor Relations Board, and Industry or the Occupational Safety and 
29.30 	Health Administration within the last five years, as determined by the office.
30.1 	(b) A health care practitioner who certifies qualifying medical conditions for patients is 
30.2 	prohibited from:
30.3 	(1) holding a direct or indirect economic interest in a cannabis business;
30.4 	(2) serving as a cooperative member, director, manager, general partner, or employee 
30.5 	of a cannabis business; or
30.6 	(3) advertising with a cannabis business in any way.
30.7 	(c) If the license holder or applicant is a business entity, every officer, director, manager, 
30.8 	and general partner of the business entity must meet each of the requirements of this section.
30.9 	(d) The ownership disqualifications and requirements under this section do not apply to 
30.10 	a hemp business license holder or applicant.

30.11 	EFFECTIVE DATE. This section is effective the day following final enactment.

30.12 	Sec. 23. Minnesota Statutes 2024, section 342.175, is amended to read:
30.13 	342.175 SOCIAL EQUITY LICENSE CLASSIFICATION.
30.14 	(a) The office must classify licenses listed in section 342.10, clauses (1) to (10) and (13)
30.15 	(14) as:
30.16 	(1) available to social equity applicants who meet the requirements of section 342.17; 
30.17 	and
30.18 	(2) available to all applicants.
30.19 	(b) The office must classify any license issued to a social equity applicant as a social 
30.20 	equity license.

30.21 	EFFECTIVE DATE. This section is effective January 1, 2027.

30.22 	Sec. 24. Minnesota Statutes 2025 Supplement, section 342.18, subdivision 2, is amended 
30.23 	to read:
30.24 		Subd. 2.Vertical integration prohibited; exceptions. (a) Except as otherwise provided 
30.25 	in this subdivision, the office shall not issue licenses to a single applicant that would result 
30.26 	in the applicant being vertically integrated in violation of the provisions of this chapter.
30.27 	(b) Nothing in this section prohibits or limits the issuance of microbusiness licenses, 
30.28 	mezzobusiness licenses, or medical cannabis combination business macrobusiness licenses, 
30.29 	or the issuance of lower-potency hemp edible manufacturer, lower-potency hemp edible 
30.30 	wholesaler, and lower-potency hemp edible retailer licenses, to the same person or entity.

31.1 	EFFECTIVE DATE. This section is effective January 1, 2027.

31.2 	Sec. 25. Minnesota Statutes 2024, section 342.185, subdivision 1, is amended to read:
31.3 		Subdivision 1.Definitions. (a) As used in this section, the following terms have the 
31.4 	meanings given.
31.5 	(b) "Control" means the power to independently order or direct the management, 
31.6 	managers, or policies of a cannabis business.
31.7 	(c) "Financial institution" means any bank, mutual savings bank, consumer loan company, 
31.8 	credit union, savings and loan association, trust company, or other lending institution under 
31.9 	the jurisdiction of the Minnesota Department of Commerce, the United States Department 
31.10 	of Commerce, or both.
31.11 	(d) "Financier" means any person that:
31.12 	(1) is not a financial institution or government entity;
31.13 	(2) provides money as a gift, grant, or loan to an applicant for a cannabis business license, 
31.14 	a cannabis business, or both; and
31.15 	(3) expects to be repaid for the money provided, with or without reasonable interest.
31.16 	(e) "Gross profit" means sales minus the cost of goods sold.
31.17 	(f) "Revenue" means the income generated from the sale of goods and services associated 
31.18 	with the main operations of a business before any costs or expenses have been deducted.
31.19 	(g)(1) "True party of interest" means an individual who as an individual or as part of 
31.20 	another business:
31.21 	(1) (i) is a sole proprietor of a sole proprietorship;
31.22 	(2) (ii) is a partner in a general partnership;
31.23 	(3) (iii) is a general partner or limited partner in a limited partnership, a limited liability 
31.24 	partnership, or a limited liability limited partnership;
31.25 	(4) (iv) is a member of a limited liability company or a manager in a limited liability 
31.26 	company;
31.27 	(5) (v) is a corporate officer or director or holds an equivalent title in a privately held 
31.28 	corporation;
31.29 	(6) (vi) is a stockholder in a privately held corporation;
31.30 	(7) (vii) is part of a multilevel ownership structure;
32.1 	(8) (viii) has membership rights to a nonprofit corporation in accordance with the 
32.2 	provisions of the articles of incorporation or bylaws for the nonprofit corporation;
32.3 	(9) (ix) has the right to receive some or all of the revenue, gross profit, or net profit from 
32.4 	a cannabis business during any full or partial calendar or fiscal year; or
32.5 	(10) (x) has the right to exercise control over a cannabis business.
32.6 	(2) True party of interest does not include:
32.7 	(1) (i) an individual receiving payment for rent on a fixed basis under a lease or rental 
32.8 	agreement;
32.9 	(2) (ii) an employee of a cannabis business who receives a salary or hourly rate 
32.10 	compensation if the employee does not otherwise hold an ownership interest in the cannabis 
32.11 	business or have the right to exercise control over the cannabis business;
32.12 	(3) (iii) an individual who receives a bonus or commission based on the individual's 
32.13 	sales, if the bonus or commission does not exceed ten percent of the individual's sales in 
32.14 	any given bonus or commission period and the terms of the bonus or commission-based 
32.15 	compensation agreement is in writing;
32.16 	(4) (iv) an individual with an ownership interest held or acquired solely for the purpose 
32.17 	of passive investment as described in Code of Federal Regulations, title 31, section 800.243;
32.18 	(5) (v) an individual contracting with a cannabis business to receive a commission for 
32.19 	the sale of a business or real property;
32.20 	(6) (vi) a consultant receiving a flat or hourly rate compensation under a written 
32.21 	contractual agreement;
32.22 	(7) (vii) any person with a contract or an agreement for services with a cannabis business, 
32.23 	such as a branding or staffing company, as long as that person does not obtain any ownership 
32.24 	or control of the cannabis business; or
32.25 	(8) (viii) a financial institution.

32.26 	Sec. 26. Minnesota Statutes 2024, section 342.185, subdivision 2, is amended to read:
32.27 		Subd. 2.Application number limitations. An individual may not be a true party of 
32.28 	interest for more than one application for (1) any single type of license, or (2) multiple types 
32.29 	of licenses if the individual would be prohibited from holding the licenses under section 
32.30 	342.18, subdivision 2. The limitation does not apply to:
32.31 	(i) an individual who holds no more than ten percent ownership of the business entity;
33.1 	(ii) a person who contracts with a city or county to operate no more than ten municipal 
33.2 	cannabis stores under section 342.32, subdivision 5; or
33.3 	(iii) an individual who holds up to 33 percent controlling ownership of up to four business 
33.4 	entities that are social equity applicants.

33.5 	Sec. 27. Minnesota Statutes 2024, section 342.185, subdivision 3, is amended to read:
33.6 		Subd. 3.License number limitations. An individual may not be a true party of interest 
33.7 	for more than one license unless explicitly allowed by this chapter. The limitation does not 
33.8 	apply to:
33.9 	(1) an individual who holds ten percent or less controlling ownership of the business 
33.10 	entity;
33.11 	(2) a person who contracts with a city or county to operate no more than ten municipal 
33.12 	cannabis stores under section 342.32, subdivision 5; or
33.13 	(3) an individual who holds up to 33 percent controlling ownership of up to four business 
33.14 	entities that hold a social equity license.

33.15 	Sec. 28. Minnesota Statutes 2024, section 342.19, subdivision 6, is amended to read:
33.16 		Subd. 6.Inspection of unlicensed businesses and facilities. (a) The office may inspect 
33.17 	any commercial premises that is not licensed under this chapter where cultivation, 
33.18 	manufacturing, processing, or sale of cannabis plants, cannabis flower, cannabis concentrate, 
33.19 	artificially derived cannabinoids, hemp-derived consumer products, or edible cannabinoid 
33.20 	products, or lower-potency hemp edibles is taking place.
33.21 	(b) A representative of the office performing an inspection under this subdivision must 
33.22 	present appropriate credentials to the owner, operator, or agent in charge and clearly state 
33.23 	the purpose of the inspection.
33.24 	(c) After providing the notice required under paragraph (b), a representative of the office 
33.25 	may enter the commercial premises and perform any of the following to determine if any 
33.26 	person is engaging in activities that are regulated by this chapter and not authorized without 
33.27 	the possession of a license and to determine the appropriate penalty under section 342.09, 
33.28 	subdivision 6:
33.29 	(1) inspect and investigate the commercial premises;
33.30 	(2) inspect and copy records; and
34.1 	(3) question privately any employer, owner, operator, agent, or employee of the 
34.2 	commercial operation.
34.3 	(d) Entry of a commercial premises must take place during regular working hours or at 
34.4 	other reasonable times.
34.5 	(e) If the office finds any cannabis plant, cannabis flower, cannabis product, artificially 
34.6 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product on 
34.7 	the inspected commercial premises, the office may either:
34.8 	(1) immediately seize the item or;
34.9 	(2) affix to the item a tag, withdrawal from distribution order, or other appropriate 
34.10 	marking providing notice that the cannabis plant, cannabis flower, cannabis product, 
34.11 	artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer 
34.12 	product is, or is suspected of being, possessed or distributed in violation of this chapter, and 
34.13 	has been detained or embargoed, and warning all persons not to remove or dispose of the 
34.14 	item by sale or otherwise until permission for removal or disposal is given by the office or 
34.15 	the court.; or
34.16 	(3) assess a civil penalty to the business pursuant to section 342.09, subdivision 6, and 
34.17 	may treat the possession of the seized, embargoed, or detained product as having been sold.
34.18 	(f) It is unlawful for a person to remove or dispose of a detained or embargoed cannabis 
34.19 	plant, cannabis flower, cannabis product, artificially derived cannabinoid, lower-potency 
34.20 	hemp edible, or hemp-derived consumer product by sale or otherwise without the office's 
34.21 	or a court's permission and each transaction may be treated as a sale for the purposes of 
34.22 	imposing a penalty pursuant to section 342.09, subdivision 6.
34.23 	(f) (g) If the office has seized, detained, or embargoed any item pursuant to paragraph 
34.24 	(e), the office must:
34.25 	(1) petition the district court in the county in which the item was found for an order 
34.26 	authorizing destruction of the product; and
34.27 	(2) notify the county attorney in the county where the item was found of the office's 
34.28 	actions.
34.29 	(g) (h) If the court finds that the seized, detained, or embargoed cannabis plant, cannabis 
34.30 	flower, cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or 
34.31 	hemp-derived consumer product was possessed or distributed in violation of this chapter 
34.32 	or rules adopted under this chapter, the office may destroy the cannabis plant, cannabis 
34.33 	flower, cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or 
35.1 	hemp-derived consumer product at the expense of the person who possessed or distributed 
35.2 	the item in violation of this chapter and all court costs, fees, storage, and other proper 
35.3 	expenses must be assessed against the person or the person's agent.
35.4 	(h) (i) The provisions of subdivision 2, paragraph (f), apply to any analysis or examination 
35.5 	performed under this subdivision.
35.6 	(i) (j) The authorization under paragraph (e) does not apply to any cannabis flower, 
35.7 	cannabis product, lower-potency hemp edible, or hemp-derived consumer product lawfully 
35.8 	purchased for personal use.

35.9 	Sec. 29. Minnesota Statutes 2024, section 342.20, subdivision 1, is amended to read:
35.10 		Subdivision 1.Not public data. The following data collected, created, or maintained 
35.11 	by the office are classified as nonpublic data, as defined by section 13.02, subdivision 9, or 
35.12 	as private data on individuals, as defined by section 13.02, subdivision 12:
35.13 	(1) application data submitted by an applicant for a cannabis business license or hemp 
35.14 	business license, other than the data listed in subdivision 2;
35.15 	(2) the identity of a complainant who has made a report concerning a license holder or 
35.16 	an applicant that appears in inactive investigative data unless the complainant consents to 
35.17 	the disclosure;
35.18 	(3) data identifying retail or wholesale customers of a cannabis business or hemp business; 
35.19 	and
35.20 	(4) data identifying cannabis workers or hemp workers.; and
35.21 	(5) data reported to the office using the statewide monitoring system established under 
35.22 	section 342.05.

35.23 	EFFECTIVE DATE. This section is effective the day following final enactment.

35.24 	Sec. 30. Minnesota Statutes 2024, section 342.20, subdivision 2, is amended to read:
35.25 		Subd. 2.Public data on license applicants. (a) The following application data submitted 
35.26 	by an applicant for a cannabis business license or hemp business license are public data:
35.27 	(1) the applicant's name and designated address;
35.28 	(2) data disclosing the ownership and control of the applicant;
35.29 	(3) proof of trade name registration;
35.30 	(4) data showing the legal possession of the premises where the business will operate;
36.1 	(5) data describing whether the volatile chemicals that will be used in any methods of 
36.2 	extraction or concentration, if applicable;
36.3 	(6) environmental plans;
36.4 	(7) the type and number of other cannabis business licenses or hemp business licenses 
36.5 	held by the applicant; and
36.6 	(8) the name, address, location, dates, and hours of where any proposed cannabis event 
36.7 	will take place.
36.8 	(b) Scoring and other data generated by the office in its review of an applicant for a 
36.9 	cannabis business license or hemp business license are public data.
36.10 	(b) The status of the applicant's application, except for an applicant's status as a social 
36.11 	equity applicant, is public data.

36.12 	Sec. 31. Minnesota Statutes 2024, section 342.20, subdivision 3, is amended to read:
36.13 		Subd. 3.Public application data on license holders. Once an applicant for a cannabis 
36.14 	business license or hemp business license becomes a license holder, all of the application 
36.15 	or renewal data that the license holder had previously submitted to the office are public data 
36.16 	except that the following data remain classified as nonpublic data or private data on 
36.17 	individuals:
36.18 	(1) data identifying retail or wholesale customers of a cannabis business or hemp business;
36.19 	(2) data identifying cannabis workers or hemp workers;
36.20 	(3) tax returns, bank account statements, and other financial account information;
36.21 	(4) business plans; and, including descriptions of sites, security, and operations of the 
36.22 	license holder;
36.23 	(5) data regarding the license holder's accounting compliance;
36.24 	(6) data contained in vehicle disclosure forms and related documentation required in 
36.25 	section 342.35, subdivision 2, clauses (1) and (2); and
36.26 	(5) (7) data classified as nonpublic data or private data on individuals by chapter 13 or 
36.27 	other applicable law.

37.1 	Sec. 32. Minnesota Statutes 2024, section 342.20, is amended by adding a subdivision to 
37.2 	read:
37.3 		Subd. 6.Test results data. Notwithstanding section 342.20, subdivision 1, clause (5), 
37.4 	test results maintained by any cannabis business or hemp business must be made available 
37.5 	for public review consistent with section 342.61, subdivision 5, paragraph (c).

37.6 	Sec. 33. Minnesota Statutes 2024, section 342.22, subdivision 1, is amended to read:
37.7 		Subdivision 1.Registration required. Before making retail sales to customers or patients, 
37.8 	a cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, medical cannabis 
37.9 	combination business macrobusiness, or lower-potency hemp edible retailer must register 
37.10 	with the city, town, or county in which the retail establishment is located. A county may 
37.11 	issue a registration in cases where a city or town has provided consent for the county to 
37.12 	issue the registration for the jurisdiction.

37.13 	EFFECTIVE DATE. This section is effective January 1, 2027.

37.14 	Sec. 34. Minnesota Statutes 2025 Supplement, section 342.22, subdivision 3, is amended 
37.15 	to read:
37.16 		Subd. 3.Issuance of registration. (a) A local unit of government shall issue a retail 
37.17 	registration to a cannabis microbusiness with a retail operations endorsement, cannabis 
37.18 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
37.19 	combination business macrobusiness operating a retail location, or lower-potency hemp 
37.20 	edible retailer that:
37.21 	(1) has a valid license or preliminary license approval issued by the office;
37.22 	(2) has paid the registration fee or renewal fee pursuant to subdivision 2;
37.23 	(3) is found to be in compliance with the requirements of this chapter at any preliminary 
37.24 	compliance check that the local unit of government performs; and
37.25 	(4) if applicable, is current on all property taxes and assessments at the location where 
37.26 	the retail establishment is located.
37.27 	(b) Before issuing a retail registration, the local unit of government may conduct a 
37.28 	preliminary compliance check to ensure that the cannabis business or hemp business is in 
37.29 	compliance with any applicable local ordinance established pursuant to section 342.13.
38.1 	(c) A local unit of government shall renew the retail registration of a cannabis business 
38.2 	or hemp business when the office renews the license of the cannabis business or hemp 
38.3 	business.
38.4 	(d) A retail registration issued under this section may not be transferred.

38.5 	EFFECTIVE DATE. This section is effective January 1, 2027.

38.6 	Sec. 35. Minnesota Statutes 2024, section 342.22, subdivision 4, is amended to read:
38.7 		Subd. 4.Compliance checks. (a) A local unit of government shall conduct compliance 
38.8 	checks of every cannabis business and hemp business with a retail registration issued by 
38.9 	the local unit of government. During a compliance check, a local unit of government shall 
38.10 	assess a business's compliance with age verification requirements and compliance with any 
38.11 	applicable local ordinance established pursuant to section 342.13.
38.12 	(b) A local unit of government must conduct unannounced age verification compliance 
38.13 	checks of every cannabis business and hemp business at least once each calendar year. Age 
38.14 	verification compliance checks must involve persons at least 17 years of age but under the 
38.15 	age of 21 who, with the prior written consent of a parent or guardian if the person is under 
38.16 	the age of 18, attempt to purchase adult-use cannabis flower, adult-use cannabis products, 
38.17 	lower-potency hemp edibles, or hemp-derived consumer products under the direct supervision 
38.18 	of a law enforcement officer or an employee of the local unit of government.
38.19 	(c) A local government with retail registration authority that performs compliance checks 
38.20 	must annually submit data regarding compliance checks to the office. The data must include:
38.21 	(1) the name of the cannabis business and the business's address, license number, and 
38.22 	type of business under chapter 342;
38.23 	(2) the results of the compliance check, including whether the business was compliant 
38.24 	with any applicable local ordinances;
38.25 	(3) the date and time of the compliance check;
38.26 	(4) a description of any specific violation of a local ordinance, including any failure to 
38.27 	request documentation for age verification, an age verification method that violates this 
38.28 	chapter, or any other violation of a local ordinance; and
38.29 	(5) any warnings, fines, suspensions, or other actions taken by the local government in 
38.30 	response to the business's violation of a local ordinance.
38.31 	(d) A local government may provide the office with data from a compliance check before 
38.32 	the annual submission date. A local government may provide the office with data from a 
39.1 	compliance check by notifying the office of a suspended retail registration according to 
39.2 	subdivision 5, paragraph (a).

39.3 	Sec. 36. Minnesota Statutes 2024, section 342.22, subdivision 5, is amended to read:
39.4 		Subd. 5.Registration suspension and cancellation; notice to office; penalties. (a) If 
39.5 	a local unit of government determines that a cannabis business or hemp business with a 
39.6 	retail registration issued by the local unit of government is not operating in compliance with 
39.7 	the requirements of a local ordinance authorized under section 342.13 or that the operation 
39.8 	of the business poses an immediate threat to the health or safety of the public, the local unit 
39.9 	of government may suspend the retail registration of the cannabis business or hemp business. 
39.10 	The local unit of government must immediately notify the office of the suspension and shall 
39.11 	include a description of the grounds for the suspension.
39.12 	(b) The office shall review the retail registration suspension and may order reinstatement 
39.13 	of the retail registration or take any action described in section 342.19 or 342.21.
39.14 	(c) The retail registration suspension must be for up to 30 days unless the office suspends 
39.15 	the license and operating privilege of the cannabis business or hemp business for a longer 
39.16 	period or revokes the license.
39.17 	(d) The local unit of government may reinstate the retail registration if the local unit of 
39.18 	government determines that any violation has been cured. The local unit of government 
39.19 	must reinstate the retail registration if the office orders reinstatement.
39.20 	(e) No cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, medical
39.21 	cannabis combination business macrobusiness, or lower-potency hemp edible retailer may 
39.22 	make any sale to a customer or patient without a valid retail registration with a local unit 
39.23 	of government and a valid license with any applicable endorsement from the office. A local 
39.24 	unit of government may impose a civil penalty of up to $2,000 for each violation of this 
39.25 	paragraph.

39.26 	EFFECTIVE DATE. This section is effective January 1, 2027.

39.27 	Sec. 37. Minnesota Statutes 2024, section 342.23, subdivision 5, is amended to read:
39.28 		Subd. 5.Financial relationship. (a) Except for the lawful sale of cannabis plants, 
39.29 	cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp 
39.30 	edibles, and hemp-derived consumer products in the ordinary course of business and as 
39.31 	otherwise provided in this subdivision, No cannabis business or hemp business may offer, 
39.32 	give, accept, receive, or borrow money or anything else of value or accept or receive credit 
40.1 	from any other cannabis business. This prohibition applies to or hemp business, including
40.2 	offering or receiving a benefit in exchange for preferential placement by a retailer, including
40.3 	and offering or receiving preferential placement on the retailer's shelves, display cases, or 
40.4 	website. This The prohibition in this paragraph applies to every cooperative member or 
40.5 	every director, manager, and general partner of a cannabis business or hemp business.
40.6 	(b) The prohibition in paragraph (a) does not apply to the lawful sale of cannabis plants, 
40.7 	cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp 
40.8 	edibles, and hemp-derived consumer products in the ordinary course of business and as 
40.9 	otherwise provided in this subdivision.
40.10 	This (c) The prohibition in paragraph (a) does not apply to merchandising credit in the 
40.11 	ordinary course of business for a period not to exceed 30 days.
40.12 	(c) This (d) The prohibition in paragraph (a) does not apply to free samples of usable 
40.13 	cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
40.14 	products packaged in a sample jar protected by a plastic or metal mesh screen to allow 
40.15 	customers to smell the cannabis flower, cannabis product, lower-potency hemp edible, or 
40.16 	hemp-derived consumer product before purchase. A sample jar may not contain more than 
40.17 	eight grams of usable cannabis flower, more than eight grams of a cannabis concentrate, an 
40.18 	edible cannabis product infused with more than 100 milligrams of tetrahydrocannabinol, a 
40.19 	lower-potency hemp edible infused with more than 50 milligrams of tetrahydrocannabinol, 
40.20 	or a hemp-derived consumer product with a total weight of more than eight grams.
40.21 	(d) This (e) The prohibition in paragraph (a) does not apply to free samples of cannabis 
40.22 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products 
40.23 	provided to a retailer or cannabis wholesaler for the purposes of quality control and to allow 
40.24 	retailers to determine whether to offer a product for sale. A sample provided for these 
40.25 	purposes may not contain more than eight grams of usable cannabis flower, more than eight 
40.26 	grams of a cannabis concentrate, an edible cannabis product infused with more than 100 
40.27 	milligrams of tetrahydrocannabinol, a lower-potency hemp edible infused with more than 
40.28 	50 milligrams of tetrahydrocannabinol, or a hemp-derived consumer product with a total 
40.29 	weight of more than eight grams.
40.30 	(e) This (f) The prohibition in paragraph (a) does not apply to any fee charged by a 
40.31 	licensed cannabis event organizer to a cannabis business or hemp business for participation 
40.32 	in a cannabis event.
41.1 	(g) The prohibition in paragraph (a) does not apply to any transaction entered into in 
41.2 	good faith by a cannabis business or hemp business for the sale of goods or services at fair 
41.3 	market value.

41.4 	EFFECTIVE DATE. This section is effective the day following final enactment.

41.5 	Sec. 38. Minnesota Statutes 2024, section 342.23, is amended by adding a subdivision to 
41.6 	read:
41.7 		Subd. 7.Cannabis and hemp business occupying the same premises. (a) A cannabis 
41.8 	business or hemp business may occupy the same premises as another cannabis or hemp 
41.9 	business provided that:
41.10 	(1) the businesses have the same majority owners in common; and
41.11 	(2) the majority owners in common each individually own more than ten percent in each 
41.12 	of the businesses.
41.13 	(b) All sales or transport of regulated products to and from licensed cannabis businesses 
41.14 	must be recorded in the statewide monitoring system.
41.15 	(c) A cannabis business occupying the same premises as another cannabis or hemp 
41.16 	business as authorized by this subdivision may transport regulated products between 
41.17 	businesses on the shared premises.
41.18 	(d) Businesses that occupy the same premises are jointly liable for any violations of this 
41.19 	chapter or Minnesota Rules, chapter 9810.

41.20 	Sec. 39. [342.245] ENDORSEMENTS.
41.21 	(a) The office must establish procedures for the processing of cannabis endorsements 
41.22 	issued under this chapter.
41.23 	(b) The office may deny an endorsement application if:
41.24 	(1) the license holder has previously had an endorsement suspended, revoked, or canceled 
41.25 	by the office within the last five years;
41.26 	(2) the license holder owes outstanding fines to the office for violations; or
41.27 	(3) the license holder does not meet the requirements to:
41.28 	(i) conduct activities authorized by the endorsement; or
41.29 	(ii) conduct activities authorized by the endorsement at the specific location indicated 
41.30 	on the application.
42.1 	(c) The office must not charge a fee to an applicant for an endorsement application.
42.2 	(d) The office must align the term and renewal period for an endorsement with the term 
42.3 	and renewal period of the applicant's license.

42.4 	Sec. 40. Minnesota Statutes 2024, section 342.25, subdivision 1, is amended to read:
42.5 		Subdivision 1.Applicability. Every (a) A cannabis business with a license or 
42.6 	endorsement authorizing the cultivation of cannabis seeking to cultivate cannabis must 
42.7 	comply with the requirements of this section apply for and obtain a cannabis cultivation 
42.8 	endorsement.
42.9 	(b) A cannabis cultivation endorsement is available to the following license holders:
42.10 	(1) cannabis microbusinesses;
42.11 	(2) cannabis mezzobusinesses;
42.12 	(3) cannabis macrobusinesses; and
42.13 	(4) cannabis cultivators.

42.14 	Sec. 41. Minnesota Statutes 2024, section 342.25, subdivision 2, is amended to read:
42.15 		Subd. 2.Cultivation records. A business licensed or authorized to cultivate cannabis
42.16 	with a cannabis cultivation endorsement must prepare a cultivation record for each batch 
42.17 	of cannabis plants and cannabis flower in the form required by the office and must maintain 
42.18 	each record for at least five years. The A cultivation record must include the quantity and 
42.19 	timing, where if applicable, of each pesticide, fertilizer, soil amendment, or plant amendment 
42.20 	used to cultivate the batch, as well as any other information required by the office in rule. 
42.21 	The A cannabis business must present provide cultivation records to the office, the 
42.22 	commissioner of agriculture, or the commissioner of health upon request.

42.23 	Sec. 42. Minnesota Statutes 2024, section 342.25, subdivision 3, is amended to read:
42.24 		Subd. 3.Agricultural chemicals and other inputs. A business licensed or authorized 
42.25 	to cultivate cannabis with a cannabis cultivation endorsement is subject to rules promulgated 
42.26 	by the office in consultation with the commissioner of agriculture, subject to subdivision 
42.27 	5, governing the use of pesticides, fertilizers, soil amendments, plant amendments, and other 
42.28 	inputs to cultivate cannabis.

43.1 	Sec. 43. Minnesota Statutes 2024, section 342.25, subdivision 4, is amended to read:
43.2 		Subd. 4.Cultivation plan. A business licensed or authorized to cultivate cannabis with 
43.3 	a cannabis cultivation endorsement must prepare, maintain, and execute an operating plan 
43.4 	and a cultivation plan as directed by the office in rule, which must include but is not limited 
43.5 	to:
43.6 	(1) water usage;
43.7 	(2) recycling;
43.8 	(3) solid waste disposal; and
43.9 	(4) a pest management protocol that incorporates integrated pest management principles 
43.10 	to control or prevent the introduction of pests to the cultivation site.

43.11 	Sec. 44. Minnesota Statutes 2024, section 342.25, subdivision 5, is amended to read:
43.12 		Subd. 5.Agricultural chemicals and other inputs; pollinator protection. (a) A business 
43.13 	licensed or authorized to cultivate cannabis with a cannabis cultivation endorsement must 
43.14 	comply with chapters 18B, 18C, 18D, and any other pesticide, fertilizer, soil amendment, 
43.15 	and plant amendment laws and rules enforced by the commissioner of agriculture.
43.16 	(b) A business licensed or authorized to cultivate cannabis with a cannabis cultivation 
43.17 	endorsement must not apply pesticides when pollinators are present or allow pesticides to 
43.18 	drift to flowering plants that are attractive to pollinators.

43.19 	Sec. 45. Minnesota Statutes 2024, section 342.25, subdivision 6, is amended to read:
43.20 		Subd. 6.Adulteration prohibited. A business licensed or authorized to cultivate cannabis
43.21 	with a cannabis cultivation endorsement must not treat or otherwise adulterate cannabis 
43.22 	plants or cannabis flower with any substance or compound that has the effect or intent of 
43.23 	altering the color, appearance, weight, potency, or odor of the cannabis.

43.24 	Sec. 46. Minnesota Statutes 2024, section 342.25, subdivision 7, is amended to read:
43.25 		Subd. 7.Indoor or outdoor cultivation authorized; security. A business licensed or 
43.26 	authorized to cultivate cannabis cultivator, cannabis microbusiness, cannabis mezzobusiness, 
43.27 	or cannabis macrobusiness with a cannabis cultivation endorsement may cultivate cannabis 
43.28 	plants either indoors or outdoors, subject to the security, fencing, lighting, and any other 
43.29 	requirements imposed by the office in rule.

44.1 	Sec. 47. Minnesota Statutes 2024, section 342.26, subdivision 1, is amended to read:
44.2 		Subdivision 1.Applicability. Every (a) A cannabis business with a license or 
44.3 	endorsement authorizing the creation of cannabis concentrate and manufacture of cannabis 
44.4 	products and hemp-derived consumer products for public consumption must comply with 
44.5 	the requirements of this section seeking to manufacture cannabis products must apply for 
44.6 	and obtain the applicable endorsement according to subdivisions 3 and 4.
44.7 	(b) An endorsement under subdivisions 3 and 4 is available to the following license 
44.8 	holders:
44.9 	(1) cannabis microbusinesses;
44.10 	(2) cannabis mezzobusinesses;
44.11 	(3) cannabis macrobusinesses; and
44.12 	(4) cannabis manufacturers.

44.13 	Sec. 48. Minnesota Statutes 2024, section 342.26, subdivision 2, is amended to read:
44.14 		Subd. 2.All manufacturer operations. (a) Cannabis manufacturing must take place in 
44.15 	an enclosed, locked facility that is used exclusively for the manufacture of cannabis products, 
44.16 	creation of hemp concentrate, creation of artificially derived cannabinoids, creation of 
44.17 	lower-potency hemp edibles, or creation of hemp-derived consumer products, except that 
44.18 	a business that also holds a cannabis cultivator license may operate in a facility that shares 
44.19 	general office space, bathrooms, entryways, and walkways.
44.20 	(b) Cannabis manufacturing must take place on equipment that is used exclusively for 
44.21 	the manufacture of cannabis products, creation of hemp concentrate, creation of artificially 
44.22 	derived cannabinoids, creation of lower-potency hemp edibles, or creation of hemp-derived 
44.23 	consumer products.
44.24 	(c) A business licensed or authorized to manufacture cannabis products with an 
44.25 	endorsement under subdivision 3 or 4 must comply with all applicable packaging, labeling, 
44.26 	and health and safety requirements.

44.27 	Sec. 49. Minnesota Statutes 2024, section 342.26, subdivision 3, is amended to read:
44.28 		Subd. 3.Cannabis extraction and concentration endorsement, hemp extraction and 
44.29 	concentration endorsement, and creation of artificially derived cannabinoids 
44.30 	endorsement. (a) A cannabis business licensed or authorized seeking to manufacture 
44.31 	cannabis products that creates cannabis concentrate, hemp concentrate, or artificially derived 
45.1 	cannabinoids must apply for and obtain ana cannabis extraction and concentration 
45.2 	endorsement from the office.
45.3 	(b) A cannabis business seeking to manufacture hemp concentrate must apply for and 
45.4 	obtain a hemp extraction and concentration endorsement.
45.5 	(c) A cannabis business seeking to manufacture artificially derived cannabinoids must 
45.6 	apply for and obtain a creation of artificially derived cannabinoids endorsement. A cannabis 
45.7 	business must hold a hemp extraction and concentration endorsement to apply for and obtain 
45.8 	a creation of artificially derived cannabinoids endorsement.
45.9 	(b) (d) A business licensed or authorized to manufacture cannabis products with a 
45.10 	cannabis extraction and concentration endorsement, hemp extraction and concentration 
45.11 	endorsement, or creation of artificially derived cannabinoids endorsement must inform the 
45.12 	office of all methods of extraction and concentration that the manufacturer intends to use 
45.13 	and identify the volatile chemicals, if any, that will be involved in the creation of cannabis 
45.14 	concentrate or hemp concentrate. A cannabis manufacturer business with a cannabis 
45.15 	extraction and concentration endorsement, hemp extraction and concentration endorsement, 
45.16 	or creation of artificially derived cannabinoids endorsement may not use a method of 
45.17 	extraction and concentration or a volatile chemical without approval by the office.
45.18 	(c) (e) A business licensed or authorized to manufacture cannabis products with a cannabis 
45.19 	extraction and concentration endorsement, hemp extraction and concentration endorsement, 
45.20 	or creation of artificially derived cannabinoids endorsement must inform the office of all 
45.21 	methods of conversion that the manufacturer will use, including any specific catalysts that 
45.22 	the manufacturer will employ, to create artificially derived cannabinoids and the molecular 
45.23 	nomenclature of all cannabinoids or other chemical compounds that the manufacturer will 
45.24 	create. A business licensed or authorized to manufacture cannabis products with a cannabis 
45.25 	extraction and concentration endorsement, hemp extraction and concentration endorsement, 
45.26 	or creation of artificially derived cannabinoids endorsement may not use a method of 
45.27 	conversion or a catalyst without approval by the office.
45.28 	(d) (f) A business licensed or authorized to manufacture cannabis products with a cannabis 
45.29 	extraction and concentration endorsement, hemp extraction and concentration endorsement, 
45.30 	or creation of artificially derived cannabinoids endorsement must obtain a certification from 
45.31 	an independent third-party industrial hygienist or professional engineer approving:
45.32 	(1) all electrical, gas, fire suppression, and exhaust systems; and
45.33 	(2) the plan for safe storage and disposal of hazardous substances, including but not 
45.34 	limited to any volatile chemicals.
46.1 	(e) (g) A business licensed or authorized to manufacture cannabis products that 
46.2 	manufactures with a cannabis extraction and concentration endorsement may manufacture
46.3 	cannabis concentrate from cannabis flower received from an unlicensed person who is at 
46.4 	least 21 years of age and must comply with all health and safety requirements established 
46.5 	by the office. At a minimum, the office shall require the manufacturer to:
46.6 	(1) store the cannabis flower in an area that is segregated from cannabis flower and hemp 
46.7 	plant parts received from a licensed cannabis business;
46.8 	(2) perform the extraction and concentration on equipment that is used exclusively for 
46.9 	extraction or concentration of cannabis flower received from unlicensed individuals;
46.10 	(3) store any cannabis concentrate in an area that is segregated from cannabis concentrate, 
46.11 	hemp concentrate, or artificially derived cannabinoids derived or manufactured from cannabis 
46.12 	flower or hemp plant parts received from a licensed cannabis business; and
46.13 	(4) provide any cannabis concentrate only to the person who provided the cannabis 
46.14 	flower.
46.15 	(f) (h) Upon the sale of cannabis concentrate, hemp concentrate, or artificially derived 
46.16 	cannabinoids to any person, cooperative, or business, a business licensed or authorized to 
46.17 	manufacture cannabis products with a cannabis extraction and concentration endorsement, 
46.18 	hemp extraction and concentration endorsement, or creation of artificially derived 
46.19 	cannabinoids endorsement must provide a statement to the buyer that discloses the method 
46.20 	of extraction and concentration or conversion used and any solvents, gases, or catalysts, 
46.21 	including but not limited to any volatile chemicals, involved in that method.

46.22 	Sec. 50. Minnesota Statutes 2024, section 342.26, subdivision 4, is amended to read:
46.23 		Subd. 4.Edible cannabinoid product handler endorsement and production of 
46.24 	consumer products endorsement. (a) A cannabis business licensed or authorized to 
46.25 	manufacture cannabis products that produces edible cannabis products or lower-potency 
46.26 	hemp ediblesseeking to produce edible cannabis products or lower-potency hemp edibles 
46.27 	must apply for and obtain an edible cannabinoid product handler endorsement from the 
46.28 	office.
46.29 	(b) A cannabis business with an edible cannabinoid product handler endorsement must 
46.30 	comply with the requirements in section 342.07, subdivision 3.
46.31 	(b) (c) A cannabis business licensed or authorized to manufacture cannabis products
46.32 	seeking to produce hemp-derived consumer products or cannabis products other than edible 
47.1 	cannabis products must apply for and obtain ana production of consumer products 
47.2 	endorsement from the office to produce:.
47.3 	(1) cannabis products other than edible cannabis products; or
47.4 	(2) hemp-derived consumer products other than lower-potency hemp edibles.
47.5 	(c) (d) A cannabis business with an endorsement under this subdivision must ensure that
47.6 	all areas within the licensed premises of a the business licensed or authorized to manufacture 
47.7 	cannabis products producing cannabis products, lower-potency hemp edibles, or 
47.8 	hemp-derived consumer products must meet the sanitary standards specified in rules adopted 
47.9 	by the office.
47.10 	(d) (e) A cannabis business licensed or authorized to manufacture cannabis products
47.11 	with an endorsement under this subdivision may only add chemicals or compounds approved 
47.12 	by the office to cannabis concentrate, hemp concentrate, or artificially derived cannabinoids.
47.13 	(e) (f) Upon the sale of any cannabis product, lower-potency hemp edible, or 
47.14 	hemp-derived consumer product to a cannabis business or hemp business, a cannabis business 
47.15 	licensed or authorized to manufacture cannabis products with an endorsement under this 
47.16 	subdivision must provide a statement to the buyer that discloses the product's ingredients, 
47.17 	including but not limited to any chemicals or compounds and any major food allergens 
47.18 	declared by name.
47.19 	(f) (g) A business licensed or authorized to manufacture cannabis products shall with 
47.20 	an endorsement under this subdivision must not add any cannabis flower, cannabis 
47.21 	concentrate, artificially derived cannabinoid, hemp plant part, or hemp concentrate to a 
47.22 	product where if the manufacturer of the product holds a trademark to the product's name, 
47.23 	except that a business licensed or authorized to manufacture cannabis products may use a 
47.24 	trademarked food product if the manufacturer uses the product as a component or as part 
47.25 	of a recipe and where if the business licensed or authorized to manufacture cannabis products 
47.26 	does not state or advertise to the customer that the final retail cannabis product, lower-potency 
47.27 	hemp edible, or hemp-derived consumer product contains a trademarked food product.

47.28 	Sec. 51. Minnesota Statutes 2024, section 342.26, subdivision 5, is amended to read:
47.29 		Subd. 5.Exception. Nothing in this section applies to the operations of a lower-potency 
47.30 	hemp edible manufacturer. A lower-potency hemp edible manufacturer must comply with 
47.31 	section 342.45 and applicable rules.

48.1 	Sec. 52. Minnesota Statutes 2024, section 342.27, subdivision 1, is amended to read:
48.2 		Subdivision 1.Applicability. Every (a) A cannabis business with a license or 
48.3 	endorsement authorizing the seeking to conduct retail sale sales of cannabis flower or,
48.4 	cannabis products, hemp-derived consumer products, or lower-potency hemp edible products
48.5 	must comply with the requirements of this section apply for and obtain a cannabis retail 
48.6 	operations endorsement.
48.7 	(b) A cannabis retail operations endorsement is available to the following license holders:
48.8 	(1) cannabis microbusinesses;
48.9 	(2) cannabis mezzobusinesses;
48.10 	(3) cannabis macrobusinesses; and
48.11 	(4) cannabis retailers.

48.12 	Sec. 53. Minnesota Statutes 2024, section 342.27, subdivision 2, is amended to read:
48.13 		Subd. 2.Sale of cannabis and cannabinoid products. (a) A cannabis business with a 
48.14 	license or endorsement authorizing the retail sale of cannabis flower or cannabis products 
48.15 	may only sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
48.16 	cannabis products, lower-potency hemp edibles, and hemp-derived consumer products to 
48.17 	individuals who are at least 21 years of age.
48.18 	(b) A cannabis business with a license or endorsement authorizing the retail sale of 
48.19 	adult-use cannabis flower or adult-use cannabis products may sell immature cannabis plants 
48.20 	and seedlings, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
48.21 	edibles, and hemp-derived consumer products that:
48.22 	(1) are obtained from a business licensed under this chapter; and
48.23 	(2) meet all applicable packaging and labeling requirements.
48.24 	(c) A cannabis business with a license or endorsement authorizing the retail sale of 
48.25 	cannabis flower or cannabis products may sell up to two ounces of adult-use cannabis flower 
48.26 	or hemp-derived consumer products consisting primarily of hemp plant parts, up to eight 
48.27 	grams of adult-use cannabis concentrate or hemp-derived consumer products consisting 
48.28 	primarily of hemp concentrate or artificially derived cannabinoids, and edible cannabis 
48.29 	products and lower-potency hemp edibles infused with up to 800 milligrams of 
48.30 	tetrahydrocannabinol during a single transaction to a customer.
49.1 	(d) Edible adult-use cannabis products and hemp-derived consumer products intended 
49.2 	to be eaten may not include more than ten milligrams of tetrahydrocannabinol per serving 
49.3 	and a single package may not include more than a total of 200 milligrams of 
49.4 	tetrahydrocannabinol. A package may contain multiple servings of ten milligrams of 
49.5 	tetrahydrocannabinol provided that each serving is indicated by scoring, wrapping, or other 
49.6 	indicators designating the individual serving size.
49.7 	(e) Edible adult-use cannabis products and hemp-derived consumer products intended 
49.8 	to be consumed as beverages may not include more than ten milligrams of 
49.9 	tetrahydrocannabinol per serving. A single beverage container may not contain more than 
49.10 	two servings.

49.11 	EFFECTIVE DATE. This section is effective the day following final enactment.

49.12 	Sec. 54. Minnesota Statutes 2024, section 342.27, is amended by adding a subdivision to 
49.13 	read:
49.14 		Subd. 2a.Cannabis flower packaging endorsement. (a) A cannabis business seeking 
49.15 	to package cannabis flower at a point of retail sale must apply for and obtain a cannabis 
49.16 	flower packaging endorsement.
49.17 	(b) A cannabis business with a cannabis flower packaging endorsement must package 
49.18 	cannabis flower in a container that:
49.19 	(1) complies with all packaging requirements in section 342.62;
49.20 	(2) complies with all applicable rules; and
49.21 	(3) includes an affixed label on the container that, at the final point of sale to a customer, 
49.22 	meets all requirements in section 342.63 and applicable rules.
49.23 	(c) A cannabis business with a cannabis flower packaging endorsement may store bulk 
49.24 	cannabis flower intended to be packaged at the point of sale outside of the secure storage 
49.25 	area during operating hours. At the end of operating hours, the business must ensure that 
49.26 	bulk cannabis flower is placed in the secure storage area.
49.27 	(d) A cannabis flower packaging endorsement is available to the following license holders 
49.28 	only if the license holder holds a cannabis retail operations endorsement:
49.29 	(1) cannabis microbusinesses;
49.30 	(2) cannabis mezzobusinesses;
49.31 	(3) cannabis macrobusinesses; and
50.1 	(4) cannabis retailers.

50.2 	Sec. 55. Minnesota Statutes 2024, section 342.27, subdivision 12, is amended to read:
50.3 		Subd. 12.Prohibitions. A cannabis business with a license or endorsement authorizing 
50.4 	the retail sale of cannabis flower or cannabis products shall not:
50.5 	(1) sell cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
50.6 	consumer products to a person who is visibly intoxicated;
50.7 	(2) knowingly sell more cannabis flower, cannabis products, lower-potency hemp edibles, 
50.8 	or hemp-derived consumer products than a customer is legally permitted to possess;
50.9 	(3) give away immature cannabis plants or seedlings, cannabis flower, cannabis products, 
50.10 	lower-potency hemp edibles, or hemp-derived consumer products;
50.11 	(4) operate a drive-through window;
50.12 	(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
50.13 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines; or
50.14 	(6) sell cannabis plants, cannabis flower, or cannabis products if the cannabis retailer 
50.15 	knows that any required security or statewide monitoring systems are not operational.; or
50.16 	(7) sell medical cannabinoid products to a person who is not registered in the patient 
50.17 	registry or is not enrolled in the registry program as a patient or caregiver.

50.18 	Sec. 56. Minnesota Statutes 2025 Supplement, section 342.28, subdivision 1, is amended 
50.19 	to read:
50.20 		Subdivision 1.Authorized actions. A cannabis microbusiness license, consistent with 
50.21 	the specific license endorsement or endorsements, entitles the license holder to perform any 
50.22 	or all of the following within the limits established by this section:
50.23 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
50.24 	cannabis flower from a mature plant;
50.25 	(2) make cannabis concentrate;
50.26 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
50.27 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
50.28 	(4) manufacture artificially derived cannabinoids;
50.29 	(5) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
50.30 	hemp-derived consumer products for public consumption;
51.1 	(6) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products, 
51.2 	lower-potency hemp edibles, and hemp-derived consumer products from another cannabis 
51.3 	microbusiness, a cannabis mezzobusiness, a cannabis cultivator, a cannabis manufacturer, 
51.4 	a cannabis wholesaler, a medical cannabis combination business macrobusiness, a 
51.5 	lower-potency hemp edible manufacturer, or a lower-potency hemp edible wholesaler;
51.6 	(7) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
51.7 	under chapter 18K;
51.8 	(8) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
51.9 	18K;
51.10 	(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids 
51.11 	from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, 
51.12 	or a cannabis wholesaler for use in manufacturing adult-use cannabis products, lower-potency 
51.13 	hemp edibles, or hemp-derived consumer products;
51.14 	(10) package and label adult-use cannabis flower, adult-use cannabis products, 
51.15 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
51.16 	(11) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
51.17 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
51.18 	other products authorized by law to other cannabis businesses and to customers;
51.19 	(12) operate an establishment that permits on-site consumption of edible cannabis 
51.20 	products and lower-potency hemp edibles; and
51.21 	(13) perform other actions approved by the office.

51.22 	EFFECTIVE DATE. This section is effective January 1, 2027.

51.23 	Sec. 57. Minnesota Statutes 2024, section 342.28, subdivision 6, is amended to read:
51.24 		Subd. 6.Cannabis cultivation endorsement. A cannabis microbusiness that cultivates 
51.25 	cannabis plants and harvests cannabis flower must apply for and obtain a cannabis cultivation 
51.26 	endorsement and comply with the requirements in section 342.25.

51.27 	Sec. 58. Minnesota Statutes 2024, section 342.28, subdivision 7, is amended to read:
51.28 		Subd. 7.Cannabis extraction and concentration endorsement, hemp extraction and 
51.29 	concentration endorsement, and creation of artificially derived cannabinoids 
51.30 	endorsement. (a) A cannabis microbusiness that creates seeking to manufacture cannabis 
52.1 	concentrate must apply for and obtain a cannabis extraction and concentration endorsement 
52.2 	and comply with the requirements in section 342.26, subdivisions 2 and 3.
52.3 	(b) A cannabis microbusiness seeking to manufacture hemp concentrate must apply for 
52.4 	and obtain a hemp extraction and concentration endorsement and comply with the 
52.5 	requirements in section 342.26, subdivisions 2 and 3.
52.6 	(c) A cannabis microbusiness seeking to manufacture artificially derived cannabinoids 
52.7 	must apply for and obtain a creation of artificially derived cannabinoids endorsement and 
52.8 	comply with the requirements in section 342.26, subdivisions 2 and 3.

52.9 	Sec. 59. Minnesota Statutes 2025 Supplement, section 342.28, subdivision 8, is amended 
52.10 	to read:
52.11 		Subd. 8.Production of consumer products endorsement and edible cannabinoid 
52.12 	product handler endorsement. (a) A cannabis microbusiness that manufactures edible
52.13 	seeking to manufacture cannabis products, lower-potency hemp products, or hemp-derived 
52.14 	consumer products must apply for and obtain a production of consumer products endorsement 
52.15 	and comply with the requirements in section 342.26, subdivisions 2 and 4.
52.16 	(b) A cannabis microbusiness seeking to manufacture edible cannabis products or 
52.17 	lower-potency hemp edibles must apply for and obtain an edible cannabinoid product handler 
52.18 	endorsement and comply with the requirements in section 342.26, subdivisions 2 and 4.

52.19 	Sec. 60. Minnesota Statutes 2024, section 342.28, subdivision 9, is amended to read:
52.20 		Subd. 9.Retail operations endorsement. (a) A cannabis microbusiness that operates
52.21 	seeking to operate a retail location must apply for and obtain a cannabis retail operations 
52.22 	endorsement and comply with the requirements in section 342.27.
52.23 	(b) A cannabis microbusiness with a cannabis retail operations endorsement may apply 
52.24 	for and obtain a cannabis flower packaging endorsement subject to the requirements in 
52.25 	section 342.27, subdivision 2a.

52.26 	Sec. 61. Minnesota Statutes 2024, section 342.28, subdivision 11, is amended to read:
52.27 		Subd. 11.Transportation between facilities. A cannabis microbusiness may seeking 
52.28 	to transport immature cannabis plants and seedlings, cannabis flower, cannabis products, 
52.29 	artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp 
52.30 	edibles, and hemp-derived consumer products between facilities operated by the cannabis 
53.1 	microbusiness if must apply for and obtain an internal transporter endorsement. To obtain 
53.2 	an internal transporter endorsement, the cannabis microbusiness must:
53.3 	(1) provides provide the office with the information described in section 342.35, 
53.4 	subdivision 2; and
53.5 	(2) complies comply with the requirements of section 342.36.

53.6 	Sec. 62. Minnesota Statutes 2024, section 342.28, is amended by adding a subdivision to 
53.7 	read:
53.8 		Subd. 12.Medical cannabis cultivation endorsement. (a) A cannabis microbusiness 
53.9 	with a cultivation endorsement may apply for and obtain a medical cannabis cultivation 
53.10 	endorsement described in section 342.51, subdivision 1b.
53.11 	(b) A cannabis microbusiness with a medical cannabis cultivation endorsement that 
53.12 	cultivates cannabis at an indoor facility and meets the requirements of section 342.51, 
53.13 	subdivision 1b, may cultivate up to 1,000 square feet of plant canopy in addition to the 
53.14 	limits in section 342.28, subdivision 2, paragraph (a).
53.15 	(c) A cannabis microbusiness with a medical cannabis cultivation endorsement that 
53.16 	cultivates cannabis at an outdoor location and meets the requirements of section 342.51, 
53.17 	subdivision 1b, may cultivate up to one-quarter acre of mature flowering plants in addition 
53.18 	to the limits in section 342.28, subdivision 2, paragraph (b).

53.19 	EFFECTIVE DATE. This section is effective January 1, 2027.

53.20 	Sec. 63. Minnesota Statutes 2024, section 342.28, is amended by adding a subdivision to 
53.21 	read:
53.22 		Subd. 13.Medical cannabis manufacturer endorsement. (a) A cannabis microbusiness 
53.23 	may apply for and obtain a medical cannabis manufacturer endorsement as described in 
53.24 	section 342.51, subdivision 1c.
53.25 	(b) A cannabis microbusiness with a medical cannabis manufacturer endorsement that 
53.26 	meets the requirements of section 342.51, subdivision 1c, may manufacture cannabis 
53.27 	products, lower-potency hemp edibles, hemp-derived consumer products, or medical 
53.28 	cannabinoid products up to 25 percent above the limit established in rule for the 
53.29 	manufacturing capacity of a cannabis microbusiness.

53.30 	EFFECTIVE DATE. This section is effective January 1, 2027.

54.1 	Sec. 64. Minnesota Statutes 2024, section 342.28, is amended by adding a subdivision to 
54.2 	read:
54.3 		Subd. 14.Medical cannabis retail endorsement. (a) A cannabis microbusiness with a 
54.4 	retail endorsement may apply for and obtain a medical cannabis retail endorsement described 
54.5 	in section 342.51, subdivision 1d.
54.6 	(b) A cannabis microbusiness with a medical cannabis retail endorsement that meets the 
54.7 	requirements of section 342.51, subdivision 1d, may operate one additional retail location 
54.8 	in excess of the limit in section 342.28, subdivision 2, paragraph (d), if at least one retail 
54.9 	location is located in an area identified by the office as a high medical need area.

54.10 	EFFECTIVE DATE. This section is effective January 1, 2027.

54.11 	Sec. 65. Minnesota Statutes 2025 Supplement, section 342.29, subdivision 1, is amended 
54.12 	to read:
54.13 		Subdivision 1.Authorized actions. A cannabis mezzobusiness license, consistent with 
54.14 	the specific license endorsement or endorsements, entitles the license holder to perform any 
54.15 	or all of the following within the limits established by this section:
54.16 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
54.17 	cannabis flower from a mature plant for use as adult-use cannabis flower or for use in 
54.18 	adult-use cannabis products;
54.19 	(2) grow cannabis plants from seed or immature plant to mature plant and harvest 
54.20 	cannabis flower from a mature plant for use as medical cannabis flower or for use in medical 
54.21 	cannabinoid products;
54.22 	(3) make cannabis concentrate;
54.23 	(4) make hemp concentrate, including hemp concentrate with a delta-9 
54.24 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
54.25 	(5) manufacture artificially derived cannabinoids;
54.26 	(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
54.27 	hemp-derived consumer products for public consumption;
54.28 	(7) process medical cannabinoid products;
54.29 	(8) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products, 
54.30 	lower-potency hemp edibles, and hemp-derived consumer products from a cannabis 
54.31 	microbusiness, another cannabis mezzobusiness, a cannabis cultivator, a cannabis 
55.1 	manufacturer, a cannabis wholesaler, a medical cannabis combination business
55.2 	macrobusiness, a lower-potency hemp edible manufacturer, or a lower-potency hemp edible 
55.3 	wholesaler;
55.4 	(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids 
55.5 	from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis manufacturer, 
55.6 	or a cannabis wholesaler for use in manufacturing adult-use cannabis products, lower-potency 
55.7 	hemp edibles, or hemp-derived consumer products;
55.8 	(10) purchase hemp plant parts and propagules from a licensed hemp grower licensed 
55.9 	under chapter 18K;
55.10 	(11) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
55.11 	18K;
55.12 	(12) package and label adult-use cannabis flower, adult-use cannabis products, 
55.13 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
55.14 	(13) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
55.15 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
55.16 	other products authorized by law to other cannabis businesses and to customers; and
55.17 	(14) perform other actions approved by the office.

55.18 	EFFECTIVE DATE. This section is effective January 1, 2027.

55.19 	Sec. 66. Minnesota Statutes 2024, section 342.29, subdivision 5, is amended to read:
55.20 		Subd. 5.Cannabis cultivation endorsement. A cannabis mezzobusiness that cultivates
55.21 	seeking to cultivate cannabis plants and harvestsharvest cannabis flower must apply for 
55.22 	and obtain a cannabis cultivation endorsement and comply with the requirements in section 
55.23 	342.25.

55.24 	Sec. 67. Minnesota Statutes 2024, section 342.29, subdivision 6, is amended to read:
55.25 		Subd. 6.Cannabis extraction and concentration endorsement, hemp extraction and 
55.26 	concentration endorsement, and creation of artificially derived cannabinoids 
55.27 	endorsement. (a) A cannabis mezzobusiness that creates seeking to manufacture cannabis 
55.28 	concentrate must apply for and obtain a cannabis extraction and concentration endorsement 
55.29 	and comply with the requirements in section 342.26, subdivisions 2 and 3.
56.1 	(b) A cannabis mezzobusiness seeking to manufacture hemp concentrate must apply for 
56.2 	and obtain a hemp extraction and concentration endorsement and comply with the 
56.3 	requirements in section 342.26, subdivisions 2 and 3.
56.4 	(c) A cannabis mezzobusiness seeking to manufacture artificially derived cannabinoids 
56.5 	must apply for and obtain a creation of artificially derived cannabinoids endorsement and 
56.6 	comply with the requirements in section 342.26, subdivisions 2 and 3.

56.7 	Sec. 68. Minnesota Statutes 2025 Supplement, section 342.29, subdivision 7, is amended 
56.8 	to read:
56.9 		Subd. 7.Production of consumer products endorsement and edible cannabinoid 
56.10 	product handler endorsement. (a) A cannabis mezzobusiness that manufactures edible
56.11 	seeking to manufacture cannabis products, lower-potency hemp products, or hemp-derived 
56.12 	consumer products must apply for and obtain a production of consumer products endorsement 
56.13 	and comply with the requirements in section 342.26, subdivisions 2 and 4.
56.14 	(b) A cannabis mezzobusiness seeking to manufacture edible cannabis products or 
56.15 	lower-potency hemp edibles must apply for and obtain an edible cannabinoid product handler 
56.16 	endorsement and comply with the requirements in section 342.26, subdivisions 2 and 4.

56.17 	Sec. 69. Minnesota Statutes 2024, section 342.29, subdivision 8, is amended to read:
56.18 		Subd. 8.Retail operations endorsement. (a) A cannabis mezzobusiness that operates
56.19 	seeking to operate a retail location must apply for and obtain a cannabis retail operations 
56.20 	endorsement and comply with the requirements in section 342.27.
56.21 	(b) A cannabis mezzobusiness with a cannabis retail operations endorsement may apply 
56.22 	for and obtain a cannabis flower packaging endorsement subject to the requirements in 
56.23 	section 342.27, subdivision 2a.

56.24 	Sec. 70. Minnesota Statutes 2024, section 342.29, subdivision 8a, is amended to read:
56.25 		Subd. 8a.Multiple endorsements required. (a) Within 18 months of receiving a cannabis 
56.26 	mezzobusiness license, a cannabis mezzobusiness must apply for and obtain at least two of 
56.27 	the following endorsements identified in subdivisions 5, 6, 7, and 8.:
56.28 	(1) a cannabis cultivation endorsement under section 342.25;
56.29 	(2) a cannabis extraction and concentration endorsement under section 342.26;
56.30 	(3) a hemp extraction and concentration endorsement under section 342.26;
57.1 	(4) a creation of artificially derived cannabinoids endorsement under section 342.26;
57.2 	(5) an edible cannabinoid product handler endorsement under section 342.26;
57.3 	(6) a production of consumer products endorsement under section 342.26; or
57.4 	(7) a cannabis retail operations endorsement under section 342.27.
57.5 	(b) If a cannabis mezzobusiness fails to obtain multiple endorsements within 18 months, 
57.6 	the office may suspend, revoke, or not renew the license as provided in section 342.21.

57.7 	Sec. 71. Minnesota Statutes 2024, section 342.29, subdivision 10, is amended to read:
57.8 		Subd. 10.Transportation between facilities. A cannabis mezzobusiness may seeking 
57.9 	to transport immature cannabis plants and seedlings, cannabis flower, cannabis products, 
57.10 	artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp 
57.11 	edibles, and hemp-derived consumer products between facilities operated by the cannabis 
57.12 	mezzobusiness if must apply for and obtain an internal transporter endorsement. To obtain 
57.13 	an internal transporter endorsement, the cannabis mezzobusiness must:
57.14 	(1) provides provide the office with the information described in section 342.35, 
57.15 	subdivision 2; and
57.16 	(2) complies comply with the requirements of section 342.36.

57.17 	Sec. 72. Minnesota Statutes 2024, section 342.29, is amended by adding a subdivision to 
57.18 	read:
57.19 		Subd. 11.Medical cannabis cultivation endorsement. (a) A cannabis mezzobusiness 
57.20 	with a cultivation endorsement may apply for and obtain a medical cannabis cultivation 
57.21 	endorsement described in section 342.51, subdivision 1b.
57.22 	(b) A cannabis mezzobusiness with a medical cannabis cultivation endorsement that 
57.23 	cultivates cannabis at an indoor facility and meets the requirements of section 342.51, 
57.24 	subdivision 1b, may cultivate up to 3,000 square feet of plant canopy in addition to the 
57.25 	limits in section 342.29, subdivision 2, paragraph (a).
57.26 	(c) A cannabis mezzobusiness with a medical cannabis cultivation endorsement that 
57.27 	cultivates cannabis at an outdoor location and meets the requirements of section 342.51, 
57.28 	subdivision 1b, may cultivate up to one-half acre of mature flowering plants in addition to 
57.29 	the limits in section 342.29, subdivision 2, paragraph (b).

57.30 	EFFECTIVE DATE. This section is effective January 1, 2027.

58.1 	Sec. 73. Minnesota Statutes 2024, section 342.29, is amended by adding a subdivision to 
58.2 	read:
58.3 		Subd. 12.Medical cannabis manufacturer endorsement. (a) A cannabis mezzobusiness 
58.4 	may apply for and obtain a medical cannabis manufacturer endorsement as described in 
58.5 	section 342.51, subdivision 1c.
58.6 	(b) A cannabis mezzobusiness with a medical cannabis manufacturer endorsement that 
58.7 	meets the requirements of section 342.51, subdivision 1c, may manufacture cannabis 
58.8 	products, lower-potency hemp edibles, hemp-derived consumer products, or medical 
58.9 	cannabinoid products up to 25 percent above the limit established in rule for the 
58.10 	manufacturing capacity of a cannabis mezzobusiness.

58.11 	EFFECTIVE DATE. This section is effective January 1, 2027.

58.12 	Sec. 74. Minnesota Statutes 2024, section 342.29, is amended by adding a subdivision to 
58.13 	read:
58.14 		Subd. 13.Medical cannabis retail endorsement. (a) A cannabis mezzobusiness with 
58.15 	a retail endorsement may apply for and obtain a medical cannabis retail endorsement 
58.16 	described in section 342.51, subdivision 1d.
58.17 	(b) A cannabis mezzobusiness with a medical cannabis retail endorsement that meets 
58.18 	the requirements of section 342.51, subdivision 1d, may operate up to two additional retail 
58.19 	locations in excess of the limit in section 342.29, subdivision 2, paragraph (d), if at least 
58.20 	two retail locations are located in an area identified by the office as a high medical need 
58.21 	area.

58.22 	EFFECTIVE DATE. This section is effective January 1, 2027.

58.23 	Sec. 75. Minnesota Statutes 2025 Supplement, section 342.30, subdivision 1, is amended 
58.24 	to read:
58.25 		Subdivision 1.Authorized actions. (a) A cannabis cultivator seeking to cultivate cannabis 
58.26 	must apply for and obtain a cannabis cultivation endorsement.
58.27 	(b) A cannabis cultivator license entitles the license holder to with a cannabis cultivation 
58.28 	endorsement may:
58.29 	(1) grow cannabis plants within the approved amount of space from seed or immature 
58.30 	plant to mature plant;
58.31 	(2) harvest cannabis flower from a mature plant;
59.1 	(3) package and label immature cannabis plants and seedlings and cannabis flower for 
59.2 	sale to other cannabis businesses;
59.3 	(4) sell immature cannabis plants and seedlings and cannabis flower to other cannabis 
59.4 	businesses;
59.5 	(5) transport cannabis flower to a cannabis manufacturer located on the same premises; 
59.6 	and
59.7 	(6) perform other actions approved by the office.

59.8 	Sec. 76. Minnesota Statutes 2024, section 342.30, subdivision 3, is amended to read:
59.9 		Subd. 3.Additional information required. In addition to the information required to 
59.10 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
59.11 	a person, cooperative, or business seeking a cannabis cultivator license cultivation 
59.12 	endorsement must submit the following information in a form approved by the office:
59.13 	(1) an operating plan demonstrating the proposed size and layout of the cultivation 
59.14 	facility; plans for wastewater and waste disposal for the cultivation facility; plans for 
59.15 	providing electricity, water, and other utilities necessary for the normal operation of the 
59.16 	cultivation facility; and plans for compliance with the applicable building code and federal 
59.17 	and state environmental and workplace safety requirements;
59.18 	(2) a cultivation plan demonstrating the proposed size and layout of the cultivation 
59.19 	facility that will be used exclusively for cultivation including the total amount of plant 
59.20 	canopy; and
59.21 	(3) evidence that the business will comply with the applicable operation requirements 
59.22 	for the license being sought.

59.23 	Sec. 77. Minnesota Statutes 2024, section 342.30, is amended by adding a subdivision to 
59.24 	read:
59.25 		Subd. 6.Medical cannabis cultivation endorsement. (a) A cannabis cultivator with a 
59.26 	cultivation endorsement may apply for and obtain a medical cannabis cultivation endorsement 
59.27 	described in section 342.51, subdivision 1b.
59.28 	(b) A cannabis cultivator with a medical cannabis cultivation endorsement that cultivates 
59.29 	cannabis at an indoor facility and meets the requirements of section 342.51, subdivision 1b, 
59.30 	may cultivate up to 6,000 square feet of plant canopy in addition to the limits in section 
59.31 	342.30, subdivision 2, paragraph (a).
60.1 	(c) A cannabis cultivator with a medical cannabis cultivation endorsement that cultivates 
60.2 	cannabis at an outdoor location and meets the requirements of section 342.51, subdivision 
60.3 	1b, may cultivate up to one acre of mature flowering plants in addition to the limits in section 
60.4 	342.30, subdivision 2, paragraph (b).

60.5 	EFFECTIVE DATE. This section is effective January 1, 2027.

60.6 	Sec. 78. Minnesota Statutes 2024, section 342.31, subdivision 3, is amended to read:
60.7 		Subd. 3.Additional information required. In addition to the information required to 
60.8 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
60.9 	a person, cooperative, or business seeking a cannabis manufacturer license extraction and 
60.10 	concentration endorsement, a hemp extraction and concentration endorsement, a creation 
60.11 	of artificially derived cannabinoids endorsement, a production of consumer products 
60.12 	endorsement, or an edible product handler endorsement must submit the following 
60.13 	information in a form approved by the office:
60.14 	(1) an operating plan demonstrating the proposed layout of the facility, including a 
60.15 	diagram of ventilation and filtration systems; plans for wastewater and waste disposal for 
60.16 	the manufacturing facility; plans for providing electricity, water, and other utilities necessary 
60.17 	for the normal operation of the manufacturing facility; and plans for compliance with 
60.18 	applicable building code and federal and state environmental and workplace safety 
60.19 	requirements; and
60.20 	(2) evidence that the business will comply with the applicable operation requirements 
60.21 	for the endorsement being sought.

60.22 	Sec. 79. Minnesota Statutes 2024, section 342.31, subdivision 5, is amended to read:
60.23 		Subd. 5.Manufacturing operations and endorsements. (a) A cannabis manufacturer 
60.24 	must comply with the requirements in section 342.26. A cannabis manufacturer must apply 
60.25 	for and obtain a cannabis extraction and concentration endorsement, a hemp extraction and 
60.26 	concentration endorsement, a creation of artificially derived cannabinoids endorsement, a 
60.27 	production of consumer products endorsement, or an edible product handler endorsement 
60.28 	before conducting activities authorized only under the applicable endorsement.
60.29 	(b) A cannabis manufacturer may apply for and obtain a medical cannabis manufacturer 
60.30 	endorsement as described in section 342.51, subdivision 1c.

61.1 	Sec. 80. Minnesota Statutes 2025 Supplement, section 342.32, subdivision 1, is amended 
61.2 	to read:
61.3 		Subdivision 1.Authorized actions. (a) A cannabis retailer seeking to conduct retail 
61.4 	sales of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
61.5 	consumer products must apply for and obtain a cannabis retail operations endorsement.
61.6 	(b) A cannabis retailer license entitles the license holder to with a cannabis retail 
61.7 	operations endorsement may:
61.8 	(1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products, 
61.9 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
61.10 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
61.11 	cannabis wholesalers, and medical cannabis combination businesses macrobusinesses;
61.12 	(2) purchase lower-potency hemp edibles from a licensed lower-potency hemp edible 
61.13 	manufacturer or lower-potency hemp edible wholesaler;
61.14 	(3) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
61.15 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
61.16 	other products authorized by law to customers; and
61.17 	(4) perform other actions approved by the office.

61.18 	Sec. 81. Minnesota Statutes 2024, section 342.32, subdivision 3, is amended to read:
61.19 		Subd. 3.Additional information required. In addition to the information required to 
61.20 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
61.21 	a person, cooperative, or business seeking a cannabis retail license operations endorsement
61.22 	must submit the following information in a form approved by the office:
61.23 	(1) a list of every retail license held by the applicant and, if the applicant is a business, 
61.24 	every retail license held, either as an individual or as part of another business, by each 
61.25 	officer, director, manager, and general partner of the cannabis business;
61.26 	(2) an operating plan demonstrating the proposed layout of the facility, including a 
61.27 	diagram of ventilation and filtration systems; policies to avoid sales to individuals who are 
61.28 	under 21 years of age; identification of a restricted area for storage; and plans to prevent 
61.29 	the visibility of cannabis flower, cannabis products, lower-potency hemp edibles, and 
61.30 	hemp-derived consumer products to individuals outside the retail location; and
61.31 	(3) evidence that the business will comply with the applicable operation requirements 
61.32 	for the license being sought.

62.1 	Sec. 82. Minnesota Statutes 2024, section 342.32, is amended by adding a subdivision to 
62.2 	read:
62.3 		Subd. 6.Medical cannabis retail endorsement and medical cannabis delivery 
62.4 	endorsement. (a) A cannabis retailer with a retail endorsement may apply for and obtain 
62.5 	a medical cannabis retail endorsement described in section 342.51, subdivision 1d.
62.6 	(b) A cannabis retailer with a medical cannabis retail endorsement that meets the 
62.7 	requirements of section 342.51, subdivision 1d, may operate up to three additional retail 
62.8 	locations in excess of the limit in subdivision 2, if three retail locations are located in an 
62.9 	area identified by the office as a high medical need area.
62.10 	(c) A cannabis retailer with a medical cannabis retail endorsement and a cannabis delivery 
62.11 	license may apply for and obtain a medical cannabis delivery endorsement as described in 
62.12 	section 342.51, subdivision 1e.

62.13 	EFFECTIVE DATE. This section is effective January 1, 2027.

62.14 	Sec. 83. Minnesota Statutes 2024, section 342.35, subdivision 1, is amended to read:
62.15 		Subdivision 1.Authorized actions. A cannabis transporter license entitles the license 
62.16 	holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis 
62.17 	products, artificially derived cannabinoids, hemp plant parts, hemp concentrate, 
62.18 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
62.19 	microbusinesses, cannabis mezzobusinesses, cannabis macrobusinesses, cannabis cultivators, 
62.20 	cannabis manufacturers, cannabis wholesalers, lower-potency hemp edible manufacturers, 
62.21 	and industrial hemp growers to cannabis microbusinesses, cannabis mezzobusinesses, 
62.22 	cannabis macrobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis 
62.23 	wholesalers, cannabis retailers, and lower-potency hemp edible retailers, and medical 
62.24 	cannabis combination businesses and perform other actions approved by the office.

62.25 	EFFECTIVE DATE. This section is effective January 1, 2027.

62.26 	Sec. 84. Minnesota Statutes 2024, section 342.37, subdivision 1, is amended to read:
62.27 		Subdivision 1.Authorized actions. A cannabis testing facility license entitles the license 
62.28 	holder to:
62.29 	(1) obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis 
62.30 	products, hemp plant parts, hemp concentrate, artificially derived cannabinoids, 
62.31 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
62.32 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
63.1 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis 
63.2 	combination businesses macrobusinesses, and industrial hemp growers; and
63.3 	(2) perform other actions approved by the office.

63.4 	Sec. 85. Minnesota Statutes 2024, section 342.39, as amended by Laws 2025 chapter 31, 
63.5 	section 66, is amended to read:
63.6 	342.39 CANNABIS EVENT ORGANIZER LICENSING.
63.7 		Subdivision 1.Authorized actions. (a) A cannabis event organizer license entitles the 
63.8 	license holder to organize a temporary cannabis events, with each event lasting no more 
63.9 	than four days, and perform other actions approved by the office.
63.10 	(b) For each temporary cannabis event, the license holder is required to submit additional 
63.11 	information pursuant to section 342.40.
63.12 		Subd. 2.Additional information required. (a) In addition to the information required 
63.13 	to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that 
63.14 	section, a person, cooperative, or business seeking a cannabis event organizer license must 
63.15 	submit the following information in a form approved by the office:
63.16 	(1) the type and number of any other cannabis business license held by the applicant;
63.17 	(2) the address and location where the temporary cannabis event will take place;
63.18 	(3) the name of the temporary cannabis event;
63.19 	(4) a diagram of the physical layout of the temporary cannabis event showing where the 
63.20 	event will take place on the grounds, all entrances and exits that will be used by participants 
63.21 	during the event, all cannabis consumption areas, all cannabis retail areas where cannabis 
63.22 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
63.23 	will be sold, the location where cannabis waste will be stored, and any location where 
63.24 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
63.25 	products will be stored;
63.26 	(5) a list of the name, number, and type of cannabis businesses and hemp businesses 
63.27 	that will sell cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
63.28 	lower-potency hemp edibles, and hemp-derived consumer products at the event, which may 
63.29 	be supplemented or amended within 72 hours of the time at which the cannabis event begins;
63.30 	(6) the dates and hours during which the cannabis event will take place;
63.31 	(7) proof of local approval for the cannabis event; and
64.1 	(8) evidence that the business will comply with the applicable operation requirements 
64.2 	for the license being sought.
64.3 	(b) A person, cooperative, or business seeking a cannabis event organizer license may 
64.4 	also disclose whether the person or any officer, director, manager, and general partner of a 
64.5 	cannabis business is serving or has previously served in the military.
64.6 	(2) a description of the applicant's process for planning and organizing cannabis events, 
64.7 	including:
64.8 	(i) the applicant's method of selecting a venue;
64.9 	(ii) the applicant's method of coordinating with and overseeing vendors that participate 
64.10 	in cannabis events; and
64.11 	(iii) criteria that the applicant will use for selecting cannabis and hemp businesses to 
64.12 	participate in cannabis events;
64.13 	(3) a description of security measures and protocols that the applicant will use, including:
64.14 	(i) the process that the applicant will use for hiring and contracting with licensed security 
64.15 	personnel;
64.16 	(ii) the method that the applicant will use to ensure that security personnel do not consume 
64.17 	cannabis or hemp products before or during cannabis events;
64.18 	(iii) the method that the applicant will use for managing and controlling crowds at 
64.19 	cannabis events;
64.20 	(iv) the method that the applicant will use to ensure that access to an event is limited to 
64.21 	individuals who are at least 21 years of age; and
64.22 	(v) the method that the applicant will use for managing access to consumption and retail 
64.23 	areas;
64.24 	(4) a description of how the applicant will comply with state and local laws and rules at 
64.25 	each cannabis event, including:
64.26 	(i) the applicant's method of verifying that each participating business has a valid license 
64.27 	issued by the office;
64.28 	(ii) the applicant's method for ensuring that cannabis products are only sold by licensed 
64.29 	retailers in designated retail areas; and
64.30 	(iii) the applicant's methods for handling any violations of this chapter or Minnesota 
64.31 	Rules at cannabis events;
65.1 	(5) the applicant's procedures for protecting the health and safety of event participants, 
65.2 	including:
65.3 	(i) emergency response plans, fire safety protocols, and the availability of medical 
65.4 	assistance devices in the case of a medical emergency; and
65.5 	(ii) guidelines for managing consumption areas to prevent over-intoxication and other 
65.6 	health risks;
65.7 	(6) the applicant's procedures for working with licensed cannabis transporters to handle 
65.8 	the transportation of cannabis plants, products, and related items to and from events;
65.9 	(7) the applicant's management and disposal of cannabis waste in compliance with state 
65.10 	laws and rules, including methods for securely collecting, storing, and transporting cannabis 
65.11 	waste from each event site; and
65.12 	(8) the applicant's methods for reporting and documenting cannabis events to regulators 
65.13 	for inspections and post-event evaluations.
65.14 	(b) Any commitment or statement that the applicant makes in an application to the office 
65.15 	is an ongoing material condition of maintaining and renewing the applicant's cannabis event 
65.16 	organizer license.
65.17 	(c) An application for a cannabis event organizer license is not required to include the 
65.18 	information required under section 342.14, subdivision 1, paragraph (a), clauses (5), (6), 
65.19 	(9), and (10).
65.20 		Subd. 2a.Attestation required. When renewing a cannabis event organizer license, a 
65.21 	cannabis event organizer license holder with ten or more full-time equivalent employees 
65.22 	must submit to the office an attestation signed by a bona fide labor organization stating that 
65.23 	the applicant has entered into a labor peace agreement.
65.24 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
65.25 	cannabis event organizer license may not hold a cannabis testing facility license, a 
65.26 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
65.27 	license, or a lower-potency hemp edible retailer license.
65.28 	(b) The office by rule may limit the number of cannabis event licenses that a person or 
65.29 	business may hold.
65.30 	(c) (b) For purposes of this subdivision, restrictions on the number or type of license 
65.31 	that a business may hold apply to every cooperative member or every director, manager, 
65.32 	and general partner of a cannabis business.

66.1 	EFFECTIVE DATE. This section is effective January 1, 2027.

66.2 	Sec. 86. Minnesota Statutes 2024, section 342.40, subdivision 1, is amended to read:
66.3 		Subdivision 1.Local Temporary event approval. (a) To host a temporary cannabis 
66.4 	event under this section, a cannabis event organizer must receive submit a site registration 
66.5 	with the following information to the office in a form approved by the office:
66.6 	(1) proof that the event has received local approval, including obtaining proof that the 
66.7 	cannabis event organizer has obtained any necessary permits or licenses issued by a local 
66.8 	unit of government, before holding a cannabis event.;
66.9 	(2) the address and location where the temporary cannabis event will take place;
66.10 	(3) the name of the temporary cannabis event;
66.11 	(4) a diagram of the physical layout of the temporary cannabis event showing where the 
66.12 	event will take place on the grounds; all entrances and exits that will be used by participants 
66.13 	during the event; all cannabis consumption areas; all cannabis retail areas where cannabis 
66.14 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
66.15 	will be sold; the location where cannabis waste will be stored; and any location where 
66.16 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
66.17 	products will be stored;
66.18 	(5) a list that includes: (i) the name of each cannabis business and hemp business that 
66.19 	will sell cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
66.20 	lower-potency hemp edibles, and hemp-derived consumer products at the temporary cannabis 
66.21 	event; (ii) the type of each business participating in the temporary cannabis event; and (iii) 
66.22 	the number of businesses participating in the temporary cannabis event. The list may be 
66.23 	amended up to 72 hours before the temporary cannabis event begins;
66.24 	(6) the dates and hours during which the temporary cannabis event will take place; and
66.25 	(7) evidence that the cannabis event organizer will comply with all applicable operation 
66.26 	requirements.
66.27 	(b) Upon review of the temporary cannabis event application materials submitted by the 
66.28 	license holder, the office may deny a temporary cannabis event if:
66.29 	(1) the application is incomplete;
66.30 	(2) the temporary cannabis event does not have local approval;
67.1 	(3) the application contains a materially false statement about the applicant or omits 
67.2 	information required under subdivision 1;
67.3 	(4) the license holder fails to pay the applicable application fee in section 342.11, 
67.4 	paragraph (b), clause (10), item (iv); and
67.5 	(5) the license holder fails to pass any applicable site inspection for the temporary 
67.6 	cannabis event.
67.7 	(c) The office may request additional information from any applicant if the office 
67.8 	determines that the information is necessary to review or process the application. If the 
67.9 	applicant does not provide the additional requested information within seven calendar days 
67.10 	of the office's request for information, the office may deny the application.

67.11 	EFFECTIVE DATE. This section is effective January 1, 2027.

67.12 	Sec. 87. Minnesota Statutes 2025 Supplement, section 342.40, subdivision 7, is amended 
67.13 	to read:
67.14 		Subd. 7.Cannabis event sales. (a) Cannabis microbusinesses with a retail endorsement, 
67.15 	cannabis mezzobusinesses with a retail endorsement, cannabis retailers, medical cannabis 
67.16 	combination businesses macrobusinesses operating a retail location, and lower-potency 
67.17 	hemp edible retailers, including the cannabis event organizer, may be authorized to sell 
67.18 	cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency 
67.19 	hemp edibles, and hemp-derived consumer products to customers at a cannabis event.
67.20 	(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
67.21 	lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must 
67.22 	take place in a retail area as designated in the premises diagram.
67.23 	(c) Authorized retailers may only conduct sales within their specifically assigned area.
67.24 	(d) Authorized retailers must verify the age of all customers pursuant to section 342.27, 
67.25 	subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis 
67.26 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
67.27 	products to an individual under 21 years of age.
67.28 	(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use 
67.29 	cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived 
67.30 	consumer product available for sale. Display samples of adult-use cannabis and adult-use 
67.31 	cannabis products must be stored in a sample jar or display case and be accompanied by a 
67.32 	label or notice containing the information required to be affixed to the packaging or container 
68.1 	containing adult-use cannabis flower and adult-use cannabis products sold to customers. A 
68.2 	display sample may not consist of more than eight grams of adult-use cannabis flower or 
68.3 	adult-use cannabis concentrate, or an edible cannabis product infused with more than 100 
68.4 	milligrams of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the 
68.5 	adult-use cannabis flower or adult-use cannabis product before purchase.
68.6 	(f) The notice requirements under section 342.27, subdivision 6, apply to authorized 
68.7 	retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products, 
68.8 	and hemp-derived consumer products for sale at a cannabis event.
68.9 	(g) Authorized retailers may not:
68.10 	(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
68.11 	edibles, or hemp-derived consumer products to a person who is visibly intoxicated;
68.12 	(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis 
68.13 	products, lower-potency hemp edibles, or hemp-derived consumer products than a customer 
68.14 	is legally permitted to possess;
68.15 	(3) sell medical cannabis flower or medical cannabinoid products; or
68.16 	(4) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
68.17 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines.
68.18 	(h) Except for display samples of a cannabis plant, adult-use cannabis flower, adult-use 
68.19 	cannabis product, lower-potency hemp edible, and hemp-derived consumer product, all 
68.20 	cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency 
68.21 	hemp edibles, and hemp-derived consumer products for sale at a cannabis event must be 
68.22 	stored in a secure, locked container that is not accessible to the public. Such items being 
68.23 	stored at a cannabis event shall not be left unattended.
68.24 	(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
68.25 	lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis 
68.26 	event must comply with this chapter and rules adopted pursuant to this chapter regarding 
68.27 	the testing, packaging, and labeling of those items.
68.28 	(j) Authorized retailers must record in the statewide monitoring system all cannabis 
68.29 	plants, adult-use cannabis flower, and adult-use cannabis products sold, distributed, damaged, 
68.30 	or destroyed at a the cannabis event must be recorded in the statewide monitoring system.

68.31 	EFFECTIVE DATE. This section is effective January 1, 2027.

69.1 	Sec. 88. Minnesota Statutes 2024, section 342.41, subdivision 1, is amended to read:
69.2 		Subdivision 1.Authorized actions; medical cannabis delivery endorsement. (a) A 
69.3 	cannabis delivery service license entitles the license holder to purchase cannabis flower, 
69.4 	cannabis products, lower-potency hemp edibles, and hemp-derived consumer products from 
69.5 	licensed cannabis microbusinesses with a retail endorsement, cannabis mezzobusinesses 
69.6 	with a retail endorsement, cannabis retailers, and medical cannabis combination businesses
69.7 	macrobusinesses; transport and deliver cannabis flower, cannabis products, lower-potency 
69.8 	hemp edibles, and hemp-derived consumable products to customers; and perform other 
69.9 	actions approved by the office.
69.10 	(b) A cannabis delivery license holder may apply for and obtain a medical cannabis 
69.11 	delivery endorsement as described in section 342.51, subdivision 1e, to deliver medical 
69.12 	cannabis flower and medical cannabinoid products to patients and persons enrolled in the 
69.13 	registry.

69.14 	EFFECTIVE DATE. This section is effective January 1, 2027.

69.15 	Sec. 89. [342.425] CANNABIS TRANSPORT TO TESTING FACILITY.
69.16 	(a) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, and cannabis 
69.17 	manufacturer may transport samples of its cultivated or manufactured products to a cannabis 
69.18 	testing facility for testing purposes if the cannabis business:
69.19 	(1) maintains a shipping manifest that meets the requirements for transportation manifests 
69.20 	as established by rule;
69.21 	(2) transports the samples in a transport vehicle equipped with a storage compartment 
69.22 	that meets the requirements of section 342.42, subdivision 5, and the requirements for secure 
69.23 	transport as established by the office;
69.24 	(3) submits information in a form approved by the office that includes a list of all vehicles 
69.25 	to be used in the transport of samples of products, the vehicle make, the vehicle model, the 
69.26 	vehicle color, the vehicle identification number, and the license plate number; and
69.27 	(4) attests to holding an active commercial vehicle insurance policy for the transport 
69.28 	vehicle.
69.29 	(b) This section expires February 1, 2029.

69.30 	EFFECTIVE DATE. This section is effective the day following final enactment.

70.1 	Sec. 90. Minnesota Statutes 2025 Supplement, section 342.43, subdivision 2, is amended 
70.2 	to read:
70.3 		Subd. 2.Multiple licenses; limits. (a) A person, cooperative, or business may hold any 
70.4 	combination of a lower-potency hemp edible manufacturer, a lower-potency hemp edible 
70.5 	wholesaler, and a lower-potency hemp edible retailer license.
70.6 	(b) Nothing in this section prohibits a person, cooperative, or business from holding a 
70.7 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
70.8 	license, a lower-potency hemp edible retailer license, or any combination of those licenses, 
70.9 	and also holding a license to cultivate industrial hemp issued pursuant to chapter 18K.
70.10 	(c) Nothing in this section prohibits a person, cooperative, or business from holding a 
70.11 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
70.12 	license, a lower-potency hemp edible retailer license, or any combination of those licenses, 
70.13 	and also holding any other license, including but not limited to a license to prepare or sell 
70.14 	food; sell tobacco, tobacco-related devices, electronic delivery devices as defined in section 
70.15 	609.685, subdivision 1, and nicotine and lobelia delivery products as described in section 
70.16 	609.6855; or manufacture or sell alcoholic beverages as defined in section 340A.101, 
70.17 	subdivision 2.
70.18 	(d) A person, cooperative, or business holding a lower-potency hemp edible manufacturer 
70.19 	license, a lower-potency hemp edible wholesaler license, a lower-potency hemp edible 
70.20 	retailer license, or any combination of those licenses, may not hold a cannabis business 
70.21 	license.

70.22 	Sec. 91. Minnesota Statutes 2025 Supplement, section 342.44, subdivision 1, is amended 
70.23 	to read:
70.24 		Subdivision 1.Application; contents. (a) Except as otherwise provided in this 
70.25 	subdivision, the provisions of this chapter relating to license applications, license selection 
70.26 	criteria, general ownership disqualifications and requirements, and general operational 
70.27 	requirements do not apply to hemp businesses.
70.28 	(b) The office shall establish forms and procedures for the processing of hemp licenses 
70.29 	issued under this chapter. At a minimum, any application to obtain or renew a hemp license 
70.30 	shall include the following information, if applicable:
70.31 	(1) the name, address, and date of birth of the applicant;
70.32 	(2) the address and legal property description of the business;
71.1 	(3) proof of trade name registration;
71.2 	(4) certification that the applicant will comply with the requirements of this chapter 
71.3 	relating to the ownership and operation of a hemp business;
71.4 	(5) identification of one or more controlling persons or managerial employees as agents 
71.5 	who shall be responsible for dealing with the office on all matters; and
71.6 	(6) a statement that the applicant agrees to respond to the office's supplemental requests 
71.7 	for information.
71.8 	(c) An applicant for a lower-potency hemp edible manufacturer license must submit an 
71.9 	attestation signed by a bona fide labor organization stating that the applicant has entered 
71.10 	into a labor peace agreement. A labor peace agreement entered into on or after August 15, 
71.11 	2025, must address the duration of the election.
71.12 	(d) The office may determine whether any civil or regulatory violation as determined 
71.13 	by the office, another state agency, a local government, or any other jurisdiction disqualifies 
71.14 	an individual or business from receiving a hemp business license issued under this chapter. 
71.15 	The office may determine the length of the disqualification.

71.16 	Sec. 92. Minnesota Statutes 2024, section 342.44, subdivision 2, is amended to read:
71.17 		Subd. 2.Issuance; eligibility; prohibition on transfer. (a) The office may issue a hemp 
71.18 	license to an applicant who:
71.19 	(1) is at least 21 years of age;
71.20 	(2) has completed an application for licensure or application for renewal and has fully 
71.21 	and truthfully complied with all information requests relating to license application and 
71.22 	renewal;
71.23 	(3) has paid the applicable application and license fees pursuant to section 342.11; and
71.24 	(4) is not employed by the office or any state agency with regulatory authority over this 
71.25 	chapter; and.
71.26 	(5) does not hold any cannabis business license.
71.27 	(b) Licenses must be renewed annually.
71.28 	(c) Licenses may not be transferred.

72.1 	Sec. 93. Minnesota Statutes 2024, section 342.45, subdivision 3, is amended to read:
72.2 		Subd. 3.Extraction and concentration. (a) A lower-potency hemp edible manufacturer 
72.3 	that creates seeking to create hemp concentrate or must apply for and obtain a lower-potency 
72.4 	hemp extraction and concentration endorsement. A lower-potency hemp edible manufacturer 
72.5 	seeking to create artificially derived cannabinoids must apply for and obtain an a 
72.6 	lower-potency hemp creation of artificially derived cannabinoid endorsement from the 
72.7 	office.
72.8 	(b) A lower-potency hemp edible manufacturer seeking an with a lower-potency hemp 
72.9 	extraction and concentration endorsement to create hemp concentrate must inform the office 
72.10 	of all methods of extraction and concentration that the manufacturer intends to use and 
72.11 	identify the volatile chemicals, if any, that will be involved in the creation of hemp 
72.12 	concentrate. A lower-potency hemp edible manufacturer may not use a method of extraction 
72.13 	and concentration or a volatile chemical without approval by the office.
72.14 	(c) A lower-potency hemp edible manufacturer seeking an with a lower-potency hemp 
72.15 	creation of artificially derived cannabinoid endorsement to create artificially derived 
72.16 	cannabinoids must inform the office of all methods of conversion that the manufacturer will 
72.17 	use, including any specific catalysts that the manufacturer will employ, to create artificially 
72.18 	derived cannabinoids and the molecular nomenclature of all cannabinoids or other chemical 
72.19 	compounds that the manufacturer will create. A business licensed or authorized to 
72.20 	manufacture lower-potency hemp edibles lower-potency hemp edible manufacturer may 
72.21 	not use a method of conversion or a catalyst without approval by the office.
72.22 	(d) A lower-potency hemp edible manufacturer with a lower-potency hemp extraction 
72.23 	and concentration endorsement or a lower-potency hemp creation of artificially derived 
72.24 	cannabinoid endorsement must obtain a certification from an independent third-party 
72.25 	industrial hygienist or professional engineer approving:
72.26 	(1) all electrical, gas, fire suppression, and exhaust systems; and
72.27 	(2) the plan for safe storage and disposal of hazardous substances, including but not 
72.28 	limited to any volatile chemicals.
72.29 	(e) Upon the sale of hemp concentrate or artificially derived cannabinoids to any person, 
72.30 	cooperative, or business, a lower-potency hemp edible manufacturer must provide a statement 
72.31 	to the buyer that discloses the method of extraction and concentration or conversion used 
72.32 	and any solvents, gases, or catalysts, including but not limited to any volatile chemicals 
72.33 	involved in that method.

73.1 	Sec. 94. Minnesota Statutes 2025 Supplement, section 342.46, subdivision 8, is amended 
73.2 	to read:
73.3 		Subd. 8.On-site consumption. (a) A lower-potency hemp edible retailer may permit 
73.4 	on-site consumption of lower-potency hemp edibles on a portion of its premises if it has an 
73.5 	on-site consumption endorsement.
73.6 	(b) The office shall issue an on-site consumption endorsement to any lower-potency 
73.7 	hemp edible retailer that also holds an on-sale license issued under chapter 340A. The office 
73.8 	may issue an on-site consumption endorsement to a lower-potency hemp edible retailer that 
73.9 	does not also hold an on-sale license issued under chapter 340A if the lower-potency hemp 
73.10 	edible retailer submits proof of liability insurance as required by section 340A.409, except 
73.11 	that the proof must be submitted to the office.
73.12 	(c) A lower-potency hemp edible retailer must ensure that lower-potency hemp edibles 
73.13 	sold for on-site consumption comply with this chapter and rules adopted pursuant to this 
73.14 	chapter regarding testing.
73.15 	(d) Lower-potency hemp edibles sold for on-site consumption, other than lower-potency 
73.16 	hemp edibles that are intended to be consumed as a beverage, must be served in the required 
73.17 	packaging, but may be removed from the products' packaging by customers and consumed 
73.18 	on site.
73.19 	(e) Lower-potency hemp edibles that are intended to be consumed as a beverage may 
73.20 	be served outside of the edibles' packaging if the information that is required to be contained 
73.21 	on the label of a lower-potency hemp edible is posted or otherwise displayed by the 
73.22 	lower-potency hemp edible retailer. Hemp workers who serve beverages under this paragraph 
73.23 	are not required to obtain an edible cannabinoid product handler endorsement under section 
73.24 	342.07, subdivision 3.
73.25 	(f) Food and beverages not otherwise prohibited by this subdivision may be prepared 
73.26 	and sold on site if the lower-potency hemp edible retailer complies with all relevant state 
73.27 	and local laws, ordinances, licensing requirements, and zoning requirements.
73.28 	(g) A lower-potency hemp edible retailer may offer recorded or live entertainment if the 
73.29 	lower-potency hemp edible retailer complies with all relevant state and local laws, ordinances, 
73.30 	licensing requirements, and zoning requirements.
73.31 	(h) In addition to the prohibitions under subdivision 7, a lower-potency hemp edible 
73.32 	retailer with an on-site consumption endorsement may not:
74.1 	(1) sell, give, furnish, or in any way procure for another lower-potency hemp edibles 
74.2 	for the use of an obviously intoxicated person;
74.3 	(2) sell lower-potency hemp edibles that are designed or reasonably expected to be mixed 
74.4 	with an alcoholic beverage, including containers containing multiple servings of a 
74.5 	lower-potency hemp edible product intended to be consumed as a beverage; or
74.6 	(3) sell products from containers containing multiple servings of a lower-potency hemp 
74.7 	edible product intended to be consumed as a beverage for on-site consumption; or
74.8 	(4) permit lower-potency hemp edibles that have been removed from the products' 
74.9 	packaging to be removed from the premises of the lower-potency hemp edible retailer.
74.10 	(i) A lower-potency hemp edible retailer is permitted to sell and may permit the 
74.11 	consumption of lower-potency hemp edibles that are intended to be consumed as a beverage
74.12 	at an event hosted off site if:
74.13 	(1) the event has been authorized by the local unit of government exercising jurisdiction 
74.14 	over the location;
74.15 	(2) the event organizer holds an on-sale license issued under chapter 340A; and
74.16 	(3) the event does not exceed four days.

74.17 	EFFECTIVE DATE. This section is effective the day following final enactment.

74.18 	Sec. 95. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
74.19 	read:
74.20 		Subd. 1a.Types of medical cannabis endorsements; authorized actions. The office 
74.21 	may issue the following types of medical cannabis endorsements to a license holder:
74.22 	(1) a medical cannabis cultivation endorsement;
74.23 	(2) a medical cannabis manufacturer endorsement; and
74.24 	(3) a medical cannabis retail endorsement.

74.25 	EFFECTIVE DATE. This section is effective January 1, 2027.

74.26 	Sec. 96. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
74.27 	read:
74.28 		Subd. 1b.Medical cannabis cultivation endorsement. (a) A cannabis microbusiness, 
74.29 	cannabis mezzobusiness, cannabis macrobusiness, or cannabis cultivator with a cannabis 
75.1 	cultivation endorsement may apply for and obtain a medical cannabis cultivation 
75.2 	endorsement.
75.3 	(b) A cannabis business with a medical cannabis cultivation endorsement must:
75.4 	(1) comply with the requirements of section 342.25; and
75.5 	(2) otherwise meet all applicable requirements established by the office.
75.6 	(c) A medical cannabis cultivation endorsement entitles the license holder to perform 
75.7 	the actions authorized in section 342.30, subdivision 1.
75.8 	(d) A cannabis microbusiness with a medical cannabis cultivation endorsement that 
75.9 	cultivates cannabis at an indoor facility may cultivate an additional 1,000 square feet of 
75.10 	cannabis indoors or one-quarter acre outdoors in addition to the limits in section 342.28.
75.11 	(e) A cannabis mezzobusiness with a medical cannabis cultivation endorsement may 
75.12 	cultivate an additional 3,000 square feet of cannabis indoors or one-half acre outdoors in 
75.13 	addition to the limits in section 342.29.
75.14 	(f) A cannabis cultivator with a medical cannabis cultivation endorsement may cultivate 
75.15 	an additional 6,000 square feet indoors or one acre outdoors in addition to the limits in 
75.16 	section 342.30.
75.17 	(g) Annually, at least one quarter of all cannabis flower cultivated by a cannabis business 
75.18 	with a medical cannabis cultivation endorsement must be sold by the license holder to a 
75.19 	cannabis business with a medical cannabis endorsement, including the license holder if the 
75.20 	license holder has a medical cannabis manufacturing endorsement or medical cannabis retail 
75.21 	endorsement.

75.22 	EFFECTIVE DATE. This section is effective January 1, 2027.

75.23 	Sec. 97. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
75.24 	read:
75.25 		Subd. 1c.Medical cannabis manufacturer endorsement. (a) A cannabis microbusiness, 
75.26 	cannabis mezzobusiness, cannabis macrobusiness, or cannabis manufacturer with a cannabis 
75.27 	extraction and concentration endorsement, hemp extraction and concentration endorsement, 
75.28 	or creation of artificially derived cannabinoids endorsement may apply for and obtain a 
75.29 	medical cannabis manufacturer endorsement.
75.30 	(b) A cannabis business with a medical cannabis manufacturer endorsement must:
75.31 	(1) comply with the requirements of section 342.26;
76.1 	(2) manufacture high medical need products identified by the office; and
76.2 	(3) otherwise meet all applicable requirements established by the office.
76.3 	(c) A medical cannabis manufacturer endorsement entitles a license holder to:
76.4 	(1) manufacture medical cannabinoid products; and
76.5 	(2) sell medical cannabinoid products only to other cannabis businesses with a medical 
76.6 	cannabis manufacturer endorsement or medical cannabis retail endorsement.
76.7 	(d) A medical cannabinoid product must be labeled with a "Minnesota Medical Cannabis" 
76.8 	warning symbol and must only be sold to a person, patient, or caregiver enrolled in the 
76.9 	registry program or a visiting patient.
76.10 	(e) A medical cannabis manufacturer endorsement held by a cannabis microbusiness 
76.11 	entitles the license holder to exceed the manufacturing limits of cannabis by dry weight up 
76.12 	to 25 percent above the limit established by the office in rule.
76.13 	(f) A medical cannabis manufacturer endorsement held by a cannabis mezzobusiness 
76.14 	entitles the license holder to exceed the manufacturing limits of cannabis by dry weight up 
76.15 	to 25 percent above the limit established by the office in rule.

76.16 	EFFECTIVE DATE. This section is effective January 1, 2027.

76.17 	Sec. 98. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
76.18 	read:
76.19 		Subd. 1d.Medical cannabis retail endorsement. (a) A cannabis microbusiness, cannabis 
76.20 	mezzobusiness, cannabis macrobusiness, or cannabis retailer with a cannabis retail operations 
76.21 	endorsement may apply for and obtain a medical cannabis retail endorsement.
76.22 	(b) A cannabis business with a medical cannabis retail endorsement must:
76.23 	(1) comply with all requirements of this section and section 342.27;
76.24 	(2) employ or contract with a medical cannabis consultant who has a certificate issued 
76.25 	by the office and completed the required training or a licensed pharmacist under chapter 
76.26 	151 to consult and provide final authorization for a person enrolled in the registry program;
76.27 	(3) ensure availability of patient consultations as required under this section;
76.28 	(4) ensure that patients and caregivers enrolled in the registry program receive priority 
76.29 	service;
76.30 	(5) carry all products identified by the office as high medical need; and
77.1 	(6) otherwise meet all applicable requirements established by the office.
77.2 	(c) The office must identify high medical need products and publish a list of all high 
77.3 	medical need products on the office's publicly accessible website, including at least the 
77.4 	following product types:
77.5 	(1) pill;
77.6 	(2) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;
77.7 	(3) orally dissolvable product, including lozenge, gum, mint, buccal tablet, and sublingual 
77.8 	tablet; and
77.9 	(4) tincture.
77.10 	(d) A medical cannabis retail endorsement held by a cannabis business entitles the license 
77.11 	holder to perform the actions authorized in section 342.32, subdivision 1.
77.12 	(e) A cannabis microbusiness with a medical retail endorsement may operate one 
77.13 	additional retail location in excess of the limit in section 342.28, subdivision 2, paragraph 
77.14 	(d), if at least one retail location is located in an area identified by the office as a high medical 
77.15 	need area.
77.16 	(f) A cannabis mezzobusiness with a medical cannabis retail endorsement may operate 
77.17 	two additional retail locations in excess of the limit in section 342.29, subdivision 2, 
77.18 	paragraph (d), if the retail locations are located in an area identified by the office as a high 
77.19 	medical need area.
77.20 	(g) A cannabis retailer with a medical cannabis retail endorsement may operate up to 
77.21 	three additional retail locations in excess of the limit established in section 342.32, 
77.22 	subdivision 2, if the retail locations are located in an area identified by the office as a high 
77.23 	medical need area.
77.24 	(h) Notwithstanding paragraph (b), clause (2), a cannabis macrobusiness with a medical 
77.25 	cannabis retail endorsement must employ at least one employee who earned a medical 
77.26 	cannabis consultant certificate issued by the office and has completed the required training 
77.27 	or has at least one employee who is a licensed pharmacist under chapter 151.

77.28 	EFFECTIVE DATE. This section is effective January 1, 2027.

78.1 	Sec. 99. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
78.2 	read:
78.3 		Subd. 1e.Additional authorized actions; medical cannabis delivery endorsement. A 
78.4 	cannabis macrobusiness with a medical cannabis retail endorsement or a cannabis delivery 
78.5 	license holder may apply for and obtain a medical cannabis delivery endorsement to deliver 
78.6 	medical cannabis flower and medical cannabinoid products to patients enrolled in the registry 
78.7 	program; registered designated caregivers; and parents, legal guardians, and spouses of an 
78.8 	enrolled patient if the cannabis business:
78.9 	(1) provides the office with the information required in section 342.41, subdivision 2; 
78.10 	and
78.11 	(2) complies with the requirements of subdivisions 2 and 3 and section 342.42.

78.12 	EFFECTIVE DATE. This section is effective January 1, 2027.

78.13 	Sec. 100. Minnesota Statutes 2025 Supplement, section 342.51, subdivision 2, is amended 
78.14 	to read:
78.15 		Subd. 2.Distribution requirements. (a) Prior to distribution of medical cannabis flower 
78.16 	or medical cannabinoid products to a person enrolled in the registry program, an employee 
78.17 	of a cannabis business must:
78.18 	(1) review and confirm the patient's enrollment in the registry program;
78.19 	(2) verify that the person requesting the distribution of medical cannabis flower or 
78.20 	medical cannabinoid products is the patient, the patient's registered designated caregiver, 
78.21 	or the patient's parent, legal guardian, or spouse using the procedures established by the 
78.22 	office;
78.23 	(3) confirm that the patient had a consultation with (i) an employee with a valid a medical 
78.24 	cannabis consultant who has a valid certificate issued by the office; or (ii) an employee who 
78.25 	is a licensed pharmacist under chapter 151 to determine the proper medical cannabis flower 
78.26 	or medical cannabinoid product, dosage, and paraphernalia for the patient if required under 
78.27 	subdivision 3;
78.28 	(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid 
78.29 	product that includes recommended dosage requirements and other information as required 
78.30 	by the office; and
78.31 	(5) provide the patient with any other information required by the office.
79.1 	(b) A cannabis business with a medical cannabis retail endorsement may not deliver 
79.2 	medical cannabis flower or medical cannabinoid products to a person enrolled in the registry 
79.3 	program unless the cannabis business with a medical cannabis retail endorsement also holds 
79.4 	a cannabis delivery service license or a medical cannabis delivery endorsement. The delivery 
79.5 	of medical cannabis flower and medical cannabinoid products are subject to the provisions 
79.6 	of section 342.42.
79.7 	(c) A cannabis business with a medical cannabis retail endorsement may not distribute, 
79.8 	sell, or deliver medical cannabis flower and medical cannabinoid products intended to be 
79.9 	vaporized to a person enrolled in the registry program if the product is intended for a patient 
79.10 	under 21 years of age.
79.11 	(d) A cannabis macrobusiness with a medical cannabis retail endorsement must confirm 
79.12 	that the patient had a consultation with (1) an employee with a medical cannabis consultant 
79.13 	certificate issued by the office and who has completed the required training, or (2) an 
79.14 	employee who is a licensed pharmacist under chapter 151 to determine the proper medical 
79.15 	cannabis flower or medical cannabinoid product, dosage, and paraphernalia for the patient 
79.16 	if required under subdivision 3.

79.17 	EFFECTIVE DATE. Paragraph (c) is effective the day following final enactment. 
79.18 	Paragraphs (a), (b), and (d) are effective January 1, 2027.

79.19 	Sec. 101. Minnesota Statutes 2024, section 342.51, subdivision 3, is amended to read:
79.20 		Subd. 3.Final approval for distribution of medical cannabis flower and medical 
79.21 	cannabinoid products. (a) A cannabis worker who is employed by a cannabis business 
79.22 	with a medical cannabis retail endorsement who is licensed as a pharmacist pursuant to 
79.23 	chapter 151 or certified as a medical cannabis consultant by the office is the only person 
79.24 	who may give Final approval for the distribution of medical cannabis flower and medical 
79.25 	cannabinoid products. Prior to the distribution of medical cannabis flower or medical 
79.26 	cannabinoid products, a pharmacist or certified medical cannabis consultant employed by 
79.27 	the cannabis business with a medical cannabis retail endorsement must consult may only 
79.28 	be given by a licensed pharmacist under chapter 151 or a medical cannabis consultant who 
79.29 	has a certificate issued by the office after consultation with the patient to determine the 
79.30 	proper type of medical cannabis flower, medical cannabinoid product, or medical cannabis 
79.31 	paraphernalia, and the proper dosage for the patient after reviewing the range of chemical 
79.32 	compositions of medical cannabis flower or medical cannabinoid product intended for 
79.33 	distribution:
80.1 	(1) if the patient is purchasing the medical cannabis flower or medical cannabinoid 
80.2 	product for the first time;
80.3 	(2) if the patient purchases medical cannabis flower or a medical cannabinoid product 
80.4 	that the patient must administer using a different method than the patient's previous method 
80.5 	of administration;
80.6 	(3) if the patient purchases medical cannabis flower or a medical cannabinoid product 
80.7 	with a cannabinoid concentration of at least double the patient's prior dosage; or
80.8 	(4) upon the request of the patient.
80.9 	(b) For purposes of this subdivision, a consultation may be conducted remotely by secure 
80.10 	videoconference, telephone, or other remote means, as long as:
80.11 	(1) the pharmacist or consultant engaging in the consultation is able to confirm the 
80.12 	identity of the patient; and
80.13 	(2) the consultation adheres to patient privacy requirements that apply to health care 
80.14 	services delivered through telemedicine.
80.15 	(c) A cannabis macrobusiness must have an employee who is either a medical cannabis 
80.16 	consultant who has a certificate issued by the office and completed the required training or 
80.17 	a licensed pharmacist under chapter 151.

80.18 	EFFECTIVE DATE. This section is effective January 1, 2027.

80.19 	Sec. 102. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision 
80.20 	to read:
80.21 		Subd. 6.Enforcement. The office may enforce this section under the relevant provisions 
80.22 	of section 342.19, including but not limited to issuing administrative orders, embargoing 
80.23 	products, and imposing civil penalties. The office may suspend or revoke the medical 
80.24 	cannabis endorsement of a license holder if the office determines that the business is not 
80.25 	actively participating in the medical cannabis market by not making available at each retail 
80.26 	location high medical need products identified by the office within 24 hours of a patient 
80.27 	request or otherwise failing to comply with the requirements of this section or this chapter.

80.28 	EFFECTIVE DATE. This section is effective January 1, 2027.

81.1 	Sec. 103. Minnesota Statutes 2024, section 342.515, as amended by Laws 2025, chapter 
81.2 	31, sections 89 and 90, is amended to read:
81.3 	342.515 MEDICAL CANNABIS COMBINATION BUSINESSES
81.4 	MACROBUSINESSES.
81.5 		Subdivision 1.Authorized actions. (a) A person, cooperative, or business holding a 
81.6 	medical cannabis combination business license is prohibited from owning or operating any 
81.7 	other cannabis business or hemp business or holding an active registration agreement under 
81.8 	section 152.25, subdivision 1.
81.9 	(b) A person or business may hold only one medical cannabis combination business 
81.10 	license.
81.11 	(c) (a) A medical cannabis combination businessmacrobusiness license, consistent with 
81.12 	the requirements of specific license endorsements approved by the office, entitles the license 
81.13 	holder to perform any or all of the following within the limits established by this section
81.14 	actions:
81.15 	(1) grow cannabis plants from seed or immature plant to mature plant and, harvest 
81.16 	adult-use cannabis flower and medical cannabis flower from a mature plant, package and 
81.17 	label cannabis flower for sale to other cannabis businesses, and sell immature cannabis 
81.18 	plants and seedlings and cannabis flower to other cannabis businesses;
81.19 	(2) make cannabis concentrate;
81.20 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
81.21 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
81.22 	(4) manufacture artificially derived cannabinoids;
81.23 	(5) manufacture medical cannabinoid products;
81.24 	(6) (5) manufacture, package, and label adult-use cannabis products, lower-potency 
81.25 	hemp edibles, and hemp-derived consumer products for public consumption;
81.26 	(7) (6) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis 
81.27 	products, lower-potency hemp edibles, and hemp-derived consumer products from a cannabis 
81.28 	microbusiness, a cannabis mezzobusiness, a cannabis cultivator, a cannabis manufacturer, 
81.29 	a cannabis wholesaler, or another medical cannabis combination business macrobusiness, 
81.30 	a lower-potency hemp edible manufacturer, or a lower-potency hemp edible wholesaler;
81.31 	(8) (7) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
81.32 	under chapter 18K;
82.1 	(9) (8) purchase cannabis concentrate, hemp concentrate, and artificially derived 
82.2 	cannabinoids from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis 
82.3 	manufacturer, a cannabis wholesaler, or another medical cannabis combination business
82.4 	macrobusiness;
82.5 	(10) (9) purchase hemp concentrate from an industrial hemp processor licensed under 
82.6 	chapter 18K;
82.7 	(11) manufacture, package, and label medical cannabis flower and medical cannabinoid 
82.8 	products for sale to cannabis businesses with a medical cannabis processor endorsement, 
82.9 	cannabis businesses with a medical cannabis retail endorsement, other medical cannabis 
82.10 	combination businesses, and persons in the registry program;
82.11 	(12) transport and deliver medical cannabis flower and medical cannabinoid products 
82.12 	to medical cannabis processors, medical cannabis retailers, other medical cannabis 
82.13 	combination businesses, patients enrolled in the registry program, registered designated 
82.14 	caregivers, and parents, legal guardians, and spouses of an enrolled patient;
82.15 	(13) manufacture, package, and label adult-use cannabis flower, adult-use cannabis 
82.16 	products, lower-potency hemp edibles, and hemp-derived consumer products for sale to 
82.17 	customers and other cannabis businesses;
82.18 	(14) sell medical cannabis flower and medical cannabinoid products to other cannabis 
82.19 	businesses with a medical endorsement, other medical cannabis combination businesses, 
82.20 	and patients enrolled in the registry program, registered designated caregivers, and parents, 
82.21 	legal guardians, and spouses of an enrolled patient;
82.22 	(15) (10) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
82.23 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
82.24 	other products authorized by law to other cannabis businesses and to other cannabis 
82.25 	businesses and to customers;
82.26 	(16) transport immature cannabis plants and seedlings, adult-use cannabis flower, 
82.27 	adult-use cannabis products, lower-potency hemp edibles, hemp-derived consumer products, 
82.28 	and other products authorized by law to other cannabis businesses;
82.29 	(17) (11) sell and transport lower-potency hemp edibles to lower-potency hemp edible 
82.30 	retailers and lower-potency hemp edible wholesalers; and
82.31 	(18) (12) perform other actions approved by the office.
82.32 	(d) A medical cannabis combination business is not required to obtain a medical cannabis 
82.33 	endorsement to perform any actions authorized under this section.
83.1 	(b) A cannabis macrobusiness must apply for and obtain a medical cannabis 
83.2 	manufacturing endorsement and at least one other medical cannabis endorsement identified 
83.3 	in section 342.51.
83.4 		Subd. 2.Cultivation endorsement; size limitations. (a) A cannabis macrobusiness 
83.5 	seeking to cultivate cannabis plants and harvest cannabis flower must obtain a cannabis 
83.6 	cultivation endorsement and comply with section 342.25.
83.7 	(b) A cannabis macrobusiness that obtains a cannabis cultivation endorsement must 
83.8 	apply for and obtain a medical cannabis cultivation endorsement and comply with section 
83.9 	342.51, subdivision 1b.
83.10 	(a) (c) A medical cannabis combination business may cultivate cannabis to be sold as 
83.11 	medical cannabis flower or used in medical cannabinoid products in an area of up to 60,000 
83.12 	square feet of plant canopy subject to the limits on adult-use cannabis cultivation in paragraph 
83.13 	(c). A medical cannabis combination business may cultivate cannabis and manufacture 
83.14 	cannabis in more than one location, except the aggregate total of plant canopy in all locations 
83.15 	must count toward the business' canopy limit. macrobusiness that cultivates cannabis at an 
83.16 	indoor facility may cultivate up to 38,000 square feet of plant canopy. The office may adjust 
83.17 	plant canopy limits upward to meet market demand consistent with the goals identified in 
83.18 	section 342.02, subdivision 1.
83.19 	(b) (d) A medical cannabis combination businessmay cultivate cannabis to be sold as 
83.20 	adult-use cannabis flower or used in adult-use cannabis products in an area authorized by 
83.21 	the office as described in paragraph (c). macrobusiness that cultivates cannabis at an outdoor 
83.22 	location may cultivate up to one acre of mature, flowering plants.
83.23 	(c) The office shall authorize a medical cannabis combination business to cultivate 
83.24 	cannabis for sale in the adult-use market in an area of plant canopy that is equal to one-half 
83.25 	of the area the business used to cultivate cannabis sold in the medical market in the preceding 
83.26 	year. The office shall establish an annual verification and authorization procedure. The 
83.27 	office may increase the area of plant canopy in which a medical cannabis combination 
83.28 	business is authorized to cultivate cannabis for sale in the adult-use market between 
83.29 	authorization periods if the business demonstrates a significant increase in the sale of medical 
83.30 	cannabis and medical cannabis products.
83.31 	(e) A cannabis macrobusiness with a cannabis cultivation endorsement and a retail 
83.32 	operations endorsement may package and label adult-use cannabis flower, adult-use cannabis 
83.33 	products, lower-potency hemp edibles, and hemp-derived consumer products for sale to 
83.34 	customers.
84.1 	(f) A cannabis macrobusiness with a medical cannabis cultivation endorsement and a 
84.2 	medical cannabis retail endorsement may package and label medical cannabis flower and 
84.3 	medical cannabinoid products for sale to patients enrolled in the registry program; registered 
84.4 	designated caregivers; and parents, legal guardians, and spouses of an enrolled patient.
84.5 		Subd. 3.Manufacturing Manufacturer endorsement; size limitations. (a) By rule, 
84.6 	the office may establish limits on cannabis manufacturing that are consistent with the area 
84.7 	of plant canopy a business is authorized to cultivate. Until the office establishes limits by 
84.8 	rule, a cannabis macrobusiness must not use more than 90,000 pounds of cannabis or its 
84.9 	dry-weight equivalent of raw concentrates to manufacture cannabis products.
84.10 	(b) A cannabis macrobusiness must apply for and obtain a medical cannabis manufacturer 
84.11 	endorsement and must comply with section 342.51, subdivision 1c.
84.12 	(c) A cannabis macrobusiness may apply for and obtain one or more cannabis 
84.13 	manufacturer endorsements identified in section 342.26.
84.14 		Subd. 4.Retail operations endorsement; locations. (a) A medical cannabis combination 
84.15 	business macrobusiness with a retail operations endorsement may operate up to one retail 
84.16 	location in each congressional district. A medical cannabis combination business must offer 
84.17 	medical cannabis flower, medical cannabinoid products, or both at every retail location.
84.18 	eight retail locations and, if operating more than five retail locations, must ensure that at 
84.19 	least three retail locations are located in areas identified by the office as high medical need 
84.20 	areas.
84.21 	(b) A cannabis macrobusiness may apply for and obtain a retail operations endorsement 
84.22 	and must comply with section 342.27.
84.23 	(c) A cannabis macrobusiness with a retail operations endorsement must apply for and 
84.24 	obtain a medical cannabis retail operations endorsement and comply with section 342.51, 
84.25 	subdivision 1d.
84.26 	(d) A cannabis macrobusiness with a retail operations endorsement and a medical cannabis 
84.27 	retail operations endorsement must carry and make available for sale, at each retail location, 
84.28 	all high medical need products identified by the office.
84.29 		Subd. 5.Failure to participate; suspension or revocation of license; enforcement. The 
84.30 	office may enforce this section and take enforcement action described in section 342.19, 
84.31 	including issuing administrative orders, embargoing products, and imposing civil penalties, 
84.32 	or suspend or revoke a medical cannabis combination business macrobusiness license if the 
84.33 	office determines that the business is no longer actively participating in the medical cannabis 
85.1 	market by not making available in stock at each retail location high medical need products 
85.2 	identified by the office or otherwise failing to comply with the requirements of this section 
85.3 	or this chapter. The office may, by rule, establish minimum requirements related to cannabis 
85.4 	cultivation, manufacturing of medical cannabinoid products, retail sales of medical cannabis 
85.5 	flower and medical cannabinoid products, and other relevant criteria to demonstrate active 
85.6 	participation in the medical cannabis market.
85.7 		Subd. 6.Operations. A medical cannabis combination business must comply with the 
85.8 	relevant requirements of sections 342.25, 342.26, 342.27, and 342.51, subdivisions 2 to 5.
85.9 		Subd. 7.Transportation Internal transporter endorsement. (a) A medical cannabis 
85.10 	combination business macrobusiness may obtain an internal transporter endorsement to
85.11 	transport immature cannabis plants and seedlings, cannabis flower, cannabis products, 
85.12 	artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp 
85.13 	edibles, and hemp-derived consumer products between facilities owned by the license holder
85.14 	if the medical cannabis combination business macrobusiness:
85.15 	(1) provides the office with the information described in section 342.35, subdivision 2; 
85.16 	and
85.17 	(2) complies with the requirements of section 342.36.
85.18 	(b) A cannabis macrobusiness with at least two medical cannabis endorsements may 
85.19 	apply for and obtain an external transporter endorsement to transport immature cannabis 
85.20 	plants and seedlings, cannabis flower, cannabis products, artificially derived cannabinoids, 
85.21 	hemp plant parts, hemp concentrate, lower-potency hemp edibles, and hemp-derived 
85.22 	consumer products to other cannabis and hemp businesses if the cannabis macrobusiness:
85.23 	(1) provides the office with the information required under section 342.35, subdivision 
85.24 	2; and
85.25 	(2) complies with the requirements of section 342.36.
85.26 	(c) A cannabis macrobusiness with a medical cannabis endorsement is not required to 
85.27 	obtain an external transporter endorsement to transport immature cannabis plants and 
85.28 	seedlings, cannabis flower, cannabis products, lower-potency hemp edibles, hemp-derived 
85.29 	consumer products, medical cannabis flower, and medical cannabinoid products to a cannabis 
85.30 	testing facility.
85.31 		Subd. 8.Multiple licenses. (a) A person, cooperative, or business holding a cannabis 
85.32 	macrobusiness license may also hold a cannabis event organizer license.
86.1 	(b) Except as provided in paragraph (a),  a person, cooperative, or business holding a 
86.2 	cannabis macrobusiness license is prohibited from owning or operating any other cannabis 
86.3 	business or hemp business or holding more than one cannabis macrobusiness license.
86.4 	(c) For purposes of this subdivision, a restriction on the number or type of licenses that 
86.5 	a business may hold applies to every cooperative member or every director, manager, and 
86.6 	general partner of a cannabis business.
86.7 		Subd. 9.Conversion of licenses. (a) By January 1, 2027, the office must convert any 
86.8 	existing medical cannabis combination business licenses or applications to cannabis 
86.9 	macrobusiness licenses or applications.
86.10 	(b) Before January 1, 2030, the office may issue no more than eight cannabis 
86.11 	macrobusiness licenses.
86.12 		Subd. 10.Additional canopy. After the first license renewal, the office may authorize 
86.13 	an additional 2,000 square feet of plant canopy for a cannabis macrobusiness license holder 
86.14 	with a medical cannabis cultivation endorsement that cultivates cannabis at an indoor facility. 
86.15 	After the second license renewal, the office may authorize an additional 2,000 square feet 
86.16 	of plant canopy for a cannabis macrobusiness license holder with a medical cannabis 
86.17 	cultivation endorsement that cultivates cannabis at an indoor facility. After the third license 
86.18 	renewal, the office may authorize an additional 3,000 square feet of plant canopy for a 
86.19 	cannabis macrobusiness license holder with a medical cannabis cultivation endorsement 
86.20 	that cultivates cannabis at an indoor facility. The cannabis macrobusiness must be in good 
86.21 	standing with the office to be eligible for an authorization of additional plant canopy.

86.22 	EFFECTIVE DATE. This section is effective January 1, 2027, except subdivision 1, 
86.23 	paragraph (a), clause (6), is effective the day following final enactment.

86.24 	Sec. 104. Minnesota Statutes 2025 Supplement, section 342.61, subdivision 4, is amended 
86.25 	to read:
86.26 		Subd. 4.Testing of samples; disclosures. (a) On a schedule determined by the office, 
86.27 	every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
86.28 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
86.29 	hemp edible manufacturer, or medical cannabis combination business macrobusiness shall 
86.30 	make each batch of cannabis flower, cannabis products, artificially derived cannabinoids, 
86.31 	lower-potency hemp edibles, or hemp-derived consumer products grown, manufactured, or 
86.32 	imported by the cannabis business or hemp business available to a cannabis testing facility.
87.1 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
87.2 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
87.3 	hemp edible manufacturer, or medical cannabis combination business macrobusiness must 
87.4 	disclose all known information regarding pesticides, fertilizers, solvents, or other foreign 
87.5 	materials, including but not limited to catalysts used in creating artificially derived 
87.6 	cannabinoids, applied or added to the batch of cannabis flower, cannabis products, artificially 
87.7 	derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products 
87.8 	subject to testing. Disclosure must be made to the cannabis testing facility and must include 
87.9 	information about all applications by any person, whether intentional or accidental.
87.10 	(c) A cannabis business license holder shall select one or more representative samples 
87.11 	from each batch, test the samples for the presence of contaminants, and test the samples for 
87.12 	potency and homogeneity and to allow the cannabis flower, cannabis product, artificially 
87.13 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be 
87.14 	accurately labeled with its cannabinoid profile. Testing for contaminants must include testing 
87.15 	for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide 
87.16 	residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include 
87.17 	testing for other contaminants. A cannabis testing facility must destroy or return to the 
87.18 	cannabis business or hemp business license holder any part of the sample that remains after 
87.19 	testing.

87.20 	EFFECTIVE DATE. This section is effective January 1, 2027.

87.21 	Sec. 105. Minnesota Statutes 2024, section 342.61, subdivision 5, is amended to read:
87.22 		Subd. 5.Test results. (a) If a sample meets the applicable testing standards, a cannabis 
87.23 	testing facility shall issue a certification to a cannabis microbusiness, cannabis 
87.24 	mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an 
87.25 	endorsement to import products, lower-potency hemp edible manufacturer, or medical
87.26 	cannabis combination business macrobusiness and the cannabis business or hemp business 
87.27 	may then sell or transfer the batch of cannabis flower, cannabis products, artificially derived 
87.28 	cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products from which 
87.29 	the sample was taken to another cannabis business or hemp business, or offer the cannabis 
87.30 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products 
87.31 	for sale to customers or patients. If a sample does not meet the applicable testing standards 
87.32 	or if the testing facility is unable to test for a substance identified pursuant to subdivision 
87.33 	4, paragraph (b), the batch from which the sample was taken shall be subject to procedures 
87.34 	established by the office for such batches, including destruction, remediation, or retesting.
88.1 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
88.2 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
88.3 	hemp edible manufacturer, or medical cannabis combination business macrobusiness must 
88.4 	maintain the test results for cannabis flower, cannabis products, artificially derived 
88.5 	cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products grown, 
88.6 	manufactured, or imported by that cannabis business or hemp business for at least five years 
88.7 	after the date of testing.
88.8 	(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
88.9 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
88.10 	hemp edible manufacturer, or medical cannabis combination business macrobusiness shall 
88.11 	make test results maintained by that cannabis business or hemp business available for review 
88.12 	by any member of the public, upon request. Test results made available to the public must 
88.13 	be in plain language.

88.14 	EFFECTIVE DATE. This section is effective January 1, 2027.

88.15 	Sec. 106. Minnesota Statutes 2024, section 342.61, is amended by adding a subdivision 
88.16 	to read:
88.17 		Subd. 6.Testing of high medical need products. A cannabis testing facility licensed 
88.18 	under this chapter may establish a process to prioritize the testing of high medical need 
88.19 	products as identified by the office.

88.20 	EFFECTIVE DATE. This section is effective January 1, 2027.

88.21 	Sec. 107. Minnesota Statutes 2025 Supplement, section 342.62, subdivision 2, is amended 
88.22 	to read:
88.23 		Subd. 2.Packaging requirements. (a) Except as provided in paragraph (b), All cannabis 
88.24 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
88.25 	sold to customers or patients must be:
88.26 	(1) prepackaged in packaging or a container that is child-resistant, tamper-evident, and 
88.27 	opaque; or.
88.28 	(2) placed in packaging or a container that is plain, child-resistant, tamper-evident, and 
88.29 	opaque at the final point of sale to a customer.
88.30 	(b) All cannabis flower sold to customers or patients must be prepackaged unless the 
88.31 	business selling the cannabis flower holds a cannabis flower packaging endorsement.
89.1 	(b) (c) The requirement that packaging be child-resistant does not apply to a 
89.2 	lower-potency hemp edible that is intended to be consumed as a beverage.
89.3 	(c) (d) If a cannabis product, lower-potency hemp edible, or a hemp-derived consumer 
89.4 	product is packaged in a manner that includes more than a single serving, each serving must 
89.5 	be indicated by scoring, wrapping, or other indicators designating the individual serving 
89.6 	size.
89.7 	(d) (e) Notwithstanding paragraph (c) (d), any edible cannabinoid products that are 
89.8 	intended to be combined with food or beverage products before consumption must indicate 
89.9 	a single serving using one of the following methods:
89.10 	(1) the product is packaged in individual servings;
89.11 	(2) the product indicates a single serving by scoring or use of another indicator that 
89.12 	appears on the product; or
89.13 	(3) the product is sold with a calibrated dropper, measuring spoon, or similar device for 
89.14 	measuring a single serving.
89.15 	(e) (f) A package containing multiple servings of a lower-potency hemp edible that is 
89.16 	not intended to be consumed as a beverage must not contain:
89.17 	(1) more than 50 milligrams of delta-9 tetrahydrocannabinol;
89.18 	(2) more than 1,000 milligrams of cannabidiol, 1,000 milligrams of cannabigerol, 1,000 
89.19 	milligrams of cannabinol, or 1,000 milligrams of cannabichromene:;
89.20 	(3) more than the established limit of any other cannabinoid authorized by the office; 
89.21 	or
89.22 	(4) any combination of those cannabinoids that exceeds the identified amounts for each 
89.23 	cannabinoid for the applicable product category.
89.24 	(f) (g) A single single-serving container containing a lower-potency hemp edible product
89.25 	that is intended to be consumed as a beverage must not contain:
89.26 	(1) more than ten milligrams of delta-9 tetrahydrocannabinol;
89.27 	(2) more than 200 milligrams of cannabidiol, cannabigerol, cannabinol, or 
89.28 	cannabichromene;
89.29 	(3) more than the established limit of any other cannabinoid authorized by the office; 
89.30 	or
90.1 	(4) any combination of those cannabinoids that exceeds the identified amounts for the 
90.2 	applicable product category.
90.3 	(g) (h) Edible cannabis products and lower-potency hemp edibles containing more than 
90.4 	a single serving must be prepackaged or placed at the final point of sale in packaging or a 
90.5 	container that is resealable.
90.6 	(i) A container containing multiple servings of a lower-potency hemp edible product 
90.7 	that is bottled or otherwise placed in a resealable, child-resistant container intended to be 
90.8 	consumed as a beverage must not contain:
90.9 	(1) less than 750 milliliters;
90.10 	(2) more than five milligrams of delta-9 tetrahydrocannabinol per serving;
90.11 	(3) more than 17 servings;
90.12 	(4) more than 400 milligrams of cannabidiol, cannabigerol, cannabinol, or 
90.13 	cannabichromene;
90.14 	(5) more than the established limit of any other cannabinoid authorized by the office; 
90.15 	or
90.16 	(6) any combination of those cannabinoids that exceeds the identified amounts for the 
90.17 	applicable product category.

90.18 	Sec. 108. Minnesota Statutes 2025 Supplement, section 342.63, subdivision 2, is amended 
90.19 	to read:
90.20 		Subd. 2.Content of label; cannabis. All cannabis flower and hemp-derived consumer 
90.21 	products that consist of hemp plant parts sold to customers or patients must have affixed 
90.22 	on the packaging or container of the cannabis flower or hemp-derived consumer product a 
90.23 	label that contains at least the following information:
90.24 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
90.25 	cannabis cultivator, medical cannabis combination business macrobusiness, or industrial 
90.26 	hemp grower where the cannabis flower or hemp plant part was cultivated;
90.27 	(2) the net weight of cannabis flower or hemp plant parts in the package or container;
90.28 	(3) the batch number;
90.29 	(4) the cannabinoid profile;
91.1 	(5) a universal symbol established by the office indicating that the package or container 
91.2 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
91.3 	hemp-derived consumer product;
91.4 	(6) verification that the cannabis flower or hemp plant part was tested according to 
91.5 	section 342.61 and that the cannabis flower or hemp plant part complies with the applicable 
91.6 	standards;
91.7 	(7) information on the usage of the cannabis flower or hemp-derived consumer product
91.8 	the type of product, including directions on usage;
91.9 	(8) the following statement: "Keep this product out of reach of children." the warning 
91.10 	symbol established by the office indicating that the product is not for children and information 
91.11 	about the Minnesota Poison Control Center; and
91.12 	(9) any other statements or information required by the office.

91.13 	Sec. 109. Minnesota Statutes 2025 Supplement, section 342.63, subdivision 3, is amended 
91.14 	to read:
91.15 		Subd. 3.Content of label; cannabinoid products excluding lower-potency hemp 
91.16 	edibles. (a) All cannabis products, lower-potency hemp edibles, hemp concentrate, 
91.17 	hemp-derived consumer products other than products subject to the requirements under 
91.18 	subdivision 2, and medical cannabinoid products, and hemp-derived topical products sold 
91.19 	to customers or patients must have affixed to the packaging or container of the cannabis
91.20 	product a label that contains at least the following information:
91.21 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
91.22 	cannabis cultivator, medical cannabis combination business, or industrial hemp grower that 
91.23 	cultivated the cannabis flower or hemp plant parts used in the cannabis product, 
91.24 	lower-potency hemp edible, hemp-derived consumer product, or medical cannabinoid 
91.25 	product;
91.26 	(2) (1) the name and license number of the cannabis microbusiness, cannabis 
91.27 	mezzobusiness, cannabis manufacturer, lower-potency hemp edible manufacturer, medical
91.28 	cannabis combination business macrobusiness, or industrial hemp grower that manufactured 
91.29 	the cannabis concentrate, hemp concentrate, or artificially derived cannabinoid and, if 
91.30 	different, the name and license number of the cannabis microbusiness, cannabis 
91.31 	mezzobusiness, cannabis manufacturer, lower-potency hemp edible manufacturer, or medical
91.32 	cannabis combination business macrobusiness that manufactured the product;
92.1 	(3) (2) the net weight of the cannabis product, lower-potency hemp edible, or 
92.2 	hemp-derived consumer product in the package or container;
92.3 	(4) (3) the type of cannabis product, lower-potency hemp edible, or hemp-derived 
92.4 	consumer product including directions on usage;
92.5 	(5) (4) the batch number;
92.6 	(6) (5) the serving size;
92.7 	(7) (6) the cannabinoid profile per serving and in total;
92.8 	(8) (7) a list of ingredients;
92.9 	(9) (8) a universal symbol established by the office indicating that the package or 
92.10 	container contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
92.11 	hemp-derived consumer product;
92.12 	(10) (9) a warning symbol developed by the office in consultation with the commissioner 
92.13 	of health and the Minnesota Poison Control System that: established by the office indicating 
92.14 	that the product is not for children and information about the Minnesota Poison Control 
92.15 	Center;
92.16 	(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
92.17 	(ii) is in a highly visible color;
92.18 	(iii) includes a visual element that is commonly understood to mean a person should 
92.19 	stop;
92.20 	(iv) indicates that the product is not for children; and
92.21 	(v) includes the phone number of the Minnesota Poison Control System;
92.22 	(11) (10) verification that the cannabis product, lower-potency hemp edible, hemp-derived 
92.23 	consumer product, or medical cannabinoid product was tested according to section 342.61 
92.24 	and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product, 
92.25 	or medical cannabinoid product complies with the applicable standards; and
92.26 	(12) information on the usage of the product;
92.27 	(13) the following statement: "Keep this product out of reach of children."; and
92.28 	(14) (11) any other statements or information required by the office.
93.1 	(b) The office may by rule establish alternative labeling requirements for lower-potency 
93.2 	hemp edibles that are imported into the state if those requirements provide consumers with 
93.3 	information that is substantially similar to the information described in paragraph (a).
93.4 	(b) A ratio hemp-infused cannabis product as defined in section 342.01, subdivision 
93.5 	63a, must include on the label the following statement: "This product contains nonintoxicating 
93.6 	cannabinoids derived from hemp."

93.7 	EFFECTIVE DATE. Paragraph (a) is effective August 1, 2026. Paragraph (b) is effective 
93.8 	January 1, 2027.

93.9 	Sec. 110. Minnesota Statutes 2024, section 342.63, subdivision 4, is amended to read:
93.10 		Subd. 4.Additional content of label; medical cannabis flower and medical 
93.11 	cannabinoid products. In addition to the applicable requirements for labeling under 
93.12 	subdivision 2 or 3, all medical cannabis flower and medical cannabinoid products must 
93.13 	include at least the following information on the label affixed to the packaging or container 
93.14 	of the medical cannabis flower or medical cannabinoid product:
93.15 	(1) the patient's name and date of birth;
93.16 	(2) if applicable, the name and date of birth of the patient's registered designated caregiver 
93.17 	or, if listed on the registry verification, the name of the patient's parent, legal guardian, or 
93.18 	spouse, if applicable; and
93.19 	(3) the patient's registry identification number.

93.20 	Sec. 111. Minnesota Statutes 2025 Supplement, section 342.63, subdivision 5, is amended 
93.21 	to read:
93.22 		Subd. 5.Content of label; hemp-derived topical products. (a) All hemp-derived topical 
93.23 	products sold to customers must have affixed to the packaging or container of the product 
93.24 	a label that contains includes at least the following information:
93.25 	(1) the manufacturer name, location, phone number, and website;
93.26 	(2) the name and address of the independent, accredited laboratory used by the 
93.27 	manufacturer to test the product;
93.28 	(3) the net weight or volume of the product in the package or container;
93.29 	(4) the type of topical product;
94.1 	(5) the amount or percentage of cannabidiol, cannabigerol, or any other cannabinoid, 
94.2 	derivative, or extract of hemp, per serving and in total;
94.3 	(6) a list of ingredients;
94.4 	(7) a statement that the product does not claim to diagnose, treat, cure, or prevent any 
94.5 	disease and that the product has not been evaluated or approved by the United States Food 
94.6 	and Drug Administration, unless the product has been so approved; and
94.7 	(8) any other statements or information required by the office.
94.8 	(b) All hemp-derived topical products that contain THC must have affixed to the product's 
94.9 	packaging or container a label that includes at least the following information:
94.10 	(1) the information required in paragraph (a);
94.11 	(2) the amount or percentage of THC per serving and the total THC;
94.12 	(3) the universal symbol established by the office indicating that the package or container 
94.13 	contains a product containing THC;
94.14 	(4) the warning symbol established by the office indicating that the product is not for 
94.15 	children and information about the Minnesota Poison Control Center; and
94.16 	(5) information that the product was tested according to section 342.61, subdivision 4.

94.17 	Sec. 112. Minnesota Statutes 2025 Supplement, section 342.63, subdivision 6, is amended 
94.18 	to read:
94.19 		Subd. 6.Additional information. (a) A cannabis microbusiness, cannabis mezzobusiness, 
94.20 	cannabis retailer, or medical cannabis combination business macrobusiness must provide 
94.21 	customers and patients with the following information:
94.22 	(1) factual information about impairment effects and the expected timing of impairment 
94.23 	effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products, 
94.24 	lower-potency hemp edibles, and hemp-derived consumer products;
94.25 	(2) a statement that customers and patients must not operate a motor vehicle or heavy 
94.26 	machinery while under the influence of cannabis flower, cannabis products, lower-potency 
94.27 	hemp edibles, and hemp-derived consumer products;
94.28 	(3) resources customers and patients may consult to answer questions about cannabis 
94.29 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
94.30 	products, and any side effects and adverse effects;
95.1 	(4) contact information for the poison control center and a safety hotline or website for 
95.2 	customers to report and obtain advice about side effects and adverse effects of cannabis 
95.3 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
95.4 	products;
95.5 	(5) substance use disorder treatment options; and
95.6 	(6) any other information specified by the office.
95.7 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical
95.8 	cannabis combination business macrobusiness may include the information described in 
95.9 	paragraph (a) by:
95.10 	(1) including the information on the label affixed to the packaging or container of cannabis 
95.11 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
95.12 	products;
95.13 	(2) posting the information in the premises of the cannabis microbusiness, cannabis 
95.14 	mezzobusiness, cannabis retailer, or medical cannabis combination business macrobusiness; 
95.15 	or
95.16 	(3) providing the information on a separate document or pamphlet provided to customers 
95.17 	or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency 
95.18 	hemp edible, or a hemp-derived consumer product.

95.19 	EFFECTIVE DATE. This section is effective January 1, 2027.

95.20 	Sec. 113. Minnesota Statutes 2024, section 342.63, is amended by adding a subdivision 
95.21 	to read:
95.22 		Subd. 7.Labeling of lower-potency hemp edibles. (a) All lower-potency hemp edible 
95.23 	products must have affixed to the packaging or container a label that includes at least the 
95.24 	following information:
95.25 	(1) information about the business that cultivated the hemp parts used in the product, 
95.26 	including either:
95.27 	(i) the business's name, the business's address, and the country and state, if applicable, 
95.28 	where the business operates; or
95.29 	(ii) the business's name and business's license number;
95.30 	(2) information about the business that manufactured the hemp concentrate and artificially 
95.31 	derived cannabinoids used in the product, including either:
96.1 	(i) the business's name, the business's address, and the country and state, if applicable, 
96.2 	where the business operates; or
96.3 	(ii) the business's name and the business's license number;
96.4 	(3) the net weight of the lower-potency hemp edible product in the package or container;
96.5 	(4) the batch number;
96.6 	(5) the serving size;
96.7 	(6) the cannabinoid profile per serving and total THC;
96.8 	(7) a list of ingredients;
96.9 	(8) the universal symbol established by the office indicating that the package or container 
96.10 	contains a product containing THC;
96.11 	(9) the warning symbol established by the office indicating that the product is not for 
96.12 	children and information about the Minnesota Poison Control Center;
96.13 	(10) verification that the lower-potency hemp edible was tested according to section 
96.14 	342.61;
96.15 	(11) directions on the usage of the product; and
96.16 	(12) any other statements or information required by the office.
96.17 	(b) A cannabis or hemp business selling lower-potency hemp edibles to customers may 
96.18 	provide customers with the required information in paragraph (a), clauses (1) and (2), through 
96.19 	the use of a scannable barcode affixed to the label of the product if the barcode is accurate 
96.20 	and active at all times.
96.21 	(c) The label of a lower-potency hemp edible product that contains only nonintoxicating 
96.22 	cannabinoids approved by the office and that does not include THC is not required to include 
96.23 	the universal symbol in paragraph (a), clause (8).

96.24 	Sec. 114. Minnesota Statutes 2024, section 342.66, subdivision 3, is amended to read:
96.25 		Subd. 3.Approved cannabinoids. (a) Products manufactured, marketed, distributed, 
96.26 	and sold under this section may contain cannabidiol or cannabigerol. Except as provided 
96.27 	in paragraph (c), products may not contain any other cannabinoid unless approved by the 
96.28 	office.
97.1 	(b) The office may approve any cannabinoid, other than any tetrahydrocannabinol, and 
97.2 	authorize its use in manufacturing, marketing, distribution, and sales under this section if 
97.3 	the office determines that the cannabinoid is a nonintoxicating cannabinoid.
97.4 	(c) A product manufactured, marketed, distributed, and sold under this section may 
97.5 	contain cannabinoids other than cannabidiol, cannabigerol, or any other cannabinoid approved 
97.6 	by the office provided that the cannabinoids arehemp concentrate that is naturally occurring 
97.7 	in hemp plants or hemp plant parts and the total of all other cannabinoids present in a product 
97.8 	does not exceed one milligram per package must not contain more than 0.3 percent total 
97.9 	THC.

97.10 	Sec. 115. Minnesota Statutes 2024, section 342.80, is amended to read:
97.11 	342.80 LAWFUL ACTIVITIES.
97.12 	(a) Notwithstanding any law to the contrary, the cultivation, manufacturing, possessing, 
97.13 	and selling of cannabis flower, cannabis products, artificially derived cannabinoids, 
97.14 	lower-potency hemp edibles, and hemp-derived consumer products by a licensed cannabis 
97.15 	business or hemp business in conformity with the rights granted by a cannabis business 
97.16 	license or hemp business license is lawful and may not be the grounds for the seizure or 
97.17 	forfeiture of property, arrest or prosecution, or search or inspections except as provided by 
97.18 	this chapter.
97.19 	(b) A person acting as an agent of a cannabis microbusiness, cannabis mezzobusiness, 
97.20 	cannabis retailer, medical cannabis combination business macrobusiness, or lower-potency 
97.21 	hemp edible retailer who sells or otherwise transfers cannabis flower, cannabis products, 
97.22 	lower-potency hemp edibles, or hemp-derived consumer products to a person under 21 years 
97.23 	of age is not subject to arrest, prosecution, or forfeiture of property if the person complied 
97.24 	with section 342.27, subdivision 4, and any rules promulgated pursuant to this chapter.

97.25 	EFFECTIVE DATE. This section is effective January 1, 2027.

97.26 	Sec. 116. PSILOCYBIN THERAPEUTIC USE PROGRAM REPORT.
 97.27 	(a) By January 15, 2027, the Office of Cannabis Management must publish a report with 
97.28 	recommendations on administering a psilocybin therapeutic use program in which individuals 
97.29 	21 years of age and older who have qualifying medical conditions may access and use 
97.30 	psilocybin under supervision of a facilitator at a treatment facility.
97.31 	(1) Informed by the Minnesota Psychedelic Medicine Task Force's Legislative Report 
97.32 	published January 1, 2025, the office's report must assess the feasibility of administering a 
98.1 	psilocybin therapeutic use program, describe the viability of and methods for determining 
98.2 	and updating a list of qualifying medical conditions, and include recommendations for 
98.3 	program development and administration.
98.4 	(2) In developing the report, the office may consult with other federal, state, or local 
98.5 	agencies.
98.6 	(3) The office must submit the report to the chairs, co-chairs, and ranking members of 
98.7 	the legislative committees and divisions with jurisdiction over cannabis policy, health, and 
98.8 	veterans affairs by January 15, 2027.
98.9 	(b) The office must regularly analyze the availability of federal programs to provide 
98.10 	funding to support state efforts to establish a psilocybin therapeutic use program for 
98.11 	individuals 21 years of age and older who have qualifying medical conditions to access and 
98.12 	use psilocybin under medical supervision.

98.13 	Sec. 117. REVISOR INSTRUCTION.
 98.14 	The revisor of statutes must renumber Minnesota Statutes, section 342.515, as Minnesota 
98.15 	Statutes, section 342.295, and make any necessary cross-reference changes consistent with 
98.16 	this renumbering.

98.17 	EFFECTIVE DATE. This section is effective January 1, 2027.

98.18 	Sec. 118. REPEALER.
 98.19 	(a) Minnesota Statutes 2024, section 151.72, subdivisions 1, 2, 4, 5, 5b, 5c, 6, and 7, are 
98.20 	repealed.
98.21 	(b) Minnesota Statutes 2024, section 342.51, subdivision 1, is repealed.
98.22 	(c) Minnesota Statutes 2025 Supplement, section 151.72, subdivisions 3 and 5a, are 
98.23 	repealed.

98.24 	EFFECTIVE DATE. Paragraph (a) and paragraph (c) are effective the day following 
98.25 	final enactment. Paragraph (b) is effective January 1, 2027.

98.26 	Sec. 119. EFFECTIVE DATE.
 98.27 	Sections in this bill are effective August 1, 2026, unless otherwise stated or regarding 
98.28 	the creation of a cannabis macrobusiness and conversion of medical cannabis combination 
98.29 	businesses. New and stricken language in relation to the creation of a cannabis macrobusiness 
98.30 	and conversion of medical cannabis combination businesses are effective January 1, 2027.

APPENDIX 

Repealed Minnesota Statutes: UES4401-1 

151.72 SALE OF CERTAIN CANNABINOID PRODUCTS.Subdivision 1.Definitions. 
For the purposes of this section, the following terms have the meanings given. 

(a) "Artificially derived cannabinoid" means a cannabinoid extracted from a hemp plant or hemp plant parts with a chemical makeup that is changed after extraction to create a different cannabinoid or other chemical compound by applying a catalyst other than heat or light. Artificially derived cannabinoid includes but is not limited to any tetrahydrocannabinol created from cannabidiol. 

(b) "Batch" means a specific quantity of a specific product containing cannabinoids derived from hemp, including an edible cannabinoid product, that is manufactured at the same time and using the same methods, equipment, and ingredients that is uniform and intended to meet specifications for identity, strength, purity, and composition, and that is manufactured, packaged, and labeled according to a single batch production record executed and documented. 

(c) "Certified hemp" means hemp plants that have been tested and found to meet the requirements of chapter 18K and the rules adopted thereunder. 

(d) "Distributor" means a person who sells, arranges a sale, or delivers a product containing cannabinoids derived from hemp, including an edible cannabinoid product, that the person did not manufacture to a retail establishment for sale to consumers. Distributor does not include a common carrier used only to complete delivery to a retailer. 

(e) "Edible cannabinoid product" means any product that is intended to be eaten or consumed as a beverage by humans, contains a cannabinoid in combination with food ingredients, and is not a drug. 

(f) "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision 3. 

(g) "Label" has the meaning given in section 151.01, subdivision 18. 

(h) "Labeling" means all labels and other written, printed, or graphic matter that are: 

(1) affixed to the immediate container in which a product regulated under this section is sold; 

(2) provided, in any manner, with the immediate container, including but not limited to outer containers, wrappers, package inserts, brochures, or pamphlets; or 

(3) provided on that portion of a manufacturer's website that is linked by a scannable barcode or matrix barcode. 

(i) "Matrix barcode" means a code that stores data in a two-dimensional array of geometrically shaped dark and light cells capable of being read by the camera on a smartphone or other mobile device. 

(j) "Nonintoxicating cannabinoid" means substances extracted from certified hemp plants that do not produce intoxicating effects when consumed by any route of administration. 

(k) "Office" means the director of the Office of Cannabis Management. 

(l) "Synthetic cannabinoid" means a substance with a similar chemical structure and pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp plants, or hemp plant parts and is instead created or produced by chemical or biochemical synthesis. 

Subd. 2.Scope. 
(a) This section applies to the sale of any product that contains cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended for human or animal consumption by any route of administration. 

(b) This section does not apply to any product dispensed by a registered medical cannabis manufacturer pursuant to sections 152.22 to 152.37. 

(c) The office must have no authority over food products, as defined in section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from hemp. 

Subd. 3.Sale of cannabinoids derived from hemp. 
(a) Notwithstanding any other section of this chapter, a product containing nonintoxicating cannabinoids, including an edible cannabinoid product, may be sold for human or animal consumption only if all of the requirements of this section are met. A product sold for human or animal consumption must not contain more than 0.3 percent of any tetrahydrocannabinol and an edible cannabinoid product must not contain an amount of any tetrahydrocannabinol that exceeds the limits established in subdivision 5a, paragraph (f). 

(b) A product containing nonintoxicating cannabinoids, other than an edible cannabinoid product, may be sold for human or animal consumption only if it is intended for application externally to a part of the body of a human or animal. Such a product must not be manufactured, marketed, distributed, or intended to be consumed: 

(1) by combustion or vaporization of the product and inhalation of smoke, aerosol, or vapor from the product; 

(2) through chewing, drinking, or swallowing; or 

(3) through injection or application to nonintact skin or a mucous membrane, except for products applied sublingually. 

(c) No other substance extracted or otherwise derived from hemp may be sold for human consumption if the substance is intended: 

(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or other animals; or 

(2) to affect the structure or any function of the bodies of humans or other animals. 

(d) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise derived from hemp may be sold to any individual who is under the age of 21. 

(e) Products that meet the requirements of this section are not controlled substances under section 152.02. 

(f) Products may be sold for on-site consumption if all of the following conditions are met: 

(1) the retailer must also hold an on-sale license issued under chapter 340A; 

(2) products, other than products that are intended to be consumed as a beverage, must be served in original packaging, but may be removed from the products' packaging by customers and consumed on site; 

(3) products must not be sold to a customer who the retailer knows or reasonably should know is intoxicated; 

(4) products must not be permitted to be mixed with an alcoholic beverage; and 

(5) products that have been removed from packaging must not be removed from the premises. 

(g) Edible cannabinoid products that are intended to be consumed as a beverage may be served outside of the products' packaging if the information that is required to be contained on the label of an edible cannabinoid product is posted or otherwise displayed by the retailer. 

Subd. 4.Testing requirements. 
(a) A manufacturer of a product regulated under this section must submit representative samples of each batch of the product to an independent, accredited laboratory in order to certify that the product complies with the standards adopted by the office. Testing must be consistent with generally accepted industry standards for herbal and botanical substances, and, at a minimum, the testing must confirm that the product: 

(1) contains the amount or percentage of cannabinoids that is stated on the label of the product; 

(2) does not contain more than trace amounts of any mold, residual solvents or other catalysts, pesticides, fertilizers, or heavy metals; and 

(3) does not contain more than 0.3 percent of any tetrahydrocannabinol. 

(b) A manufacturer of a product regulated under this section must disclose all known information regarding pesticides, fertilizers, solvents, or other foreign materials applied to industrial hemp or added to industrial hemp during any production or processing stages of any batch from which a representative sample has been sent for testing, including any catalysts used to create artificially derived cannabinoids. The disclosure must be made to the laboratory performing testing or sampling and, upon request, to the office. The disclosure must include all information known to the manufacturer regardless of whether the application or addition was made intentionally or accidentally, or by the manufacturer or any other person. 

(c) Upon the request of the office, the manufacturer of the product must provide the office with the results of the testing required in this section. 

(d) The office may determine that any testing laboratory that does not operate formal management systems under the International Organization for Standardization is not an accredited laboratory and require that a representative sample of a batch of the product be retested by a testing laboratory that meets this requirement. 

(e) Testing of the hemp from which the nonintoxicating cannabinoid was derived, or possession of a certificate of analysis for such hemp, does not meet the testing requirements of this section. 

Subd. 5.Labeling requirements. 
(a) A product regulated under this section must bear a label that contains, at a minimum: 

(1) the name, location, contact phone number, and website of the manufacturer of the product; 

(2) the name and address of the independent, accredited laboratory used by the manufacturer to test the product; 

(3) the batch number; and 

(4) an accurate statement of the amount or percentage of cannabinoids found in each unit of the product meant to be consumed. 

(b) The information in paragraph (a) may be provided on an outer package if the immediate container that holds the product is too small to contain all of the information. 

(c) The information required in paragraph (a) may be provided through the use of a scannable barcode or matrix barcode that links to a page on the manufacturer's website if that page contains all of the information required by this subdivision. 

(d) The label must also include a statement stating that the product does not claim to diagnose, treat, cure, or prevent any disease and has not been evaluated or approved by the United States Food and Drug Administration (FDA) unless the product has been so approved. 

(e) The information required by this subdivision must be prominently and conspicuously placed on the label or displayed on the website in terms that can be easily read and understood by the consumer. 

(f) The labeling must not contain any claim that the product may be used or is effective for the prevention, treatment, or cure of a disease or that it may be used to alter the structure or function of human or animal bodies, unless the claim has been approved by the FDA. 

Subd. 5a.Additional requirements for edible cannabinoid products. 
(a) In addition to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid must meet the requirements of this subdivision. 

(b) An edible cannabinoid product must not: 

(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person, animal, or fruit that appeals to children; 

(2) be modeled after a brand of products primarily consumed by or marketed to children; 

(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a commercially available candy or snack food item; 

(4) be substantively similar to a meat food product; poultry food product as defined in section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 7; 

(5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved by the United States Food and Drug Administration for use in food; 

(6) be packaged in a way that resembles the trademarked, characteristic, or product-specialized packaging of any commercially available food product; or 

(7) be packaged in a container that includes a statement, artwork, or design that could reasonably mislead any person to believe that the package contains anything other than an edible cannabinoid product. 

(c) An edible cannabinoid product must be prepackaged in packaging or a container that is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The requirement that packaging be child-resistant does not apply to an edible cannabinoid product that is intended to be consumed as a beverage. 

(d) If an edible cannabinoid product, other than a product that is intended to be consumed as a beverage, is intended for more than a single use or contains multiple servings, each serving must be indicated by scoring, wrapping, or other indicators designating the individual serving size that appear on the edible cannabinoid product. If it is not possible to indicate a single serving by scoring or use of another indicator that appears on the product, the edible cannabinoid product may not be packaged in a manner that includes more than a single serving in each container, except that a calibrated dropper, measuring spoon, or similar device for measuring a single serving, when sold with the product, may be used for any edible cannabinoid products that are intended to be combined with food or beverage products prior to consumption. 

(e) A label containing at least the following information must be affixed to the packaging or container of all edible cannabinoid products sold to consumers: 

(1) the serving size; 

(2) the cannabinoid profile per serving and in total; 

(3) a list of ingredients, including identification of any major food allergens declared by name; and 

(4) the following statement: "Keep this product out of reach of children." 

(f) An edible cannabinoid product that is not intended to be consumed as a beverage must not contain more than five milligrams of any tetrahydrocannabinol in a single serving and must not contain more than a total of 50 milligrams of any tetrahydrocannabinol per package. 

(g) An edible cannabinoid product that is intended to be consumed as a beverage must not contain more than ten milligrams of any tetrahydrocannabinol in a single container. 

(h) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9 tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and HHC, unless the office authorizes use of the artificially derived cannabinoid in edible cannabinoid products. Edible cannabinoid products are prohibited from containing synthetic cannabinoids. 

(i) Every person selling edible cannabinoid products to consumers, other than products that are intended to be consumed as a beverage, must ensure that all edible cannabinoid products are displayed behind a checkout counter where the public is not permitted or in a locked case. 

Subd. 5b.Registration; prohibitions. 
(a) Every person selling an edible cannabinoid product to a consumer must be registered with the office. Existing registrations through the Department of Health must be transferred to the office by July 1, 2024. All other persons required to register must register in a form and manner established by the office. The sale of edible cannabinoid products by a person who is not registered with the office is prohibited and subject to the penalties in section 342.09, subdivision 6; any applicable criminal penalty; and any other applicable civil or administrative penalty. 

(b) The registration form must contain an attestation of compliance and each registrant must affirm that it is operating and will continue to operate in compliance with the requirements of this section and all other applicable state and local laws and ordinances. 

(c) The office must not charge a fee for registration under this subdivision. 

Subd. 5c.Age verification. 
(a) Prior to initiating a sale or otherwise providing an edible cannabinoid product to an individual, an employee of a retailer must verify that the individual is at least 21 years of age. 

(b) Proof of age may be established only by one of the following: 

(1) a valid driver's license or identification card issued by Minnesota, another state, or a province of Canada and including the photograph and date of birth of the licensed person; 

(2) a valid Tribal identification card as defined in section 171.072, paragraph (b); 

(3) a valid passport issued by the United States; 

(4) a valid instructional permit issued under section 171.05 to a person of legal age to purchase edible cannabinoid products, which includes a photograph and the date of birth of the person issued the permit; or 

(5) in the case of a foreign national, by a valid passport. 

(c) A registered retailer may seize a form of identification listed under paragraph (b) if the registered retailer has reasonable grounds to believe that the form of identification has been altered or falsified or is being used to violate any law. A registered retailer that seizes a form of identification as authorized under this paragraph must deliver it to a law enforcement agency within 24 hours of seizing it. 

Subd. 6.Noncompliant products; enforcement. 
(a) A product regulated under this section, including an edible cannabinoid product, shall be considered a noncompliant product if the product is offered for sale in this state or if the product is manufactured, imported, distributed, or stored with the intent to be offered for sale in this state in violation of any provision of this section, including but not limited to if: 

(1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance; 

(2) it has been produced, prepared, packed, or held under unsanitary conditions where it may have been rendered injurious to health, or where it may have been contaminated with filth; 

(3) its container is composed, in whole or in part, of any poisonous or deleterious substance that may render the contents injurious to health; 

(4) it contains any food additives, color additives, or excipients that have been found by the FDA to be unsafe for human or animal consumption; 

(5) it contains an amount or percentage of nonintoxicating cannabinoids that is different than the amount or percentage stated on the label; 

(6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits established in subdivision 5a, paragraph (f); or 

(7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers, or heavy metals. 

(b) A product regulated under this section shall be considered a noncompliant product if the product's labeling is false or misleading in any manner or in violation of the requirements of this section. 

(c) The office may assume that any product regulated under this section that is present in the state, other than a product lawfully possessed for personal use, has been manufactured, imported, distributed, or stored with the intent to be offered for sale in this state if a product of the same type and brand was sold in the state on or after July 1, 2023, or if the product is in the possession of a person who has sold any product in violation of this section. 

(d) The office may enforce this section, including enforcement against a manufacturer or distributor of a product regulated under this section, under section 342.19. 

(e) The office may enter into an interagency agreement with the commissioner of agriculture to perform inspections and take other enforcement actions on behalf of the office. 

Subd. 7.Violations; criminal penalties. 
(a) A person who does any of the following regarding a product regulated under this section is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than 364 days or to payment of a fine of not more than $3,000, or both: 

(1) knowingly alters or otherwise falsifies testing results; 

(2) intentionally alters or falsifies any information required to be included on the label of an edible cannabinoid product; or 

(3) intentionally makes a false material statement to the office. 

(b) A person who does any of the following on the premises of a registered retailer or another business that sells retail goods to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than 364 days or to payment of a fine of not more than $3,000, or both: 

(1) sells an edible cannabinoid product knowing that the product does not comply with the limits on the amount or types of cannabinoids that a product may contain; 

(2) sells an edible cannabinoid product knowing that the product does not comply with the applicable testing, packaging, or labeling requirements; or 

(3) sells an edible cannabinoid product to a person under the age of 21, except that it is an affirmative defense to a charge under this clause if the defendant proves by a preponderance of the evidence that the defendant reasonably and in good faith relied on proof of age as described in subdivision 5c. 

342.51 MEDICAL CANNABIS ENDORSEMENTS.Subdivision 1.Endorsement; authorized actions. 
(a) The office may issue a medical cannabis endorsement to a cannabis business authorizing the business to: 

(1) cultivate medical cannabis; 

(2) process medical cannabinoid products; or 

(3) sell or distribute medical cannabis flower and medical cannabinoid products to any person authorized to receive medical cannabis flower or medical cannabinoid products. 

(b) The office must issue a medical cannabis cultivation endorsement to a cannabis license holder if the license holder: 

(1) is authorized to cultivate cannabis; 

(2) submits a medical cannabis endorsement application to the office; and 

(3) otherwise meets all applicable requirements established by the office. 

(c) A medical cannabis cultivation endorsement entitles the license holder to grow cannabis plants within the approved amount of space from seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package and label cannabis flower as medical cannabis flower, sell medical cannabis flower to cannabis businesses with a medical cannabis endorsement, and perform other actions approved by the office. 

(d) The office must issue a medical cannabis processor endorsement to a cannabis license holder if the license holder: 

(1) is authorized to manufacture cannabis products; 

(2) submits a medical cannabis endorsement application to the office; and 

(3) otherwise meets all applicable requirements established by the office. 

(e) A medical cannabis processor endorsement entitles the license holder to: 

(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, and hemp concentrate from cannabis businesses with a medical cannabis cultivator endorsement or a medical cannabis processor endorsement; 

(2) purchase hemp plant parts from industrial hemp growers; 

(3) make cannabis concentrate from medical cannabis flower; 

(4) make hemp concentrate, including hemp concentrate with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight; 

(5) manufacture medical cannabinoid products; 

(6) package and label medical cannabinoid products for sale to cannabis businesses with a medical cannabis processer endorsement or a medical cannabis retailer endorsement; and 

(7) perform other actions approved by the office. 

(f) The office must issue a medical cannabis retailer endorsement to a cannabis license holder if the license holder: 

(1) submits a medical cannabis retail endorsement application to the office; 

(2) has at least one employee who earned a medical cannabis consultant certificate issued by the office and has completed the required training or has at least one employee who is a licensed pharmacist under chapter 151; and 

(3) otherwise meets all applicable requirements established by the office. 

(g) A medical cannabis retail endorsement entitles the license holder to purchase medical cannabis flower and medical cannabinoid products from cannabis businesses with medical cannabis cultivator endorsements and medical cannabis processor endorsements, and sell or distribute medical cannabis flower, medical cannabinoid products, and associated paraphernalia to any person authorized to receive medical cannabis flower or medical cannabinoid products. 

(h) A medical cannabis business with a medical cannabis retail endorsement must verify that all medical cannabis flower and medical cannabinoid products have passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabis flower and medical cannabinoid products before the cannabis business with a medical cannabis retail endorsement may distribute the medical cannabis flower or medical cannabinoid product to any person enrolled in the registry program.